{"meta":{"query_hash":"48e507805529","filters":{"venue":"Neurology and Therapy"},"cohort_total":99,"direct_labels_cover":0,"predictions_cover":99,"exported":99,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/48e507805529","api":"https://metacan.xera.ac/api/v1/cohort?venue=Neurology+and+Therapy"},"results":[{"id":"W1993130299","doi":"10.1007/s40120-013-0012-3","title":"Perampanel: What is its Place in the Management of Partial Onset Epilepsy?","year":2013,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research","keywords":"Perampanel; Epilepsy; Medicine; AMPA receptor; Adjunctive treatment; Dosing; Context (archaeology); Pharmacology; Neuroscience; Anesthesia; Glutamate receptor; Psychiatry; Psychology; Internal medicine; Receptor; Biology","score_opus":0.07848670123672485,"score_gpt":0.3740838144762321,"score_spread":0.29559711323950727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993130299","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003884298,0.9960665,0.000048168407,0.0026387153,0.000287416,0.000006741081,0.000024368415,0.0000032663056,0.00053644297],"genre_scores_gemma":[0.004426476,0.99253666,0.00025568463,0.0017185872,0.0007821018,0.000015707414,0.00003079233,0.0000025462466,0.0002314922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993703,0.00016988708,0.00016700775,0.000099026045,0.00015730217,0.00003655528],"domain_scores_gemma":[0.99677175,0.0016872704,0.00082539296,0.000046852754,0.0005075447,0.000161267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025706834,0.00047592667,0.0023844752,0.0017563801,0.00024062864,0.0019270153,0.0009919538,0.0018264307,0.00469909],"category_scores_gemma":[0.0037021104,0.00023706206,0.0008138321,0.0026144064,0.00086626614,0.0037975642,0.00042323206,0.001317191,0.0012995395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009570791,0.00007120718,0.0008582155,0.14680323,0.00040494563,0.0005632143,0.00031729293,0.0002401609,0.001984337,0.0035647487,0.018063305,0.82617235],"study_design_scores_gemma":[0.00066394144,0.001679662,0.007072818,0.26290014,0.0031567654,0.005157292,0.0017286555,0.0003869465,0.0011741273,0.0055926004,0.7103438,0.00014336272],"about_ca_topic_score_codex":0.0012736941,"about_ca_topic_score_gemma":0.0030117505,"teacher_disagreement_score":0.00469909,"about_ca_system_score_codex":0.0011403185,"about_ca_system_score_gemma":0.0025059937,"threshold_uncertainty_score":0.01572001},"labels":[],"label_agreement":null},{"id":"W1999230231","doi":"10.1007/s40120-012-0005-7","title":"Effect of Tetrabenazine on Motor Function in Patients with Huntington Disease","year":2012,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tetrabenazine; Huntington's disease; Neurology; Medicine; Motor function; Neuroscience; Disease; Physical medicine and rehabilitation; Internal medicine; Psychology; Psychiatry","score_opus":0.007995521505863837,"score_gpt":0.22744759279401863,"score_spread":0.2194520712881548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999230231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986828,0.000849002,0.000031266238,0.00004447648,0.0000061370197,0.0000114610675,0.000032644657,0.000007283292,0.00033491754],"genre_scores_gemma":[0.9994754,0.00019276931,0.00008110208,0.00003383879,0.000005380153,0.0000072051553,0.00005990058,8.583382e-7,0.00014362496],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99984944,0.000071080016,0.000015340058,0.000024607223,0.000023050963,0.000016484655],"domain_scores_gemma":[0.9996599,0.000113908056,0.00008887258,0.000015125529,0.00003254048,0.00008963131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036911937,0.00031097734,0.00050405745,0.00012637669,0.00020738934,0.00017292173,0.00012745023,0.0002263711,0.00069238665],"category_scores_gemma":[0.0009016142,0.00007961468,0.00021544247,0.00012398524,0.00016869747,0.00013726979,0.00012963603,0.00029907323,0.00010344355],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14170374,0.0050475816,0.59065676,0.0005260282,0.0013166605,0.0011080998,0.00056358374,0.0012436152,0.04893042,0.00005178512,0.0011115392,0.2077402],"study_design_scores_gemma":[0.0017934036,0.045939263,0.9472452,0.000023573306,0.00026795833,0.0005124977,0.00009854506,0.0006153489,0.0027638397,0.000030135425,0.00070048816,0.000009798181],"about_ca_topic_score_codex":0.0014618782,"about_ca_topic_score_gemma":0.0031702332,"teacher_disagreement_score":0.0014618782,"about_ca_system_score_codex":0.0002762859,"about_ca_system_score_gemma":0.0001974057,"threshold_uncertainty_score":0.00290668},"labels":[],"label_agreement":null},{"id":"W2004034787","doi":"10.1007/s40120-012-0001-y","title":"A Markov Model Approach Assessing the Cost of Illness of Generalized Anxiety Disorder in Canada","year":2012,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"GlaxoSmithKline","keywords":"Medicine; Generalized anxiety disorder; Pharmacotherapy; Absenteeism; Discontinuation; Anxiety; Psychiatry; Demography; Pediatrics; Psychology","score_opus":0.03323368080884807,"score_gpt":0.31709635684278187,"score_spread":0.2838626760339338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004034787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5793513,0.0065023135,0.2580297,0.012007226,0.00048403395,0.0020547835,0.039252076,0.0007340107,0.101584665],"genre_scores_gemma":[0.94556,0.0025126592,0.024866726,0.00034079858,0.000106398664,0.000730719,0.006579937,0.00009865121,0.01920422],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99872166,0.00042779362,0.00005420972,0.00017512101,0.00022947199,0.00039180883],"domain_scores_gemma":[0.99402267,0.003982019,0.0003483992,0.00009615744,0.0012673702,0.0002834657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025466138,0.0011256284,0.0014639887,0.0029457735,0.0017651713,0.0029081313,0.0027074327,0.0019152381,0.010578251],"category_scores_gemma":[0.011380932,0.0012200112,0.0016029014,0.0033024428,0.0010260879,0.0013030488,0.00135885,0.0019663367,0.00044948506],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009373676,0.000036715188,0.0073757237,0.0001029539,0.00009639937,0.0002267771,0.00008642479,0.9516843,0.00005821902,0.03153257,0.0035730472,0.005133123],"study_design_scores_gemma":[0.000033723005,0.000018356188,0.0018920221,0.000046054993,0.000049960334,0.000038720846,0.00009884763,0.98818433,0.000022271928,0.00780012,0.0017922011,0.000023353407],"about_ca_topic_score_codex":0.884969,"about_ca_topic_score_gemma":0.79616576,"teacher_disagreement_score":0.115031004,"about_ca_system_score_codex":0.030766327,"about_ca_system_score_gemma":0.028127663,"threshold_uncertainty_score":0.23141682},"labels":[],"label_agreement":null},{"id":"W2073883789","doi":"10.1007/s40120-015-0026-0","title":"Concurrent Use of Benzodiazepines and Antidepressants and the Risk of Motor Vehicle Accident in Older Drivers: A Nested Case–Control Study","year":2015,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Older Adults Driving Studies","field":"Health Professions","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Odds ratio; Cohort; Nested case-control study; Confidence interval; Internal medicine; Population; Logistic regression; Cohort study; Psychiatry; Environmental health","score_opus":0.06609463873192555,"score_gpt":0.3676319648305371,"score_spread":0.30153732609861156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073883789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990701,0.00034616957,0.00020230944,0.000018588335,0.000007564825,0.000028144179,0.00019630075,0.0000026296218,0.00012811366],"genre_scores_gemma":[0.9992124,0.00012772065,0.00023689828,0.00002564633,0.000009712745,0.000029069499,0.00024318595,0.0000014386748,0.000113867485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885833,0.00031403216,0.00010758884,0.00038339876,0.00023337822,0.000103241764],"domain_scores_gemma":[0.9977982,0.00039682625,0.00078070443,0.00029835882,0.0004538197,0.00027223406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014574239,0.00033391867,0.00047021126,0.0006523939,0.000702048,0.000684459,0.00057894504,0.00042768894,0.00073975656],"category_scores_gemma":[0.0030548077,0.00051836204,0.000721926,0.0007072132,0.00038495593,0.00025095386,0.0003850475,0.00037624603,0.000120769815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025031378,0.00010385715,0.9976604,0.000022501914,0.00035780435,0.0001871348,0.00019043667,0.000023446468,0.00048415316,0.00002037148,0.00009716643,0.0006024814],"study_design_scores_gemma":[0.00006492519,0.00027987148,0.99776435,0.000019006286,0.00028591204,0.0006029931,0.00018108918,0.00029101645,0.00009325363,0.000023677288,0.0003866572,0.0000072919324],"about_ca_topic_score_codex":0.050709944,"about_ca_topic_score_gemma":0.056807704,"teacher_disagreement_score":0.050709944,"about_ca_system_score_codex":0.00070060696,"about_ca_system_score_gemma":0.00071299,"threshold_uncertainty_score":0.10082954},"labels":[],"label_agreement":null},{"id":"W2168919398","doi":"10.1007/s40120-015-0033-1","title":"Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience","year":2015,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University","funders":"","keywords":"Medicine; Dimethyl fumarate; Pregnancy; Postmarketing surveillance; Clinical trial; Neurology; Reproductive medicine; Pharmacology; Obstetrics; Anesthesia; Internal medicine; Adverse effect; Psychiatry; Multiple sclerosis","score_opus":0.3501967812369235,"score_gpt":0.5069049779139999,"score_spread":0.15670819667707642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168919398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81318796,0.16119681,0.004543401,0.002299188,0.00017871757,0.0024812527,0.0028274478,0.00007859214,0.013206581],"genre_scores_gemma":[0.9510585,0.041315984,0.0025523868,0.0010717737,0.00033988847,0.0005250004,0.0018906787,0.000021410928,0.0012242831],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98908895,0.0060768337,0.0012342746,0.00050956797,0.0028501286,0.00024029895],"domain_scores_gemma":[0.9649069,0.01714513,0.012022335,0.0013797872,0.0037234933,0.000822288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029397862,0.0005486842,0.0008453332,0.0012571567,0.00045038215,0.0010821059,0.0006861044,0.0009658465,0.0034602042],"category_scores_gemma":[0.02809965,0.00028150054,0.0010006741,0.0013462648,0.0011090186,0.0008927041,0.00072364457,0.001011275,0.00057562557],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053750318,0.0064478084,0.20338736,0.0106010465,0.0024131872,0.0016633424,0.0025491267,0.0011857514,0.022328995,0.0021433192,0.0054312404,0.6880986],"study_design_scores_gemma":[0.0152435955,0.36101916,0.41349941,0.006428427,0.008535546,0.014030428,0.0022064594,0.00298238,0.08344597,0.0028448193,0.089438945,0.00032487133],"about_ca_topic_score_codex":0.0005540087,"about_ca_topic_score_gemma":0.00083768804,"teacher_disagreement_score":0.029397862,"about_ca_system_score_codex":0.0010171594,"about_ca_system_score_gemma":0.001147712,"threshold_uncertainty_score":0.15547258},"labels":[],"label_agreement":null},{"id":"W2173983813","doi":"10.1007/s40120-015-0037-x","title":"Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi Study","year":2015,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Biogen","keywords":"Dimethyl fumarate; Medicine; Adverse effect; Tolerability; Multiple sclerosis; Delphi method; Internal medicine; Psychiatry","score_opus":0.07491696866877938,"score_gpt":0.3312264611467177,"score_spread":0.2563094924779383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173983813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90430343,0.00047916768,0.011779118,0.0026489194,0.0001626233,0.07228113,0.0004896556,0.00004297204,0.0078129005],"genre_scores_gemma":[0.81211877,0.00059487106,0.025449136,0.0033521897,0.000072182156,0.15724984,0.0003424935,0.00002401552,0.0007964432],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.8537654,0.12473509,0.009153723,0.0026057202,0.004887981,0.0048521813],"domain_scores_gemma":[0.87226206,0.089603975,0.006803173,0.005053583,0.021656286,0.004620906],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18990794,0.0010880884,0.0010757677,0.001638158,0.003157911,0.0018520551,0.0017210697,0.00254273,0.0043137623],"category_scores_gemma":[0.14657542,0.0012217811,0.0022220511,0.0009899875,0.0024442924,0.0027451562,0.009132072,0.002949786,0.0008400912],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020221956,0.014537276,0.092185944,0.015117529,0.0013773236,0.0017233565,0.57249165,0.0047979862,0.0070095886,0.009583856,0.01560442,0.24534911],"study_design_scores_gemma":[0.028153237,0.06293024,0.16717072,0.015493867,0.0020069885,0.0017740349,0.5771081,0.02024507,0.011371948,0.015052921,0.097451575,0.0012413128],"about_ca_topic_score_codex":0.0015596183,"about_ca_topic_score_gemma":0.0020562038,"teacher_disagreement_score":0.18990794,"about_ca_system_score_codex":0.0041746013,"about_ca_system_score_gemma":0.013862181,"threshold_uncertainty_score":0.99898773},"labels":[],"label_agreement":null},{"id":"W2411351210","doi":"10.1007/s40120-016-0045-5","title":"Neuropsychiatric Adverse Reactions to Mefloquine: a Systematic Comparison of Prescribing and Patient Safety Guidance in the US, UK, Ireland, Australia, New Zealand, and Canada","year":2016,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; MedDRA; Drug reaction; Mefloquine; Family medicine; Drug; Adverse drug reaction; Patient safety; Psychiatry; Pharmacovigilance; Malaria; Pathology; Health care; Chloroquine","score_opus":0.060984874766783125,"score_gpt":0.3718949081555471,"score_spread":0.310910033388764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411351210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8009948,0.18518698,0.0010314684,0.0011010232,0.00008736465,0.0014957952,0.0068366956,0.000046629728,0.0032191856],"genre_scores_gemma":[0.9558115,0.038341053,0.0022188316,0.00058997684,0.000031285454,0.0005547462,0.0022475151,0.00001595354,0.00018902247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9587205,0.013789521,0.015127806,0.0024366262,0.009412572,0.0005129965],"domain_scores_gemma":[0.8383292,0.07669931,0.06224957,0.0030558333,0.018449083,0.0012169944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02663318,0.0002808411,0.001618703,0.007245014,0.0004617414,0.001087288,0.00062262616,0.0006990503,0.00050907035],"category_scores_gemma":[0.087360725,0.00034303253,0.0020861935,0.010101682,0.0009025206,0.00078041543,0.0010004624,0.00045730892,0.00005679222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029687965,0.00013156496,0.76396227,0.06581573,0.010504205,0.00039183313,0.010243061,0.00045613278,0.0011179689,0.00027502884,0.002816177,0.14131716],"study_design_scores_gemma":[0.0004887418,0.0008959019,0.94365174,0.028890206,0.010567939,0.00075224024,0.0036483991,0.00068629655,0.0006879588,0.000089899535,0.009532234,0.00010839405],"about_ca_topic_score_codex":0.071267635,"about_ca_topic_score_gemma":0.16099189,"teacher_disagreement_score":0.071267635,"about_ca_system_score_codex":0.0039039818,"about_ca_system_score_gemma":0.0106903585,"threshold_uncertainty_score":0.14170563},"labels":[],"label_agreement":null},{"id":"W2535734852","doi":"10.1007/s40120-016-0053-5","title":"Evaluation of Quality of Life in Patients With Narcolepsy Treated With Sodium Oxybate: Use of the 36-Item Short-Form Health Survey in a Clinical Trial","year":2016,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto","funders":"","keywords":"Placebo; Medicine; Narcolepsy; SF-36; Quality of life (healthcare); Post-hoc analysis; Population; Randomized controlled trial; Internal medicine; Physical therapy; Neurology; Health related quality of life; Psychiatry; Alternative medicine","score_opus":0.336758150808247,"score_gpt":0.4327083332960083,"score_spread":0.09595018248776127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535734852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98467225,0.010650545,0.00045428588,0.00039385437,0.00015574819,0.0024238783,0.0005126571,0.00002939221,0.0007073443],"genre_scores_gemma":[0.98915625,0.003429446,0.0010280643,0.00038967683,0.00028483197,0.0046926,0.00067397003,0.0000069461707,0.00033812894],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99745303,0.0018189634,0.0002197851,0.00019666793,0.00020810323,0.000103468534],"domain_scores_gemma":[0.9976845,0.00086349953,0.0007913605,0.00013357864,0.00018934472,0.00033772457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052053416,0.00082072435,0.002675482,0.0002694031,0.0003342104,0.00082450494,0.00055445667,0.001060055,0.002052747],"category_scores_gemma":[0.0028480685,0.00031685716,0.001829838,0.0004257198,0.00064215774,0.00039866506,0.00033793674,0.0011126471,0.00025292477],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9493063,0.003706274,0.008394913,0.0019025656,0.0034900266,0.000038036847,0.00006964673,0.00034621736,0.003856513,0.0000507784,0.00035834487,0.028480386],"study_design_scores_gemma":[0.7200156,0.24170366,0.032872394,0.00017988656,0.0025445123,0.00007342872,0.00003847494,0.0004994434,0.0010216511,0.000097223456,0.0009305042,0.000023230357],"about_ca_topic_score_codex":0.00046024975,"about_ca_topic_score_gemma":0.00090343255,"teacher_disagreement_score":0.0052053416,"about_ca_system_score_codex":0.00049788906,"about_ca_system_score_gemma":0.0011906725,"threshold_uncertainty_score":0.027528822},"labels":[],"label_agreement":null},{"id":"W2734970544","doi":"10.1007/s40120-017-0076-6","title":"Correlation of Changes in Patient-Reported Quality of Life With Physician-Rated Global Impression of Change in Patients With Narcolepsy Participating in a Clinical Trial of Sodium Oxybate: A Post Hoc Analysis","year":2017,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto","funders":"Jazz Pharmaceuticals","keywords":"Medicine; Narcolepsy; Quality of life (healthcare); Post-hoc analysis; Vitality; SF-36; Population; Clinical Global Impression; Clinical trial; Neurology; Post hoc; Physical therapy; Internal medicine; Disease; Health related quality of life; Psychiatry; Alternative medicine","score_opus":0.1515670147074061,"score_gpt":0.4139817489890378,"score_spread":0.26241473428163165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734970544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99932146,0.00009888267,0.00013093805,0.000019891462,0.000011653643,0.000053943695,0.00019638929,0.0000057769325,0.00016111477],"genre_scores_gemma":[0.998985,0.000020335789,0.00012379148,0.000015987338,0.000017666456,0.00011860748,0.00054760266,0.0000032439386,0.00016781013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976707,0.0010440545,0.00017799211,0.0004369893,0.00044053554,0.00022966311],"domain_scores_gemma":[0.9945846,0.003471393,0.0008311502,0.0002757783,0.00041527365,0.0004217141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035661382,0.0004062531,0.0012114357,0.00046849035,0.00029486575,0.00052392675,0.0004185241,0.00041891905,0.002194857],"category_scores_gemma":[0.0054148934,0.00023723053,0.0013706727,0.00037383838,0.00040299547,0.0004808969,0.0003997533,0.00083653023,0.00020295057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08287109,0.0017224792,0.8949534,0.00015250462,0.0050126836,0.000173874,0.00026273253,0.0010261418,0.0031340255,0.00003713738,0.0007838461,0.009869991],"study_design_scores_gemma":[0.0021360908,0.019993844,0.97340965,0.00000831065,0.000849135,0.000116824725,0.00011271047,0.0022973844,0.0006819729,0.000025708036,0.00034872314,0.000019685842],"about_ca_topic_score_codex":0.0006866922,"about_ca_topic_score_gemma":0.0007840758,"teacher_disagreement_score":0.0035661382,"about_ca_system_score_codex":0.0004838101,"about_ca_system_score_gemma":0.00046272908,"threshold_uncertainty_score":0.018859744},"labels":[],"label_agreement":null},{"id":"W2790537473","doi":"10.1007/s40120-018-0091-2","title":"Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate","year":2018,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto","funders":"","keywords":"Substantia nigra; Neuroscience; Pars compacta; Neuroprotection; Parkinson's disease; Neuron; Dopaminergic; Medicine; Degeneration (medical); Disease; Dopamine; Biology; Internal medicine; Pathology","score_opus":0.01559085316679454,"score_gpt":0.2528604754054529,"score_spread":0.23726962223865838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790537473","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06882129,0.89938194,0.0014146933,0.0060408306,0.0013380259,0.000053984084,0.00042684263,0.000058602862,0.022463746],"genre_scores_gemma":[0.37237072,0.57466197,0.0017831251,0.002172778,0.00085480977,0.0001199781,0.00056022115,0.000015172824,0.047461223],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999355,0.000012327756,0.000006012642,0.000017589213,0.000018413992,0.000010205469],"domain_scores_gemma":[0.99990416,0.000013193791,0.000037729053,0.0000038298776,0.000020487045,0.000020544057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018969968,0.00051012833,0.00029325258,0.00038451047,0.00030848655,0.00082095515,0.00021085372,0.00087663135,0.0031648355],"category_scores_gemma":[0.00015227155,0.00013953146,0.00029851374,0.0003916654,0.00048808297,0.00041756092,0.00042068626,0.0008175113,0.0005767302],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043411027,0.0008492243,0.010573973,0.007767607,0.00048397537,0.003851366,0.0005618433,0.00089187745,0.2918738,0.025049506,0.026208201,0.6275475],"study_design_scores_gemma":[0.00037747427,0.0037487946,0.077198245,0.0013032485,0.00044174542,0.008701532,0.00077854743,0.0009081596,0.083066486,0.017335825,0.8060565,0.00008352829],"about_ca_topic_score_codex":0.0035993252,"about_ca_topic_score_gemma":0.0067728297,"teacher_disagreement_score":0.0035993252,"about_ca_system_score_codex":0.0007029849,"about_ca_system_score_gemma":0.0004970097,"threshold_uncertainty_score":0.010587394},"labels":[],"label_agreement":null},{"id":"W2903056119","doi":"10.1007/s40120-018-0121-0","title":"A Videogame-Based Digital Therapeutic to Improve Processing Speed in People with Multiple Sclerosis: A Feasibility Study","year":2018,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute of Neurological Disorders and Stroke; Doris Duke Charitable Foundation","keywords":"Medicine; Multiple sclerosis; Physical therapy; Expanded Disability Status Scale; Cognition; Physical medicine and rehabilitation; Psychiatry","score_opus":0.07012734933937709,"score_gpt":0.32466153608279963,"score_spread":0.25453418674342254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903056119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660194,0.00007617701,0.00021336802,0.00005861715,0.000009193132,0.0024698356,0.000081151826,0.000008665065,0.00048102764],"genre_scores_gemma":[0.9907486,0.00032162576,0.0029447295,0.00017838794,0.00005007928,0.0050198343,0.00016877291,0.000004794285,0.0005631381],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99879444,0.0006954316,0.00009266542,0.00011857695,0.0001546131,0.00014429059],"domain_scores_gemma":[0.9985929,0.0005375436,0.00017077563,0.00011282242,0.00022831456,0.00035754498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030082045,0.0007151016,0.00062645774,0.0006760735,0.0007488746,0.00054560753,0.00065240724,0.0007937718,0.0024232836],"category_scores_gemma":[0.0034391857,0.00040104744,0.00074230693,0.0002791175,0.0004648677,0.0008666001,0.00065570883,0.0008631591,0.00041370594],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06844009,0.5247858,0.11259731,0.0021194427,0.0007496672,0.0014064541,0.007643251,0.0006802002,0.020609954,0.0004474677,0.0015713512,0.25894895],"study_design_scores_gemma":[0.026675401,0.7665713,0.19573139,0.00013532236,0.00053531444,0.00079273473,0.0026537303,0.0015063705,0.002592467,0.00020985058,0.002520195,0.000075896],"about_ca_topic_score_codex":0.0017491657,"about_ca_topic_score_gemma":0.0025956144,"teacher_disagreement_score":0.0030082045,"about_ca_system_score_codex":0.00036661298,"about_ca_system_score_gemma":0.0009890656,"threshold_uncertainty_score":0.015909076},"labels":[],"label_agreement":null},{"id":"W2909923106","doi":"10.1007/s40120-018-0124-x","title":"Intravenous Milrinone Salvage Therapy in Acute Internal Carotid Artery Occlusion: Case Report","year":2019,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Milrinone; Internal carotid artery; Neurology; Occlusion; Carotid arteries; Cardiology; Internal medicine; Anesthesia; Heart failure","score_opus":0.009646331308357846,"score_gpt":0.2506238095484474,"score_spread":0.24097747824008953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909923106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9557609,0.011480975,0.0072869444,0.0045178724,0.0006126913,0.00036148305,0.00020709563,0.00030149426,0.019470613],"genre_scores_gemma":[0.9915093,0.0028269168,0.0014228098,0.0009562547,0.0010846946,0.000058541624,0.000090931855,0.000017475957,0.0020331277],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995473,0.00006633827,0.000044845943,0.00007072246,0.00006959395,0.00020123701],"domain_scores_gemma":[0.99934894,0.00020590056,0.00016088982,0.00007039543,0.000028908,0.00018481219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002821804,0.0020850543,0.0011778779,0.0022331318,0.0017751185,0.0015072849,0.0012385336,0.005558147,0.001953137],"category_scores_gemma":[0.0017583718,0.0007577311,0.0009141889,0.0011861287,0.0015270713,0.0011676913,0.0009793773,0.0023512286,0.00081090414],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026690781,0.00004859058,0.0018279725,0.000021039092,0.0000065466293,0.9963194,0.00006622337,0.00004782558,0.00026140845,0.00009947697,0.00015017239,0.0011244834],"study_design_scores_gemma":[0.000020723966,0.000097435346,0.0016800123,0.000015268686,0.0000135800565,0.9967828,0.0000572824,0.00024248731,0.00039782614,0.00011555307,0.0005699075,0.0000072236853],"about_ca_topic_score_codex":0.0007840721,"about_ca_topic_score_gemma":0.0010404413,"teacher_disagreement_score":0.005558147,"about_ca_system_score_codex":0.00089027936,"about_ca_system_score_gemma":0.0008165696,"threshold_uncertainty_score":0.006533861},"labels":[],"label_agreement":null},{"id":"W2913440059","doi":"10.1007/s40120-019-0126-3","title":"Neurology and Therapy: Looking Back on 2018 and Forward to 2019","year":2019,"lang":"en","type":"letter","venue":"Neurology and Therapy","topic":"Neurology and Historical Studies","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universidade Federal do Rio de Janeiro; Ottawa Hospital Research Institute","keywords":"Neurology; Medicine; Clinical neurology; Physical medicine and rehabilitation; Neuroscience; Psychology; Psychiatry","score_opus":0.03199121748331405,"score_gpt":0.25315100876839547,"score_spread":0.22115979128508143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913440059","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002380586,0.0050385394,0.00003982594,0.94858944,0.039954495,0.000004411545,0.000022223456,0.00000932549,0.0061037624],"genre_scores_gemma":[0.008462042,0.009379157,0.00018333453,0.7963725,0.16262086,0.000021771522,0.00003845008,0.000029858806,0.022891972],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733186,0.0006455954,0.00037183973,0.0002661208,0.00071288145,0.00067165826],"domain_scores_gemma":[0.99281293,0.0024809716,0.00070453924,0.00021280143,0.0016367123,0.002152106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022475168,0.0010212162,0.0013817976,0.0015902898,0.008147866,0.008315948,0.0018304642,0.057573676,0.018765429],"category_scores_gemma":[0.022645986,0.00053042255,0.0009493369,0.0017443325,0.007031734,0.008339098,0.0034415708,0.052628487,0.009401734],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003586599,0.000029489787,0.00041122502,0.00011373452,0.000010074499,0.0092755295,0.00024673605,0.000040443218,0.00006806753,0.007685083,0.9738479,0.008235877],"study_design_scores_gemma":[0.000087181805,0.000033900928,0.00090745435,0.0017129853,0.000034502504,0.02101244,0.0014808805,0.00017291788,0.00009752072,0.026891606,0.9475021,0.00006648667],"about_ca_topic_score_codex":0.010537078,"about_ca_topic_score_gemma":0.026154611,"teacher_disagreement_score":0.057573676,"about_ca_system_score_codex":0.012022792,"about_ca_system_score_gemma":0.01045885,"threshold_uncertainty_score":0.087231874},"labels":[],"label_agreement":null},{"id":"W2960106648","doi":"10.1007/s40120-019-0145-0","title":"Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?","year":2019,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Medicine; Biopharmaceutical; Multiple sclerosis; Pharmacy; Intensive care medicine; Family medicine; Internal medicine; Psychiatry; Biotechnology","score_opus":0.037013532446487245,"score_gpt":0.2776106795977571,"score_spread":0.24059714715126984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2960106648","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020126835,0.13195042,0.0026790367,0.82803947,0.010653931,0.000058929392,0.00020369618,0.00016947751,0.024232363],"genre_scores_gemma":[0.077863045,0.21393624,0.01431054,0.64736086,0.03079715,0.00023248147,0.0007524782,0.00025916565,0.014488126],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9793076,0.0066993786,0.0022028,0.0018912656,0.008704012,0.0011949553],"domain_scores_gemma":[0.9205828,0.035098948,0.011324969,0.004365592,0.019683281,0.008944377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.034511656,0.00073171424,0.0015828626,0.0016119588,0.002161432,0.011536069,0.002675879,0.022682056,0.025012488],"category_scores_gemma":[0.10036283,0.00047059267,0.0012535881,0.002810387,0.0086058555,0.016835986,0.0037630228,0.015311086,0.006296889],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025099044,0.0002845497,0.0012048478,0.001555057,0.000063376145,0.00077037676,0.0006487773,0.00034055038,0.0011441432,0.18806437,0.3542055,0.45146742],"study_design_scores_gemma":[0.00008227411,0.0001763641,0.00093434483,0.0033533492,0.000033320714,0.0013587036,0.0007732897,0.00032623007,0.00033315143,0.06218066,0.9303909,0.0000574252],"about_ca_topic_score_codex":0.0011708835,"about_ca_topic_score_gemma":0.0010915451,"teacher_disagreement_score":0.034511656,"about_ca_system_score_codex":0.0031679568,"about_ca_system_score_gemma":0.011745513,"threshold_uncertainty_score":0.18251729},"labels":[],"label_agreement":null},{"id":"W2963912492","doi":"10.1007/s40120-019-0146-z","title":"Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials","year":2019,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"Novartis Pharma; Javna Agencija za Raziskovalno Dejavnost RS","keywords":"Fingolimod; Medicine; Expanded Disability Status Scale; Multiple sclerosis; Placebo; Relapsing remitting; Internal medicine; Post-hoc analysis; Randomization; Clinical trial; Immunology; Pathology","score_opus":0.03219779123218237,"score_gpt":0.2880480217703848,"score_spread":0.25585023053820244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963912492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65874946,0.33122984,0.0017204492,0.00031162225,0.0005003695,0.00068120763,0.0055018947,0.00009963574,0.0012055426],"genre_scores_gemma":[0.97076863,0.02307847,0.0011776275,0.0003567171,0.00042299685,0.0007294267,0.0029587545,0.000023167364,0.00048432252],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9943246,0.003243043,0.0011425886,0.00069453346,0.00040160987,0.0001936815],"domain_scores_gemma":[0.9927939,0.003595431,0.002412705,0.000540351,0.00036905287,0.00028865025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0123584755,0.0016439399,0.0076845163,0.0010803703,0.0002361025,0.0015552257,0.0005106255,0.001027402,0.0016276621],"category_scores_gemma":[0.0098747965,0.0006241701,0.015521161,0.0010260928,0.00032604142,0.00068378967,0.0007527346,0.00080622773,0.00015526741],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39778572,0.0002632882,0.039016817,0.011581868,0.5126815,0.00015615595,0.0001255142,0.0017773855,0.0018766794,0.00007681403,0.0010326811,0.033625625],"study_design_scores_gemma":[0.09992265,0.030794434,0.16346309,0.0017201748,0.6971514,0.00034260185,0.00014372879,0.001386406,0.0011880037,0.0003532905,0.003382004,0.00015227997],"about_ca_topic_score_codex":0.0011655444,"about_ca_topic_score_gemma":0.0021302141,"teacher_disagreement_score":0.0123584755,"about_ca_system_score_codex":0.00050657603,"about_ca_system_score_gemma":0.0007893438,"threshold_uncertainty_score":0.06535864},"labels":[],"label_agreement":null},{"id":"W2973051044","doi":"10.1007/s40120-019-00154-7","title":"Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review","year":2019,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Eisai","keywords":"Dementia with Lewy bodies; Medicine; Dementia; Donepezil; Clinical trial; Randomized controlled trial; Disease; Quality of life (healthcare); Psychological intervention; Psychiatry; Systematic review; MEDLINE; Intensive care medicine; Internal medicine","score_opus":0.03453986119457354,"score_gpt":0.36624187789760326,"score_spread":0.33170201670302973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973051044","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004102439,0.99867177,0.000055141994,0.00045228613,0.00006340537,0.00003969684,0.00010403196,0.0000033371282,0.00020014588],"genre_scores_gemma":[0.004335883,0.99481446,0.00023596246,0.00032921002,0.00007736908,0.000061806306,0.000109045155,0.0000018075484,0.000034495333],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99431336,0.0014037269,0.0026397884,0.00045180236,0.0010066966,0.00018461946],"domain_scores_gemma":[0.9730584,0.018304259,0.005542693,0.0002782842,0.0024475714,0.00036882245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070822337,0.0011689127,0.0049042213,0.018740488,0.0007538717,0.0033289348,0.0019317413,0.0017292505,0.003175083],"category_scores_gemma":[0.029584847,0.000996906,0.004568158,0.015132668,0.0009950498,0.0034713272,0.001659933,0.0012968206,0.00036975738],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017612752,0.000038397855,0.0020510599,0.7858514,0.003048034,0.00022648611,0.0005242857,0.00020837139,0.00014204261,0.0008366687,0.005942981,0.20095414],"study_design_scores_gemma":[0.00007753598,0.000108674074,0.005718361,0.9370643,0.013920162,0.00086906145,0.0005814214,0.00009532887,0.00009948803,0.0007360823,0.040688764,0.000040897652],"about_ca_topic_score_codex":0.008416706,"about_ca_topic_score_gemma":0.01844566,"teacher_disagreement_score":0.018740488,"about_ca_system_score_codex":0.0039558937,"about_ca_system_score_gemma":0.012128291,"threshold_uncertainty_score":0.037454903},"labels":[],"label_agreement":null},{"id":"W2975995412","doi":"10.1007/s40120-019-00156-5","title":"Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population","year":2019,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Multiple sclerosis; Dosing; Population; Methylprednisolone; Medical prescription; Pediatrics; Relapse prevention; Internal medicine; Fingolimod; Neurology; Psychiatry","score_opus":0.08588918681136075,"score_gpt":0.33635967359676505,"score_spread":0.2504704867854043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975995412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580437,0.0015151754,0.0001358026,0.0002895755,0.000010102446,0.00003111348,0.0013507638,0.000015096159,0.00084811053],"genre_scores_gemma":[0.9991843,0.00017051553,0.00007413008,0.00005211253,0.000019354815,0.000015536049,0.00043931996,0.0000016623515,0.000043109256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981371,0.00081955007,0.00022291558,0.00026354898,0.0004113808,0.00014551019],"domain_scores_gemma":[0.99602085,0.0008565441,0.0027224408,0.0000952969,0.00012718856,0.00017766321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002718126,0.00014520438,0.0003505965,0.0009769938,0.00024201444,0.00052366836,0.0003145264,0.0003411576,0.0020882385],"category_scores_gemma":[0.005221597,0.00010764673,0.00091923086,0.0010550527,0.00019896579,0.00048741972,0.00036971932,0.00047108546,0.0001087564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003683807,0.00010781961,0.9916304,0.000047507205,0.000455206,0.000039269606,0.000050497423,0.00021565803,0.00011279459,0.00008148243,0.00041398843,0.00647702],"study_design_scores_gemma":[0.000028266888,0.000184071,0.99844426,0.00002307413,0.0001578868,0.0001415423,0.00006186569,0.0006360493,0.00006058457,0.000032822485,0.00022632595,0.0000031894647],"about_ca_topic_score_codex":0.0035992484,"about_ca_topic_score_gemma":0.003591551,"teacher_disagreement_score":0.0035992484,"about_ca_system_score_codex":0.000543487,"about_ca_system_score_gemma":0.0004932595,"threshold_uncertainty_score":0.014374971},"labels":[],"label_agreement":null},{"id":"W2978197534","doi":"10.1007/s40120-019-00158-3","title":"Cognitive Fatigability Interventions in Neurological Conditions: A Systematic Review","year":2019,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; Ottawa Hospital","funders":"","keywords":"PsycINFO; Medicine; MEDLINE; Psychological intervention; Cochrane Library; Randomized controlled trial; Systematic review; Data extraction; Cognition; Physical therapy; Physical medicine and rehabilitation; Psychiatry; Internal medicine","score_opus":0.16186607822065543,"score_gpt":0.44346544846650143,"score_spread":0.281599370245846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978197534","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010256242,0.99792236,0.000089162815,0.00018528728,0.00005807155,0.00037153548,0.00011643861,0.0000068999466,0.00022466379],"genre_scores_gemma":[0.015465311,0.9821431,0.00065648666,0.00044094695,0.00009021971,0.0009867263,0.00011818918,0.000003322841,0.0000956533],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9943453,0.0022242155,0.0015758217,0.00038145803,0.0012465467,0.00022669326],"domain_scores_gemma":[0.9767203,0.017770145,0.0035813192,0.00023405127,0.0014105799,0.00028364803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007459729,0.0012792015,0.0078347325,0.0071492,0.00063802436,0.0025882106,0.0019508166,0.002098902,0.0045552314],"category_scores_gemma":[0.030205961,0.00086608453,0.006231108,0.0064378367,0.00079547934,0.0020423294,0.0012892436,0.0013072715,0.00030144406],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018320215,0.000025181038,0.00035826577,0.96026015,0.0036908267,0.000062374325,0.00015968694,0.00006441373,0.00008318691,0.00011914894,0.000846414,0.034147143],"study_design_scores_gemma":[0.00046840293,0.00034882623,0.0041703954,0.9515105,0.03234117,0.00031861773,0.00027554456,0.00009613951,0.00011958584,0.00023151586,0.010085943,0.000033330005],"about_ca_topic_score_codex":0.0073430804,"about_ca_topic_score_gemma":0.020914996,"teacher_disagreement_score":0.0078347325,"about_ca_system_score_codex":0.004072406,"about_ca_system_score_gemma":0.011987087,"threshold_uncertainty_score":0.0394513},"labels":[],"label_agreement":null},{"id":"W3000343054","doi":"10.1007/s40120-020-00176-6","title":"Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing–Remitting Multiple Sclerosis: Quantifying the Patient’s Perspective","year":2020,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Roche","keywords":"Cronbach's alpha; Item response theory; Medicine; Interquartile range; Classical test theory; Confirmatory factor analysis; Relapsing remitting; Expanded Disability Status Scale; Reliability (semiconductor); Scale (ratio); Physical therapy; Psychometrics; Clinical psychology; Multiple sclerosis; Structural equation modeling; Psychiatry; Statistics; Internal medicine","score_opus":0.0955429705972189,"score_gpt":0.2910573773475456,"score_spread":0.19551440675032672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000343054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892753,0.00013755503,0.00019726355,0.00006485685,0.000007855591,0.000052140644,0.00015597364,0.0000054282436,0.00045138277],"genre_scores_gemma":[0.999111,0.000055801836,0.00034105906,0.00004681724,0.000009910006,0.00007061256,0.00026139044,0.0000020137504,0.00010151552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825066,0.0008969649,0.00022749833,0.00011979097,0.00041638897,0.000088653396],"domain_scores_gemma":[0.9930086,0.003915496,0.0016496563,0.00027393328,0.0006179065,0.0005343314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048883017,0.00040441923,0.0006722769,0.001006241,0.00028862376,0.00046013808,0.0003480648,0.0006553905,0.0014118139],"category_scores_gemma":[0.0155207105,0.00018291325,0.0009537802,0.0007890088,0.00045726448,0.0007267309,0.0007460272,0.00064280163,0.0003365852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009185019,0.00041894428,0.9786149,0.00009132145,0.0003258253,0.000107753,0.0006550176,0.0006514691,0.0004968797,0.00005686595,0.00044420827,0.017218275],"study_design_scores_gemma":[0.000100462195,0.0016452498,0.9959793,0.000021858903,0.000032931282,0.00021789937,0.00036316804,0.0011677844,0.0000849401,0.000085463456,0.00028795985,0.000012916977],"about_ca_topic_score_codex":0.0006733692,"about_ca_topic_score_gemma":0.00062314473,"teacher_disagreement_score":0.0048883017,"about_ca_system_score_codex":0.00024000746,"about_ca_system_score_gemma":0.00030808654,"threshold_uncertainty_score":0.025852084},"labels":[],"label_agreement":null},{"id":"W3011755412","doi":"10.1007/s40120-020-00181-9","title":"Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical Benefit","year":2020,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; Toronto Western Hospital; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke","keywords":"Deep brain stimulation; Computer science; Neuroimaging; Neuroscience; Essential tremor; Medicine; Biomedical engineering; Parkinson's disease; Physical medicine and rehabilitation; Psychology; Disease; Pathology","score_opus":0.12966503099995536,"score_gpt":0.4329764095297719,"score_spread":0.30331137852981654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011755412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032962994,0.8526997,0.010945471,0.116246,0.005616368,0.00019335386,0.00025105505,0.00029308317,0.010458733],"genre_scores_gemma":[0.03424728,0.8781593,0.028793264,0.04120024,0.011781994,0.0005925316,0.0005418332,0.00013268787,0.0045509487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985259,0.000583405,0.00021153915,0.00021068471,0.0003439384,0.00012466856],"domain_scores_gemma":[0.994113,0.0035198159,0.00047116264,0.00020115328,0.0012516624,0.0004431779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059348494,0.0009878286,0.0013708717,0.0012998123,0.00046938373,0.0031008904,0.0025202828,0.0048672236,0.010846868],"category_scores_gemma":[0.004943567,0.00034317042,0.0017315256,0.0012311988,0.0019579867,0.0045321323,0.0010412933,0.0061321375,0.0036583531],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021795689,0.0011758725,0.00080007006,0.011842619,0.00034984737,0.00043204278,0.00020060514,0.0019173089,0.004754631,0.03733973,0.072390094,0.8666176],"study_design_scores_gemma":[0.0018158802,0.0038109012,0.0029331355,0.010829113,0.0008098975,0.0010665026,0.00045989922,0.0042530317,0.00317317,0.081811465,0.88886553,0.00017155924],"about_ca_topic_score_codex":0.0014994522,"about_ca_topic_score_gemma":0.0026468313,"teacher_disagreement_score":0.010846868,"about_ca_system_score_codex":0.0016927128,"about_ca_system_score_gemma":0.004697329,"threshold_uncertainty_score":0.036286414},"labels":[],"label_agreement":null},{"id":"W3016131637","doi":"10.1007/s40120-020-00186-4","title":"A Case Report of Myoclonus-Dystonia with Isolated Myoclonus Phenotype and Novel Mutation Successfully Treated with Deep Brain Stimulation","year":2020,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Glycogen Storage Diseases and Myoclonus","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Myoclonus; Dystonia; Myoclonic Jerk; Deep brain stimulation; Medicine; Globus pallidus; Movement disorders; Neuroscience; Psychology; Internal medicine; Anesthesia; Psychiatry; Basal ganglia; Parkinson's disease; Disease; Central nervous system","score_opus":0.014332266108547884,"score_gpt":0.2460717604870046,"score_spread":0.23173949437845673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016131637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9449044,0.013824809,0.010033663,0.008232175,0.0018300536,0.00058395404,0.0006631723,0.0005431977,0.019384466],"genre_scores_gemma":[0.98712164,0.002145002,0.003091549,0.0021176273,0.0018171245,0.00010076221,0.00021133975,0.000074907046,0.0033200379],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9985935,0.00012579489,0.00011682601,0.0004797192,0.00018708133,0.0004970774],"domain_scores_gemma":[0.9984586,0.00028368176,0.000309327,0.00017259746,0.000117557436,0.0006582106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041575267,0.0035404086,0.003018875,0.0044958605,0.00446596,0.0023088963,0.0023533448,0.008455671,0.0029318472],"category_scores_gemma":[0.002520815,0.0018811444,0.0030118865,0.0030165077,0.0021831577,0.0031194182,0.0028819428,0.005398519,0.001278691],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009461067,0.000018943701,0.0007720157,0.000010012654,0.0000055936844,0.99838746,0.000059071757,0.000023850263,0.00018633323,0.00005588414,0.000115560964,0.00035578653],"study_design_scores_gemma":[0.000009111234,0.000024902041,0.0006708539,0.000005976011,0.000007903485,0.99879766,0.000035357716,0.00008932268,0.000098119825,0.00006932555,0.00018474794,0.0000067849655],"about_ca_topic_score_codex":0.0035013969,"about_ca_topic_score_gemma":0.0039318893,"teacher_disagreement_score":0.008455671,"about_ca_system_score_codex":0.0022477189,"about_ca_system_score_gemma":0.0017791511,"threshold_uncertainty_score":0.016308427},"labels":[],"label_agreement":null},{"id":"W3024180170","doi":"10.1007/s40120-020-00191-7","title":"Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies","year":2020,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Sanofi","keywords":"Medicine; Expanded Disability Status Scale; Alemtuzumab; Multiple sclerosis; Thyroid; Adverse effect; Quality of life (healthcare); Internal medicine; Post-hoc analysis; Visual analogue scale; Health related quality of life; Physical therapy; Immunology; Disease","score_opus":0.05676913280950129,"score_gpt":0.3111541731663431,"score_spread":0.2543850403568418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024180170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663925,0.002473163,0.000115616116,0.00004982285,0.000025055584,0.000065530454,0.00036184315,0.000007142333,0.00026256288],"genre_scores_gemma":[0.9988908,0.00021803964,0.00011644083,0.00005054779,0.000034510795,0.00006694681,0.0005035642,0.0000022016297,0.00011693092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954377,0.0030579823,0.00040903568,0.00045712086,0.00037552338,0.00026266108],"domain_scores_gemma":[0.9954579,0.0017880573,0.0015242926,0.00040446318,0.00042861718,0.0003967313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068381405,0.00061266817,0.0018280622,0.0006851863,0.0003383934,0.00078408513,0.0004469184,0.00045160585,0.001157149],"category_scores_gemma":[0.006387119,0.00020253091,0.0039856946,0.0007762371,0.00035112732,0.00064925157,0.00074886746,0.0007079455,0.00011023979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27646762,0.0015757416,0.6464689,0.00095961255,0.033866882,0.00018001531,0.00030605186,0.0011320874,0.0023855607,0.00007582503,0.0011475118,0.035434287],"study_design_scores_gemma":[0.008687986,0.03333259,0.9463614,0.00005847296,0.00856634,0.00019753077,0.000114319206,0.0010536315,0.00057537796,0.000109690765,0.000910939,0.000031707536],"about_ca_topic_score_codex":0.0008379511,"about_ca_topic_score_gemma":0.0017478683,"teacher_disagreement_score":0.0068381405,"about_ca_system_score_codex":0.00039554143,"about_ca_system_score_gemma":0.0005374165,"threshold_uncertainty_score":0.036163986},"labels":[],"label_agreement":null},{"id":"W3106029492","doi":"10.1007/s40120-020-00219-y","title":"Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis","year":2020,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Propensity score matching; Medical prescription; Internal medicine; Multiple sclerosis; Retrospective cohort study; Family medicine; Health care; Psychiatry","score_opus":0.06549670668876888,"score_gpt":0.295872571729544,"score_spread":0.23037586504077512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106029492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989496,0.00015949713,0.000011337226,0.0003433607,0.000009991079,0.0000065049103,0.00025476777,0.0000013205373,0.00026365838],"genre_scores_gemma":[0.99951994,0.00007455805,0.000013934253,0.00010131078,0.000011504506,0.000005669473,0.00021087068,5.6652e-7,0.00006158943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988715,0.000398385,0.0001469421,0.0001268485,0.00019916125,0.0002570448],"domain_scores_gemma":[0.9923003,0.0010563694,0.004978827,0.00022528466,0.00033929266,0.0010999442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013201853,0.0001834341,0.0002582486,0.0005078439,0.001042102,0.0008050347,0.00035523553,0.00069751276,0.0024980628],"category_scores_gemma":[0.0064330287,0.00019564989,0.0005592203,0.0009647765,0.00043166193,0.00049565476,0.001062324,0.0011762175,0.00016943838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000170037,0.00009086465,0.99779236,0.0000068517334,0.000030940537,0.00009458788,0.000119358265,0.00004239464,0.000030214116,0.000027462009,0.00026926055,0.0013256428],"study_design_scores_gemma":[0.000011413369,0.00007436967,0.99892944,0.00001536276,0.000018271172,0.00013892772,0.00047235424,0.00015012015,0.000016103075,0.000024163,0.00014616428,0.0000032289126],"about_ca_topic_score_codex":0.023629418,"about_ca_topic_score_gemma":0.03549641,"teacher_disagreement_score":0.023629418,"about_ca_system_score_codex":0.0010673597,"about_ca_system_score_gemma":0.0013166995,"threshold_uncertainty_score":0.04698378},"labels":[],"label_agreement":null},{"id":"W3124790920","doi":"10.1007/s40120-021-00230-x","title":"Quantifying Knowledge of Alzheimer’s Disease: An Analysis of the Psychometric Properties of the Alzheimer’s Disease Knowledge Scale","year":2021,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Roche España","keywords":"Item response theory; Disease; Scale (ratio); Psychology; Depression (economics); Clinical psychology; Medicine; Psychometrics; Internal medicine","score_opus":0.09553282751054976,"score_gpt":0.36469278569025354,"score_spread":0.2691599581797038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124790920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98199296,0.009758183,0.0047582174,0.00026630098,0.000072552626,0.00042844462,0.00089707534,0.000028528822,0.0017977501],"genre_scores_gemma":[0.99356526,0.0013531763,0.0037955907,0.00006474771,0.000025909572,0.0004466794,0.00061417505,0.000009059407,0.00012541274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9769818,0.01399192,0.0026712555,0.001258448,0.0048840307,0.00021259737],"domain_scores_gemma":[0.8619604,0.115321375,0.012395395,0.0033645448,0.006256707,0.00070164975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.052226137,0.00056788564,0.0015229848,0.004398803,0.00039683198,0.0013765614,0.0009841805,0.0008006296,0.0013162505],"category_scores_gemma":[0.09114427,0.0005046028,0.0063186237,0.003866712,0.0008001126,0.0012825845,0.0016064821,0.0009798926,0.00014408665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020205516,0.0005243644,0.9059753,0.0016113591,0.018757395,0.00009212836,0.0013636603,0.0018902203,0.00039265552,0.0004840157,0.00057884416,0.06630956],"study_design_scores_gemma":[0.00054195727,0.003695376,0.9735153,0.0008441852,0.007633057,0.00032439115,0.0010436939,0.008388773,0.00052398554,0.0012332808,0.0021510378,0.00010502644],"about_ca_topic_score_codex":0.0013833914,"about_ca_topic_score_gemma":0.0013855676,"teacher_disagreement_score":0.052226137,"about_ca_system_score_codex":0.0008904749,"about_ca_system_score_gemma":0.0010831419,"threshold_uncertainty_score":0.27620155},"labels":[],"label_agreement":null},{"id":"W3138642635","doi":"10.1007/s40120-021-00238-3","title":"Global Peginterferon Beta-1a Tolerability Management Best Practices: A Nurse-Focused Delphi Approach","year":2021,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"Biogen","keywords":"Medicine; Discontinuation; Delphi method; Tolerability; Delphi; Internal medicine; Adverse effect","score_opus":0.11435784276983815,"score_gpt":0.37110336991867643,"score_spread":0.25674552714883825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138642635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8496455,0.0014681066,0.07013115,0.019610286,0.0004347511,0.0372196,0.0007601909,0.00015908654,0.020571277],"genre_scores_gemma":[0.8649122,0.0017429367,0.08573077,0.003990206,0.000080213664,0.04073887,0.0003447156,0.00005289295,0.0024070896],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.8921588,0.09453142,0.0036337085,0.0019160609,0.0032294008,0.0045306454],"domain_scores_gemma":[0.9421133,0.0391845,0.0023620108,0.0016302172,0.011964536,0.0027454745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12225882,0.0014398366,0.000828299,0.0041410294,0.004226666,0.0035383434,0.0025228541,0.0018660263,0.0036640638],"category_scores_gemma":[0.07110725,0.0010943041,0.0013829271,0.002458972,0.0045614303,0.0036368594,0.014193214,0.002834183,0.0005856114],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080855156,0.00071547984,0.022796785,0.005024676,0.0002534965,0.0013001399,0.788367,0.0043047965,0.0041171685,0.014643274,0.013581682,0.14408696],"study_design_scores_gemma":[0.00031223465,0.001329451,0.02129837,0.00479705,0.00013551555,0.00081159425,0.8984324,0.012377649,0.0019220092,0.017729996,0.040555622,0.0002981702],"about_ca_topic_score_codex":0.0048904177,"about_ca_topic_score_gemma":0.0052471207,"teacher_disagreement_score":0.12225882,"about_ca_system_score_codex":0.007942998,"about_ca_system_score_gemma":0.021097079,"threshold_uncertainty_score":0.64657414},"labels":[],"label_agreement":null},{"id":"W3183672670","doi":"10.1007/s40120-021-00264-1","title":"How have Economic Evaluations in Relapsing Multiple Sclerosis Evolved Over Time? A Systematic Literature Review","year":2021,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novartis Pharma","keywords":"Medicine; Systematic review; MEDLINE; Reimbursement; Health technology; Family medicine; Cohort study; Health care; Pathology; Political science","score_opus":0.11775590514556157,"score_gpt":0.37728595010986177,"score_spread":0.2595300449643002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183672670","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014252901,0.99566853,0.0004221145,0.0011675319,0.0001760058,0.00043976615,0.0003786514,0.000008247152,0.00031392917],"genre_scores_gemma":[0.04268476,0.9509841,0.0020819602,0.0015603075,0.0002299445,0.0019405825,0.00039596605,0.000018100669,0.00010426551],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.90367997,0.055845104,0.024383528,0.003554084,0.011287001,0.0012504096],"domain_scores_gemma":[0.5879014,0.3496709,0.04109533,0.0036315029,0.016711708,0.0009890964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08772808,0.0017087976,0.010947154,0.021186365,0.00107379,0.007705073,0.0026771226,0.0036150273,0.0039259437],"category_scores_gemma":[0.3385527,0.0018406624,0.011559398,0.023386477,0.0022570696,0.008345421,0.0030226419,0.003211289,0.00025583417],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003844498,0.000030619794,0.0016068126,0.9187513,0.013188502,0.0000914918,0.00043571828,0.0005028655,0.000049727525,0.0015098033,0.0017041678,0.06174463],"study_design_scores_gemma":[0.00021846866,0.00016715912,0.0033113563,0.959238,0.025651172,0.00019844846,0.00038676272,0.0002593056,0.00007844137,0.0010608904,0.00938346,0.000046519497],"about_ca_topic_score_codex":0.010407543,"about_ca_topic_score_gemma":0.017105332,"teacher_disagreement_score":0.08772808,"about_ca_system_score_codex":0.015532896,"about_ca_system_score_gemma":0.024073867,"threshold_uncertainty_score":0.463956},"labels":[],"label_agreement":null},{"id":"W3201511800","doi":"10.1007/s40120-021-00274-z","title":"Systematic Review of Exercise Studies in Persons with Multiple Sclerosis: Exploring the Quality of Interventions According to the Principles of Exercise Training","year":2021,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; CINAHL; Physical therapy; MEDLINE; Psychological intervention; Aerobic exercise; Exercise prescription; Randomized controlled trial; Sports medicine; Medical prescription; Intervention (counseling); Clinical trial; Physical medicine and rehabilitation; Alternative medicine; Systematic review; Internal medicine; Pathology","score_opus":0.6117735547135543,"score_gpt":0.46962414539215125,"score_spread":0.14214940932140308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201511800","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023452786,0.99366707,0.0005998779,0.0006307484,0.00029428635,0.0015727702,0.00046711968,0.000016576361,0.00040625787],"genre_scores_gemma":[0.052597918,0.93442875,0.0053726006,0.0013036558,0.00022215112,0.005357686,0.0005211849,0.000022102951,0.0001739852],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8752856,0.056219604,0.047965966,0.004368817,0.015272051,0.00088791904],"domain_scores_gemma":[0.7230883,0.21741164,0.041294083,0.004151293,0.013130763,0.0009238848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06353013,0.0020198203,0.016111655,0.015565567,0.0011263062,0.0057480307,0.0027099447,0.0030379982,0.0029900372],"category_scores_gemma":[0.2545488,0.0018721056,0.00940308,0.017029306,0.002705771,0.0045217667,0.0026028983,0.0018375228,0.00028724983],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016005682,0.000009989129,0.00076138077,0.9705495,0.010236244,0.000045917834,0.00028505415,0.000075227246,0.00011763196,0.00019791898,0.00048092552,0.017080113],"study_design_scores_gemma":[0.000359248,0.00020345829,0.004014221,0.9289186,0.05877417,0.00016637247,0.000389942,0.00009825445,0.0001901119,0.00040595996,0.0064430637,0.000036566773],"about_ca_topic_score_codex":0.0070890132,"about_ca_topic_score_gemma":0.020032829,"teacher_disagreement_score":0.06353013,"about_ca_system_score_codex":0.0069951187,"about_ca_system_score_gemma":0.021667358,"threshold_uncertainty_score":0.33598346},"labels":[],"label_agreement":null},{"id":"W3209567033","doi":"10.1007/s40120-021-00293-w","title":"Use of a Novel EEG-Based Objective Test, the Cognalyzer®, in Quantifying the Strength and Determining the Action Time of Cannabis Psychoactive Effects and Factors that May Influence Them Within an Observational Study Framework","year":2021,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ontario Centre of Innovation; Ontario Centres of Excellence","keywords":"Cannabis; Observational study; Medicine; Action (physics); Test (biology); Electroencephalography; Neurology; Psychiatry; Internal medicine; Biology","score_opus":0.17927169245526403,"score_gpt":0.3831984949532664,"score_spread":0.20392680249800238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209567033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8686551,0.0020141657,0.12156004,0.00018995383,0.00016897598,0.0010759431,0.0005211368,0.0001936499,0.0056209667],"genre_scores_gemma":[0.93283546,0.0013213785,0.06289823,0.00019424944,0.00011676042,0.00082393707,0.00036965334,0.000032293312,0.0014080658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975228,0.0011580545,0.00019246152,0.00051048805,0.00055423705,0.00006196477],"domain_scores_gemma":[0.9946785,0.002561957,0.0013062673,0.00048550012,0.0007940707,0.00017371023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038374201,0.00059859373,0.00039573567,0.00067450706,0.00026406912,0.0006654283,0.0003871396,0.00056262995,0.0008465242],"category_scores_gemma":[0.0063528097,0.00019621446,0.00027755077,0.00047174803,0.0004716464,0.0005646637,0.0005702997,0.0004793948,0.0002225326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027973885,0.0013152118,0.63713044,0.0008976986,0.00076496665,0.00030234756,0.0007765012,0.0011176852,0.11627719,0.00067173026,0.00065370376,0.23729512],"study_design_scores_gemma":[0.00022435476,0.010342857,0.94763446,0.00010632624,0.0003403361,0.0016286634,0.00051257235,0.0067914845,0.028440392,0.0006028786,0.0032939434,0.00008191883],"about_ca_topic_score_codex":0.0008776205,"about_ca_topic_score_gemma":0.002850423,"teacher_disagreement_score":0.0038374201,"about_ca_system_score_codex":0.0001473119,"about_ca_system_score_gemma":0.00044521608,"threshold_uncertainty_score":0.020294487},"labels":[],"label_agreement":null},{"id":"W4210816119","doi":"10.1007/s40120-022-00326-y","title":"Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis","year":2022,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute on Aging; University of Southampton","keywords":"Receiver operating characteristic; Cutoff; Medicine; Dementia; Internal medicine; Clinical Dementia Rating; Neurology; Disease; Population; Alzheimer's disease; Psychiatry","score_opus":0.07268052579107506,"score_gpt":0.3558980312520183,"score_spread":0.28321750546094326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210816119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836541,0.00042104212,0.007444412,0.000033563472,0.000017652837,0.0010312168,0.006092587,0.00006241332,0.0012430004],"genre_scores_gemma":[0.97853756,0.00028351936,0.007478105,0.000039148454,0.000023126266,0.0015591342,0.011593808,0.000031186668,0.0004544556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99659294,0.0010030724,0.0007644418,0.0005832106,0.0008815722,0.00017475324],"domain_scores_gemma":[0.99002904,0.0013699117,0.002835577,0.0016258303,0.0037635055,0.00037616518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066962154,0.00042911153,0.00071012304,0.0030781548,0.0004794567,0.0007219672,0.0004360822,0.0002035362,0.0003975133],"category_scores_gemma":[0.0093861325,0.00035272498,0.0006594669,0.0028165088,0.0004087626,0.0004986461,0.0008611099,0.00048429225,0.00023584712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046896338,0.000046135563,0.98906285,0.000054722168,0.00017061947,0.00006859516,0.0002703608,0.00035455232,0.00074219896,0.00009574738,0.00042624678,0.0082390765],"study_design_scores_gemma":[0.000023235598,0.0006149973,0.99485165,0.000026607551,0.0001082166,0.00032237306,0.00023432817,0.0012368894,0.0010818858,0.00007769583,0.0014010768,0.000020975764],"about_ca_topic_score_codex":0.0050380756,"about_ca_topic_score_gemma":0.005490066,"teacher_disagreement_score":0.0066962154,"about_ca_system_score_codex":0.000555705,"about_ca_system_score_gemma":0.0011272851,"threshold_uncertainty_score":0.035413384},"labels":[],"label_agreement":null},{"id":"W4213217769","doi":"10.1007/s40120-022-00335-x","title":"The Humanistic and Economic Burden of Alzheimer's Disease","year":2022,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Eisai","keywords":"Quality of life (healthcare); Dementia; Medicine; Caregiver burden; Disease; Gerontology; Cognition; Disease burden; Activities of daily living; Comorbidity; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.05961626731245458,"score_gpt":0.3671856582136772,"score_spread":0.30756939090122265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213217769","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043906667,0.9884897,0.00017342113,0.0032693811,0.0004163907,0.000021970676,0.0002858255,0.0000041326657,0.0029485414],"genre_scores_gemma":[0.03812674,0.9588655,0.00051662273,0.0015773355,0.00047313588,0.000037814843,0.00016411052,0.000003678017,0.00023508015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99600405,0.0016023552,0.00079628767,0.00025149333,0.0012152172,0.00013055989],"domain_scores_gemma":[0.9854032,0.010309109,0.0022484206,0.00018993016,0.0015983287,0.00025099085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038787113,0.00048480678,0.0012922193,0.005176856,0.00063165143,0.00319723,0.000671195,0.0009551407,0.0031147373],"category_scores_gemma":[0.014634038,0.00028122854,0.0012912325,0.006885949,0.0011177533,0.0021275613,0.0010734489,0.0009649999,0.00026195846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019379749,0.000057913083,0.012687366,0.22166638,0.002783092,0.0010049941,0.0021442154,0.00043849184,0.000535551,0.013971834,0.033283595,0.7112327],"study_design_scores_gemma":[0.00009517701,0.00029962248,0.0968985,0.32205486,0.0063587218,0.005364379,0.007660543,0.00040231668,0.0005570974,0.018070517,0.5420702,0.00016807634],"about_ca_topic_score_codex":0.0066763903,"about_ca_topic_score_gemma":0.013438871,"teacher_disagreement_score":0.0066763903,"about_ca_system_score_codex":0.002439972,"about_ca_system_score_gemma":0.005287106,"threshold_uncertainty_score":0.02051282},"labels":[],"label_agreement":null},{"id":"W4220742828","doi":"10.1007/s40120-022-00341-z","title":"COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab","year":2022,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Sanofi Genzyme; Greenwich Biosciences; EMD Serono; National Institutes of Health; Genentech; Multiple Sclerosis Society; International Progressive MS Alliance; Race to Erase MS; TG Therapeutics; Bristol-Myers Squibb; University of Miami; Biogen; Celgene; Alexion Pharmaceuticals; U.S. Department of Defense; Conrad N. Hilton Foundation; Sanofi; National Multiple Sclerosis Society; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries","keywords":"Medicine; Vaccination; Ofatumumab; Coronavirus disease 2019 (COVID-19); Multiple sclerosis; Internal medicine; Pandemic; Pediatrics; Disease; Immunology; Rituximab","score_opus":0.05366258251714152,"score_gpt":0.3011824989109759,"score_spread":0.24751991639383442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220742828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820733,0.0006832266,0.000035617533,0.00008806677,0.000005856067,0.000007947112,0.0004222163,0.0000037576103,0.0005460907],"genre_scores_gemma":[0.99916613,0.00020037792,0.000036027785,0.000035267687,0.000019594863,0.0000070539345,0.00046351983,0.000001378265,0.00007062144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999374,0.0001659396,0.000106204774,0.00010659402,0.00012523461,0.00012218244],"domain_scores_gemma":[0.99654657,0.0003189958,0.0025791663,0.0000763474,0.00017524861,0.00030372015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010322473,0.00017226247,0.00037068067,0.00058647717,0.00039882454,0.00059747254,0.00019243198,0.00027380337,0.0014500397],"category_scores_gemma":[0.002888537,0.0001116614,0.00040130503,0.00087364775,0.00023909843,0.00050427153,0.00046268667,0.00043083404,0.00017524624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002551382,0.000020093259,0.9971253,0.0000207283,0.000033959204,0.00007360828,0.00007346761,0.000025235759,0.00008304773,0.000009399853,0.00011017924,0.0021697937],"study_design_scores_gemma":[0.00001575626,0.00019252894,0.99884254,0.000023240164,0.00002888707,0.0004118563,0.000099758,0.0000672309,0.000060354887,0.000025217601,0.00022985546,0.0000028173279],"about_ca_topic_score_codex":0.0016837047,"about_ca_topic_score_gemma":0.0019195626,"teacher_disagreement_score":0.0016837047,"about_ca_system_score_codex":0.0002954012,"about_ca_system_score_gemma":0.00031267395,"threshold_uncertainty_score":0.00545913},"labels":[],"label_agreement":null},{"id":"W4220907749","doi":"10.1007/s40120-022-00340-0","title":"Correction to: Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis","year":2022,"lang":"en","type":"erratum","venue":"Neurology and Therapy","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"University of Southampton","keywords":"Medicine; Neurology; Disease; Internal medicine; Retrospective cohort study; Psychiatry","score_opus":0.09003641099511255,"score_gpt":0.3756017194699634,"score_spread":0.28556530847485084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220907749","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005808937,0.0009782168,0.0017872456,0.04486836,0.90898925,0.00014521227,0.03791837,0.0008455859,0.0038869234],"genre_scores_gemma":[0.05446506,0.009534897,0.03299479,0.1455791,0.3320645,0.0030469883,0.0837906,0.009976142,0.32854795],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9893059,0.0022451268,0.0034893523,0.0012881303,0.002842936,0.0008285709],"domain_scores_gemma":[0.90966177,0.03167085,0.00661786,0.00838305,0.041352104,0.0023142807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010097929,0.0025696359,0.002192272,0.007197835,0.0021935657,0.0039850627,0.003118963,0.0035110577,0.11138043],"category_scores_gemma":[0.17671023,0.0017309035,0.0026031989,0.0070752054,0.0014788292,0.0021372451,0.0020882844,0.007406028,0.049567454],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006505314,0.0000070911005,0.00039537463,0.00023536063,0.00003157676,0.00010241462,0.000024136647,0.000036737503,0.000019411587,0.00033132284,0.99506503,0.0036866048],"study_design_scores_gemma":[0.00039772014,0.00004288255,0.00853934,0.0021271338,0.00023971449,0.0008786527,0.00026838994,0.0005006806,0.0005052551,0.0030134148,0.9833484,0.00013838435],"about_ca_topic_score_codex":0.03587069,"about_ca_topic_score_gemma":0.039693005,"teacher_disagreement_score":0.11138043,"about_ca_system_score_codex":0.003445673,"about_ca_system_score_gemma":0.0076317405,"threshold_uncertainty_score":0.37260467},"labels":[],"label_agreement":null},{"id":"W4221041873","doi":"10.1007/s40120-022-00338-8","title":"Alzheimer’s Disease: Epidemiology and Clinical Progression","year":2022,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":566,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Eisai","keywords":"Dementia; Medicine; Epidemiology; Cognitive decline; Disease; Neurodegeneration; Neurology; Alzheimer's disease; Biomarker; Gerontology; Internal medicine; Psychiatry; Biology","score_opus":0.2497319148056762,"score_gpt":0.5273113714621325,"score_spread":0.2775794566564563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221041873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020560019,0.9719192,0.0004938997,0.0013519926,0.00036978733,0.00013564619,0.002338002,0.000029787085,0.0028016597],"genre_scores_gemma":[0.19678134,0.7940899,0.0021129863,0.00091470324,0.0013791844,0.00024070119,0.003677199,0.000021310356,0.0007825808],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963936,0.00080712297,0.0012180175,0.000497775,0.0009572609,0.00012624382],"domain_scores_gemma":[0.9916191,0.0023342492,0.0035909521,0.00022512744,0.0019473267,0.00028323938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046838294,0.00059052045,0.0014417341,0.0060663735,0.0004229034,0.002701956,0.00064446643,0.00082274695,0.0017327104],"category_scores_gemma":[0.013148238,0.0003927233,0.0013094653,0.010356827,0.0006277311,0.0018293426,0.0008307449,0.0015356957,0.0005066002],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00103525,0.00019144731,0.48088565,0.048563924,0.0042435657,0.0009637567,0.00095624477,0.0006895516,0.00041681383,0.0036640584,0.028887365,0.42950234],"study_design_scores_gemma":[0.00020336441,0.00056481146,0.84359735,0.03846867,0.0040489966,0.009916361,0.0013469368,0.0009845035,0.00022572947,0.008727834,0.091778144,0.00013732794],"about_ca_topic_score_codex":0.0057838345,"about_ca_topic_score_gemma":0.006322193,"teacher_disagreement_score":0.0060663735,"about_ca_system_score_codex":0.0010153992,"about_ca_system_score_gemma":0.0022557063,"threshold_uncertainty_score":0.024770737},"labels":[],"label_agreement":null},{"id":"W4224223845","doi":"10.1007/s40120-022-00351-x","title":"Comparative Effectiveness of Carbidopa–Levodopa Enteral Suspension and Deep Brain Stimulation on Parkinson’s Disease-Related Pill Burden Reduction in Advanced Parkinson’s Disease: A Retrospective Real-World Cohort Study","year":2022,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; Toronto Western Hospital; University of Toronto","funders":"AbbVie","keywords":"Medicine; Pill; Deep brain stimulation; Parkinson's disease; Retrospective cohort study; Cohort; Enteral administration; Internal medicine; Pediatrics; Disease; Parenteral nutrition; Pharmacology","score_opus":0.014683356933362493,"score_gpt":0.2930636290510469,"score_spread":0.2783802721176844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224223845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976928,0.0011610293,0.00005874318,0.00004082653,0.00001576229,0.000037119098,0.0007876127,0.0000022250058,0.00020379886],"genre_scores_gemma":[0.9979031,0.0004961438,0.00011571384,0.000054312917,0.000029471577,0.00004154732,0.0012713074,0.0000021306953,0.000086255124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997675,0.00091910455,0.00033896058,0.00058165146,0.0003029072,0.00018236703],"domain_scores_gemma":[0.9945095,0.0013969147,0.0026574542,0.000534697,0.00031037795,0.0005910885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030245804,0.00041525203,0.00096964947,0.0005517585,0.00034936148,0.0009903479,0.00068891724,0.00069088844,0.0011962975],"category_scores_gemma":[0.007394581,0.00041435484,0.0029815785,0.0009909596,0.0003270507,0.00064035517,0.0005368382,0.0007240101,0.0001722349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0338383,0.00061889546,0.94972193,0.00023564512,0.0077100582,0.00012809272,0.000098367986,0.00035159485,0.0003106682,0.00007000905,0.00036281606,0.0065536145],"study_design_scores_gemma":[0.0024279084,0.006286267,0.9853532,0.00007199914,0.003614231,0.0002748488,0.00012216912,0.0011032195,0.00014659415,0.00007692129,0.0004885374,0.000034149638],"about_ca_topic_score_codex":0.0031286937,"about_ca_topic_score_gemma":0.0037640135,"teacher_disagreement_score":0.0031286937,"about_ca_system_score_codex":0.0006587542,"about_ca_system_score_gemma":0.0006041552,"threshold_uncertainty_score":0.015995681},"labels":[],"label_agreement":null},{"id":"W4224862282","doi":"10.1007/s40120-022-00350-y","title":"Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling","year":2022,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Eisai","keywords":"Medicine; Dementia; Disease; Neurology; Internal medicine; Alzheimer's disease; Quality of life (healthcare); Cognitive decline; Oncology; Pediatrics; Psychiatry","score_opus":0.05726727534140876,"score_gpt":0.3496279505558316,"score_spread":0.2923606752144229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224862282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618535,0.0023512465,0.02216398,0.002263438,0.0001473428,0.00028682846,0.0036004325,0.0001637254,0.0071695223],"genre_scores_gemma":[0.9922884,0.0006457771,0.003683547,0.00019318737,0.000033958335,0.00027444583,0.0015759919,0.000015436628,0.0012892904],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99951315,0.00028300134,0.000025320569,0.000070590606,0.000037477876,0.00007029434],"domain_scores_gemma":[0.99511456,0.0037370818,0.0004624343,0.000101172154,0.00030681744,0.00027799865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015530629,0.0011347666,0.0013024813,0.0008385853,0.00047013597,0.0012162554,0.0010198783,0.001382769,0.002843687],"category_scores_gemma":[0.0063831746,0.00049001334,0.0020841,0.0006226858,0.0003813328,0.00049947767,0.00082562445,0.0013775718,0.0002624279],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006225272,0.00025236973,0.016744968,0.00007640588,0.00031505513,0.00013390978,0.00005600053,0.97650003,0.00013417874,0.0012199063,0.00076957565,0.0031750845],"study_design_scores_gemma":[0.0001570455,0.00021386745,0.0018879415,0.000029052382,0.00013374654,0.000025322981,0.000027510887,0.9957587,0.00007012487,0.001239368,0.00044323577,0.00001402143],"about_ca_topic_score_codex":0.047228575,"about_ca_topic_score_gemma":0.025946569,"teacher_disagreement_score":0.047228575,"about_ca_system_score_codex":0.00217156,"about_ca_system_score_gemma":0.0019188694,"threshold_uncertainty_score":0.093907356},"labels":[],"label_agreement":null},{"id":"W4225326898","doi":"10.1007/s40120-022-00346-8","title":"Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab","year":2022,"lang":"en","type":"erratum","venue":"Neurology and Therapy","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Multiple sclerosis; Coronavirus disease 2019 (COVID-19); Ofatumumab; Neurology; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Vaccination; MEDLINE; Natalizumab; Pandemic; Virology; Family medicine; Internal medicine; Immunology; Psychiatry","score_opus":0.038334396382768955,"score_gpt":0.3130202134119375,"score_spread":0.2746858170291685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225326898","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005652214,0.00047375355,0.0001842631,0.052764043,0.9439501,0.000021107091,0.0008133963,0.00012342322,0.0016133563],"genre_scores_gemma":[0.0072538485,0.008041117,0.002698682,0.14134082,0.66974056,0.00033755202,0.0036481908,0.0011093466,0.16582987],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947267,0.0010360262,0.0011516938,0.0006520904,0.001965006,0.00046849137],"domain_scores_gemma":[0.9590291,0.01094324,0.0021621832,0.0016662261,0.023758814,0.0024403713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060489294,0.0022780956,0.0019606946,0.003285785,0.0034327868,0.005073652,0.0034632343,0.007200531,0.058833614],"category_scores_gemma":[0.086946696,0.0010217831,0.0019953554,0.002590436,0.0018421437,0.002486564,0.0017995953,0.013131605,0.02970137],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018158658,0.0000036215627,0.000048598424,0.000052969917,0.0000053340195,0.000062972715,0.000010657417,0.000014260725,0.0000056967683,0.00018500046,0.99753845,0.0020542524],"study_design_scores_gemma":[0.00010572472,0.000022288383,0.0008162103,0.00081993674,0.000047214304,0.00042812695,0.00010551914,0.0002212317,0.00013728575,0.0011983113,0.99605954,0.000038634655],"about_ca_topic_score_codex":0.027178263,"about_ca_topic_score_gemma":0.030981388,"teacher_disagreement_score":0.058833614,"about_ca_system_score_codex":0.0047960137,"about_ca_system_score_gemma":0.008834239,"threshold_uncertainty_score":0.19681805},"labels":[],"label_agreement":null},{"id":"W4226000077","doi":"10.1007/s40120-022-00343-x","title":"Pharmacokinetics of XEN496, a Novel Pediatric Formulation of Ezogabine, Under Fed and Fasted Conditions: A Phase 1 Trial","year":2022,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Pharmacokinetics; Medicine; Neurology; Pharmacology; Phase (matter); Internal medicine; Chemistry; Psychiatry","score_opus":0.08842120990572219,"score_gpt":0.40617810077464206,"score_spread":0.3177568908689199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226000077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622667,0.0014208803,0.00057066686,0.00011436529,0.00004561927,0.00066035934,0.0004177008,0.000063561056,0.00048027094],"genre_scores_gemma":[0.99276555,0.0022200549,0.0017851151,0.00030778832,0.00010365131,0.0008674944,0.00094413356,0.000030345565,0.00097590464],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999716,0.00014531332,0.000014367015,0.000051192765,0.000036639765,0.000036480636],"domain_scores_gemma":[0.9996717,0.000071662274,0.00009493048,0.00002825803,0.000031853695,0.000101547026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009148634,0.00090319937,0.0014182073,0.00021424882,0.00025385563,0.00053753477,0.0005068127,0.0009181529,0.0019958331],"category_scores_gemma":[0.0008396839,0.00039110467,0.0006071071,0.00022538581,0.00062714977,0.0008569901,0.0001852298,0.0017743895,0.00036335672],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7629693,0.046668082,0.0033781482,0.0008648323,0.0008078648,0.00034516494,0.0002448048,0.0018780392,0.08495838,0.00036751063,0.0017720711,0.09574576],"study_design_scores_gemma":[0.20778045,0.7642366,0.011577669,0.000036985326,0.00037484287,0.00046287224,0.00006821775,0.0021368752,0.010429435,0.00015857184,0.0026953397,0.000042071366],"about_ca_topic_score_codex":0.00044024352,"about_ca_topic_score_gemma":0.00074239535,"teacher_disagreement_score":0.0019958331,"about_ca_system_score_codex":0.0005027151,"about_ca_system_score_gemma":0.00074337196,"threshold_uncertainty_score":0.0066767335},"labels":[],"label_agreement":null},{"id":"W4229062821","doi":"10.1007/s40120-022-00352-w","title":"Assessing the Clinical Meaningfulness of the Alzheimer’s Disease Composite Score (ADCOMS) Tool","year":2022,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute on Aging","keywords":"Dementia; Clinical Dementia Rating; Medicine; Clinical trial; Neuroimaging; Disease; Neurology; Alzheimer's disease; Alzheimer's Disease Neuroimaging Initiative; Rating scale; Receiver operating characteristic; Internal medicine; Psychology; Psychiatry; Developmental psychology","score_opus":0.09013134555555159,"score_gpt":0.40435803474261006,"score_spread":0.3142266891870585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229062821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8855074,0.010153408,0.031532932,0.0015977893,0.00041456093,0.006496408,0.04190834,0.00043528905,0.02195398],"genre_scores_gemma":[0.9452953,0.0012730687,0.030448247,0.00039174105,0.00016047135,0.0058805365,0.015343933,0.00003282577,0.0011739099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99063593,0.0041694758,0.0017040856,0.0008331626,0.002414524,0.00024281724],"domain_scores_gemma":[0.9812959,0.007559212,0.005479537,0.0009452877,0.0040102396,0.0007097191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013817004,0.0006411903,0.0012560621,0.0026350378,0.0003834915,0.0013086811,0.00096845283,0.0005332784,0.0031380593],"category_scores_gemma":[0.032978557,0.00018276054,0.0013803495,0.0018670744,0.00052394194,0.0008322622,0.0013842093,0.000708232,0.0004895474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005968617,0.00054914784,0.74930423,0.0027405282,0.0034203946,0.00015681071,0.00076393265,0.0020923775,0.0018498019,0.0025653914,0.023981586,0.20660707],"study_design_scores_gemma":[0.00084266794,0.0018628931,0.9691029,0.0006730583,0.00093536905,0.00044702183,0.00027432927,0.0030947353,0.0016071575,0.004000852,0.017045313,0.00011369314],"about_ca_topic_score_codex":0.001048764,"about_ca_topic_score_gemma":0.0019017932,"teacher_disagreement_score":0.013817004,"about_ca_system_score_codex":0.00062013115,"about_ca_system_score_gemma":0.0014217733,"threshold_uncertainty_score":0.073072135},"labels":[],"label_agreement":null},{"id":"W4247759492","doi":"10.1007/s40120-020-00178-4","title":"Correction to: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMSII Trials","year":2020,"lang":"en","type":"erratum","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Fingolimod; Relapsing remitting; Multiple sclerosis; Medicine; Neurology; Term (time); Internal medicine; Pediatrics; Oncology; Immunology; Psychiatry","score_opus":0.03766881059752894,"score_gpt":0.2968666545273557,"score_spread":0.2591978439298268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247759492","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003029617,0.00437826,0.0021484555,0.052448757,0.8759369,0.00022304349,0.05737955,0.00091379567,0.006268309],"genre_scores_gemma":[0.03202032,0.02445813,0.025976665,0.14991629,0.35488793,0.003587359,0.093564086,0.008413778,0.30717552],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9909773,0.0029694291,0.002075027,0.0007980568,0.0025819745,0.00059822184],"domain_scores_gemma":[0.9442647,0.026250161,0.005354959,0.0028958828,0.019475669,0.0017585963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015435397,0.0035311147,0.004096418,0.005123053,0.0016114909,0.005517068,0.004290725,0.0044487263,0.22807154],"category_scores_gemma":[0.14331168,0.0021849398,0.005258295,0.006869794,0.0012693857,0.0028250727,0.0018132421,0.007456859,0.056094978],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001623528,0.0000028734403,0.000059451664,0.0009605738,0.00008210849,0.0000450675,0.000011674884,0.00006298281,0.000015717527,0.00034301274,0.99417084,0.0040832325],"study_design_scores_gemma":[0.0023030674,0.00007433778,0.0022471587,0.005298681,0.0010224658,0.00052601966,0.00007590901,0.0006384884,0.00033102708,0.0033313215,0.9840216,0.00012980601],"about_ca_topic_score_codex":0.022753885,"about_ca_topic_score_gemma":0.03192957,"teacher_disagreement_score":0.22807154,"about_ca_system_score_codex":0.0048782476,"about_ca_system_score_gemma":0.0080783665,"threshold_uncertainty_score":0.76297534},"labels":[],"label_agreement":null},{"id":"W4281644083","doi":"10.1007/s40120-022-00366-4","title":"Therapeutic Decision-Making Under Uncertainty in the Management of Spinal Muscular Atrophy: Results From DECISIONS-SMA Study","year":2022,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; St. Michael's Hospital","funders":"Roche","keywords":"Spinal muscular atrophy; SMA*; Medicine; Neurology; Physical medicine and rehabilitation; Neuroscience; Physical therapy; Pathology; Psychology; Computer science; Disease; Psychiatry","score_opus":0.04258665417488318,"score_gpt":0.34644262919573465,"score_spread":0.3038559750208515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281644083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986929,0.00013255737,0.00011315193,0.00010429324,0.000004306593,0.0000958287,0.00006870076,0.0000028587153,0.00078552635],"genre_scores_gemma":[0.99880135,0.00013817898,0.0005611909,0.00007554417,0.000009941507,0.00013964869,0.00013001119,0.0000016737094,0.00014252965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952667,0.0035343526,0.0002863743,0.0002615637,0.0004385998,0.0002123952],"domain_scores_gemma":[0.9397293,0.049385834,0.0062400377,0.0013208666,0.0014102948,0.0019137766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011603048,0.00038892624,0.00043662186,0.00038309288,0.0005061576,0.0009924477,0.00056402467,0.0008303291,0.0028852029],"category_scores_gemma":[0.047204256,0.00024572088,0.0011356707,0.0002949661,0.0007640648,0.0009766476,0.0008923596,0.0009945509,0.00028158966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020214524,0.02089055,0.8111456,0.0016310962,0.002440974,0.00069689006,0.01100207,0.0069810543,0.0006850129,0.0013521747,0.0024687327,0.120491296],"study_design_scores_gemma":[0.0049786014,0.031414263,0.92061734,0.00087636505,0.0016735668,0.0008597478,0.0101578375,0.017437333,0.0010750138,0.0034243183,0.0073024817,0.00018298045],"about_ca_topic_score_codex":0.0018539221,"about_ca_topic_score_gemma":0.0021258085,"teacher_disagreement_score":0.011603048,"about_ca_system_score_codex":0.000983946,"about_ca_system_score_gemma":0.0020871449,"threshold_uncertainty_score":0.06136346},"labels":[],"label_agreement":null},{"id":"W4282975754","doi":"10.1007/s40120-022-00372-6","title":"Outcomes of Endovascular Therapy in Young Patients with Acute Basilar Artery Occlusion: A Substudy of BASILAR Registry Study","year":2022,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Laboratoires d'excellence Nanostructures en Interaction avec leur Environnement","keywords":"Medicine; Basilar artery; Neurology; Occlusion; Internal medicine; Cardiology; Psychiatry","score_opus":0.008850043664875747,"score_gpt":0.23489500199660193,"score_spread":0.2260449583317262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282975754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997801,0.0006681053,0.00007584391,0.00004674208,0.000009903413,0.000027737406,0.0009867998,0.0000029009298,0.00038098783],"genre_scores_gemma":[0.9977858,0.00050947885,0.00008928207,0.000054129076,0.00004882801,0.000055919692,0.0013894995,0.0000015462894,0.00006537924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992118,0.00028269,0.00012049253,0.00013760259,0.00012790597,0.00011942084],"domain_scores_gemma":[0.99784243,0.00025076134,0.0012666654,0.0001299617,0.00016926085,0.00034082276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013515076,0.00023904056,0.0006088666,0.00080104906,0.00038081096,0.0005658889,0.00024988997,0.0003598481,0.00071385456],"category_scores_gemma":[0.0017665211,0.0001598921,0.0005621628,0.0013562901,0.0002258395,0.00058889185,0.0005324391,0.00031951568,0.00018472342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018060175,0.000035217294,0.99840564,0.000030523985,0.00012401075,0.000075512806,0.00005068583,0.000017145398,0.00007862625,0.000012882079,0.00011542914,0.0008737058],"study_design_scores_gemma":[0.000021820337,0.00014107017,0.9992353,0.0000171357,0.00008796457,0.00017857805,0.000087605156,0.0000388148,0.000023276989,0.000011369285,0.0001540868,0.0000030714887],"about_ca_topic_score_codex":0.0024031892,"about_ca_topic_score_gemma":0.004462809,"teacher_disagreement_score":0.0024031892,"about_ca_system_score_codex":0.00024610257,"about_ca_system_score_gemma":0.0003972404,"threshold_uncertainty_score":0.0071475506},"labels":[],"label_agreement":null},{"id":"W4283159318","doi":"10.1007/s40120-022-00373-5","title":"The Potential Economic Value of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling","year":2022,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Eisai","keywords":"Willingness to pay; Medicine; Disease; Quality of life (healthcare); Health care; Quality-adjusted life year; Neurology; Gerontology; Psychiatry; Internal medicine; Cost effectiveness; Economics; Nursing","score_opus":0.01945440523287799,"score_gpt":0.28915242062595764,"score_spread":0.26969801539307964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283159318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87429947,0.0043427153,0.071700685,0.0058061182,0.0002476939,0.0007414186,0.0044341087,0.00018053486,0.038247228],"genre_scores_gemma":[0.98414433,0.0010915868,0.008232252,0.00033766814,0.00004188021,0.00044887583,0.0008661522,0.000020721927,0.0048165177],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99923563,0.00051014026,0.000026860838,0.00006204642,0.000062651015,0.00010272879],"domain_scores_gemma":[0.9930877,0.0057581356,0.00048422374,0.00007768784,0.00034130207,0.00025092106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019858577,0.0011710012,0.0011988196,0.0011019234,0.0005046957,0.0018960626,0.0012950647,0.0019876314,0.0055467864],"category_scores_gemma":[0.007058205,0.00063520216,0.0022962869,0.000992443,0.0005441912,0.0008484332,0.00095122564,0.0016116842,0.00032201043],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022607762,0.000073382165,0.002740111,0.00005138926,0.000095654825,0.00007826219,0.000025506675,0.9923658,0.00009017866,0.002487169,0.00034396746,0.0014225511],"study_design_scores_gemma":[0.00017531076,0.00015194152,0.0006817848,0.0000460404,0.000100992824,0.000034072254,0.00003462288,0.994803,0.000077740435,0.0030424162,0.00083748356,0.000014405406],"about_ca_topic_score_codex":0.03361913,"about_ca_topic_score_gemma":0.018398324,"teacher_disagreement_score":0.03361913,"about_ca_system_score_codex":0.003056391,"about_ca_system_score_gemma":0.0030318866,"threshold_uncertainty_score":0.06684691},"labels":[],"label_agreement":null},{"id":"W4283764603","doi":"10.1007/s40120-022-00379-z","title":"Clinical Staging of Alzheimer’s Disease: Concordance of Subjective and Objective Assessments in the Veteran’s Affairs Healthcare System","year":2022,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"Eisai Incorporated; National Institute on Aging; National Institutes of Health; Eisai; U.S. Department of Veterans Affairs","keywords":"Concordance; Medicine; Veterans Affairs; Neurology; Health care; Disease; Healthcare system; Gerontology; Family medicine; Psychiatry; Pathology; Internal medicine","score_opus":0.04860978337695539,"score_gpt":0.40361071278878835,"score_spread":0.355000929411833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283764603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793977,0.00026511107,0.0004898058,0.00006058879,0.000009935613,0.000034994944,0.0007122339,0.000007884333,0.00047968095],"genre_scores_gemma":[0.99862385,0.00006492431,0.0005052785,0.000018485756,0.000008629827,0.000016538366,0.00070050295,0.000002956494,0.000058945436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9890826,0.005491631,0.002174888,0.0011064317,0.0017041597,0.00044028697],"domain_scores_gemma":[0.9708835,0.012987481,0.009193164,0.0022958354,0.0040985104,0.00054141507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011050092,0.00019192841,0.00033071032,0.0024775865,0.00041615838,0.0014681023,0.0005483219,0.00028236743,0.0006386711],"category_scores_gemma":[0.037159305,0.00022890049,0.00034845786,0.0025905678,0.0005393598,0.00057896134,0.0015087755,0.00027241837,0.00016639556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077839846,0.000008658007,0.9955367,0.00002960266,0.000054064727,0.000029040697,0.00059728295,0.00006070319,0.00013472883,0.00002181421,0.00015398774,0.0032955382],"study_design_scores_gemma":[0.0000031072916,0.00003263641,0.9980392,0.00002611159,0.000015944184,0.000091007954,0.00062078575,0.0006852719,0.0001925562,0.000034510387,0.00025443707,0.0000043775894],"about_ca_topic_score_codex":0.0071529006,"about_ca_topic_score_gemma":0.012500336,"teacher_disagreement_score":0.011050092,"about_ca_system_score_codex":0.0006496995,"about_ca_system_score_gemma":0.00069639354,"threshold_uncertainty_score":0.058439136},"labels":[],"label_agreement":null},{"id":"W4283770967","doi":"10.1007/s40120-022-00376-2","title":"Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”","year":2022,"lang":"en","type":"letter","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Neuromyelitis optica; Medicine; Food and drug administration; Neurology; Spectrum disorder; Aquaporin 4; Drug; Antibody; Immunology; Pharmacology; Psychiatry; Internal medicine","score_opus":0.04097943961968167,"score_gpt":0.29064898686716745,"score_spread":0.24966954724748577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283770967","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037294455,0.0015211465,0.00011934209,0.9492577,0.047320068,0.00002100773,0.00036487746,0.00004532938,0.0009776283],"genre_scores_gemma":[0.0023952296,0.0011369969,0.00020864076,0.91541475,0.07860045,0.00006510908,0.000105718165,0.00003373736,0.0020393904],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939004,0.0025772152,0.001188889,0.00074011635,0.001168493,0.000424884],"domain_scores_gemma":[0.9719015,0.01791284,0.0030499906,0.00065610284,0.0046833646,0.0017961984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008301874,0.00096870796,0.0027240524,0.0013539561,0.0025161183,0.003765859,0.00196928,0.026288336,0.0056652483],"category_scores_gemma":[0.06741314,0.0009968769,0.0018318763,0.0013408299,0.0013616288,0.0022053176,0.0011483681,0.017515907,0.0056201993],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010677184,0.000017030758,0.00054140924,0.000116040195,0.00006255507,0.0005804127,0.00004082868,0.00003930142,0.00004940073,0.000292078,0.9943561,0.00379819],"study_design_scores_gemma":[0.0014467684,0.00020379224,0.0045397733,0.0020940853,0.00081234373,0.003944334,0.00046606042,0.0014601153,0.0005724184,0.008243501,0.97603774,0.00017907756],"about_ca_topic_score_codex":0.0046057845,"about_ca_topic_score_gemma":0.007465635,"teacher_disagreement_score":0.026288336,"about_ca_system_score_codex":0.0029003862,"about_ca_system_score_gemma":0.005494296,"threshold_uncertainty_score":0.04390502},"labels":[],"label_agreement":null},{"id":"W4291146664","doi":"10.1007/s40120-022-00393-1","title":"A Simulation Model to Evaluate the Potential Impact of Disease-Modifying Treatments on Burden of Illness in Alzheimer’s Disease","year":2022,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Eisai","keywords":"Medicine; Disease; Dementia; Alzheimer's disease; Epidemiology; Disease burden; Neurology; Gerontology; Caregiver burden; Indirect costs; Psychiatry; Environmental health; Internal medicine","score_opus":0.05488187758269159,"score_gpt":0.39359092334242146,"score_spread":0.3387090457597299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291146664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80631244,0.0017618526,0.12267812,0.0061604353,0.00039110857,0.0007600591,0.010977492,0.00050358946,0.050454848],"genre_scores_gemma":[0.9782612,0.00057005294,0.012432883,0.00027905242,0.000043475775,0.00048229823,0.001839293,0.00002401496,0.006067798],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99891126,0.00066659926,0.00003681302,0.00010903459,0.00007397997,0.00020233978],"domain_scores_gemma":[0.99416107,0.0043299953,0.00044346505,0.000106478816,0.0005991142,0.0003598211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021269033,0.0014747354,0.0012336893,0.0014277828,0.00084972684,0.0017924331,0.0019666727,0.002897818,0.008003237],"category_scores_gemma":[0.007605783,0.0006892374,0.0017259488,0.0015409867,0.00082862657,0.0012504011,0.0011808826,0.0019883646,0.0004820723],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001266858,0.000067939756,0.0022930868,0.000026836078,0.000048632945,0.000073177405,0.000027232389,0.9920365,0.00006471811,0.0037628792,0.0005694189,0.0009029566],"study_design_scores_gemma":[0.000113110844,0.0000800169,0.00047248846,0.000015905622,0.00003379019,0.000020712243,0.00004426288,0.99657625,0.000033611595,0.0020366565,0.00056361884,0.000009604926],"about_ca_topic_score_codex":0.08364325,"about_ca_topic_score_gemma":0.039732985,"teacher_disagreement_score":0.08364325,"about_ca_system_score_codex":0.004039574,"about_ca_system_score_gemma":0.0037952198,"threshold_uncertainty_score":0.16631281},"labels":[],"label_agreement":null},{"id":"W4307947172","doi":"10.1007/s40120-022-00408-x","title":"Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient’s Perspective: A Qualitative Study","year":2022,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Alexion Pharmaceuticals; AstraZeneca","keywords":"Myasthenia gravis; Medicine; Perspective (graphical); Neurology; Qualitative research; Family medicine; Intensive care medicine; Physical therapy; Internal medicine; Psychiatry; Sociology; Artificial intelligence; Social science","score_opus":0.06029704980408308,"score_gpt":0.349289097090994,"score_spread":0.2889920472869109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307947172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936526,0.0007418633,0.0010467028,0.0019282663,0.000045400575,0.000089903006,0.000105023,0.0000083325085,0.0023819949],"genre_scores_gemma":[0.997558,0.00059559377,0.0004367925,0.0005384683,0.000013609036,0.00009888521,0.000040146504,0.00000961349,0.0007089017],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99278295,0.0056027086,0.00019847164,0.0002858943,0.00042125297,0.00070879975],"domain_scores_gemma":[0.98624355,0.0108583085,0.00080907164,0.00021842548,0.00078849256,0.001082099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009032909,0.00056761375,0.00085874676,0.0013011948,0.0048058196,0.0032247903,0.001405478,0.0014137048,0.002541638],"category_scores_gemma":[0.0133557515,0.000566739,0.00053382997,0.0010578738,0.0054263826,0.003985598,0.004456244,0.0024387073,0.0002687743],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003016824,0.000030337222,0.003277875,0.00012882336,0.00000666941,0.0006624208,0.992238,0.00002831974,0.0005139894,0.0003658118,0.00025241377,0.00246519],"study_design_scores_gemma":[0.0000047745416,0.00004234807,0.0013798208,0.00011658382,0.000004738425,0.00034168907,0.99472874,0.000064246306,0.00011130045,0.00015303945,0.003040885,0.000011827534],"about_ca_topic_score_codex":0.0053794906,"about_ca_topic_score_gemma":0.009058444,"teacher_disagreement_score":0.009032909,"about_ca_system_score_codex":0.0034354434,"about_ca_system_score_gemma":0.0029771847,"threshold_uncertainty_score":0.047771156},"labels":[],"label_agreement":null},{"id":"W4309923835","doi":"10.1007/s40120-022-00423-y","title":"Treatment Preference for Alzheimer’s Disease: A Multicriteria Decision Analysis with Caregivers, Neurologists, and Payors","year":2022,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Eisai Incorporated; University of California, San Francisco","keywords":"Neurology; Medicine; Preference; Disease; Neuroscience; Physical medicine and rehabilitation; Psychiatry; Psychology; Internal medicine","score_opus":0.04672954928704472,"score_gpt":0.32257178770880507,"score_spread":0.27584223842176037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309923835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861421,0.00074237015,0.008907406,0.0010332476,0.00007624253,0.0015349312,0.00034572184,0.000015131863,0.0012027154],"genre_scores_gemma":[0.9842524,0.00020401785,0.013375186,0.00025215582,0.000053490006,0.0012701332,0.00033808532,0.0000062449817,0.00024821953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8947328,0.09444398,0.0032259037,0.0026942384,0.0029694932,0.001933521],"domain_scores_gemma":[0.74948233,0.22791101,0.012019372,0.0023404374,0.0043225274,0.0039243726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08464743,0.002043041,0.0034695102,0.004779965,0.0025875214,0.0049426877,0.002394037,0.002762752,0.008011415],"category_scores_gemma":[0.12940189,0.0012904124,0.009327145,0.0027610613,0.001936869,0.0030571003,0.004804989,0.004173634,0.00045066237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025426753,0.009152426,0.73451614,0.0030324906,0.011976662,0.0015072735,0.014643348,0.10020219,0.0008386576,0.010665656,0.0050404207,0.08299794],"study_design_scores_gemma":[0.0034877819,0.012336963,0.118934385,0.0011507174,0.002947327,0.0014913033,0.02313293,0.8068637,0.0007775588,0.025028793,0.003385478,0.0004629481],"about_ca_topic_score_codex":0.0055574016,"about_ca_topic_score_gemma":0.0040013157,"teacher_disagreement_score":0.08464743,"about_ca_system_score_codex":0.005567398,"about_ca_system_score_gemma":0.0043127136,"threshold_uncertainty_score":0.44766378},"labels":[],"label_agreement":null},{"id":"W4313680745","doi":"10.1007/s40120-022-00436-7","title":"Clinical Burden of Angiographic Vasospasm and Its Complications After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Idorsia Pharmaceuticals","keywords":"Medicine; Subarachnoid hemorrhage; Vasospasm; Neurology; Cardiology; Radiology; Internal medicine; Intensive care medicine","score_opus":0.059842483018534155,"score_gpt":0.3549191436832379,"score_spread":0.2950766606647037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313680745","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002573168,0.9961279,0.00014820477,0.00019180366,0.00007893738,0.00027777557,0.00043722033,0.0000083655195,0.00015659232],"genre_scores_gemma":[0.04029593,0.95710915,0.0007538935,0.00049945933,0.000092637805,0.00077428774,0.0003553342,0.000007521277,0.000111900896],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9916347,0.002946606,0.0033192702,0.0006045397,0.0012723984,0.00022243493],"domain_scores_gemma":[0.9697897,0.02115371,0.005679506,0.00049325835,0.0026154493,0.00026846168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009694275,0.0016940039,0.010599128,0.009168713,0.00060698413,0.0030188449,0.0015147893,0.0018594231,0.0027139517],"category_scores_gemma":[0.04062003,0.0014384962,0.010534448,0.009520395,0.000880519,0.0020057438,0.001562005,0.0010804773,0.00022042407],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020507096,0.0000126365785,0.0013083494,0.95498836,0.028574498,0.00008043402,0.00016581958,0.000097364995,0.00011976475,0.000094166215,0.0005973984,0.013756133],"study_design_scores_gemma":[0.00037214256,0.00033154016,0.009726012,0.6751391,0.30498174,0.00047930784,0.0003585691,0.00016881397,0.00021557152,0.00027294148,0.00788872,0.00006539242],"about_ca_topic_score_codex":0.008724249,"about_ca_topic_score_gemma":0.02512763,"teacher_disagreement_score":0.010599128,"about_ca_system_score_codex":0.0031777387,"about_ca_system_score_gemma":0.0093756,"threshold_uncertainty_score":0.051268876},"labels":[],"label_agreement":null},{"id":"W4317209673","doi":"10.1007/s40120-022-00433-w","title":"Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson’s Disease","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Pill; Medicine; Parkinson's disease; Deep brain stimulation; Enteral administration; Carbidopa; Polypharmacy; Levodopa; Internal medicine; Disease; Parenteral nutrition; Pharmacology","score_opus":0.015604509761700606,"score_gpt":0.2826522068468737,"score_spread":0.2670476970851731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317209673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973979,0.0018565923,0.000029521396,0.00008277127,0.00001798883,0.00006256227,0.00009963367,0.0000027156148,0.00045037252],"genre_scores_gemma":[0.9988267,0.00059713225,0.00012605212,0.000091533606,0.000041511754,0.000048831982,0.00015719575,8.6688965e-7,0.00011013328],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9985545,0.00077727565,0.00020835649,0.00016929218,0.00017350097,0.00011704929],"domain_scores_gemma":[0.9977476,0.0008140733,0.00073161826,0.00010086588,0.00008759127,0.00051832624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016054988,0.000356263,0.001058916,0.00041132077,0.0002194335,0.0005277799,0.00033237477,0.00045202448,0.0013466785],"category_scores_gemma":[0.0039225365,0.00019858181,0.0021003236,0.0004055152,0.00036238704,0.0006241713,0.0004567311,0.0008386013,0.00011281297],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6147908,0.017583378,0.11567111,0.0010985284,0.00694739,0.00011862476,0.00032932314,0.001770224,0.0024060698,0.00024629154,0.00070107554,0.23833722],"study_design_scores_gemma":[0.08292458,0.36505815,0.5393767,0.00029545635,0.005004674,0.0002474983,0.000375158,0.003448642,0.0013139592,0.0003505828,0.0015221493,0.00008250796],"about_ca_topic_score_codex":0.0014538656,"about_ca_topic_score_gemma":0.00408168,"teacher_disagreement_score":0.0016054988,"about_ca_system_score_codex":0.0008275798,"about_ca_system_score_gemma":0.0006145247,"threshold_uncertainty_score":0.008490801},"labels":[],"label_agreement":null},{"id":"W4319827031","doi":"10.1007/s40120-023-00445-0","title":"Assessing What Matters to People Affected by Alzheimer’s Disease: A Quantitative Analysis","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"H. Lundbeck A/S; Otsuka Pharmaceutical; Biogen","keywords":"Medicine; Neurology; Disease; Alzheimer's disease; Neuroscience; Gerontology; Psychology; Pathology; Psychiatry","score_opus":0.041159801294563855,"score_gpt":0.3859470541010277,"score_spread":0.34478725280646383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319827031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904355,0.0002837562,0.0038811737,0.00059620966,0.000029203733,0.00078724936,0.0008541258,0.00001957016,0.0031133273],"genre_scores_gemma":[0.994501,0.00014330252,0.003546604,0.00012996192,0.000018238654,0.0010792873,0.00034608785,0.000007594479,0.00022786048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9838087,0.010159057,0.001332558,0.0007843893,0.0034248712,0.00049042597],"domain_scores_gemma":[0.9493446,0.027719883,0.008521323,0.0017529165,0.011245219,0.0014160665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033223942,0.00025973807,0.00043133023,0.0034412863,0.0011826678,0.0014450207,0.00056305167,0.00027280042,0.001972227],"category_scores_gemma":[0.046221647,0.00022094653,0.0008701535,0.0028165006,0.0017378184,0.0017035746,0.0018250801,0.00044017032,0.00018032368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042532975,0.00031791418,0.8373468,0.0012689744,0.00031292357,0.0000914147,0.08870895,0.0002815986,0.0015146715,0.00153155,0.0026128893,0.06558691],"study_design_scores_gemma":[0.000058621394,0.0009447089,0.87455916,0.0005292447,0.00011466604,0.00013753287,0.1120509,0.0015561577,0.000701258,0.002068816,0.0071992865,0.00007977194],"about_ca_topic_score_codex":0.0015791518,"about_ca_topic_score_gemma":0.0019319996,"teacher_disagreement_score":0.033223942,"about_ca_system_score_codex":0.0017210771,"about_ca_system_score_gemma":0.0017700546,"threshold_uncertainty_score":0.1757071},"labels":[],"label_agreement":null},{"id":"W4320856890","doi":"10.1007/s40120-023-00443-2","title":"Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Clinical Dementia Rating; Dementia; Rating scale; Disease; Psychology; Cognition; Gerontology; Medicine; Alzheimer's disease; Activities of daily living; Neurology; Clinical psychology; Neuroscience; Psychiatry; Internal medicine; Developmental psychology","score_opus":0.09589878507492791,"score_gpt":0.5055491533534149,"score_spread":0.409650368278487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320856890","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053785526,0.97068024,0.009411609,0.006079594,0.0036051401,0.0038939635,0.0020933743,0.00012301384,0.0035751697],"genre_scores_gemma":[0.011015931,0.92061013,0.03804086,0.007369242,0.0028748673,0.014842922,0.003623427,0.0001677994,0.0014547743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.88315016,0.04376703,0.04353503,0.005317101,0.02335602,0.0008747138],"domain_scores_gemma":[0.64011806,0.18431666,0.037700534,0.011362805,0.1248586,0.0016433978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.114648186,0.001956827,0.006372761,0.01967864,0.00132035,0.00530913,0.00450829,0.0027323267,0.004725477],"category_scores_gemma":[0.2729837,0.0016736335,0.007068848,0.016541265,0.002269352,0.0050024698,0.0044890707,0.0035750703,0.0023115748],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022414347,0.00004630604,0.0015927664,0.37376994,0.002093638,0.00010224963,0.0005664487,0.00031766001,0.0005333375,0.0044657057,0.043884307,0.57240355],"study_design_scores_gemma":[0.00021013556,0.00038236222,0.009153671,0.57223743,0.0073121134,0.0005480054,0.0004416774,0.00045674693,0.000707547,0.0043769144,0.404045,0.00012835592],"about_ca_topic_score_codex":0.0077168103,"about_ca_topic_score_gemma":0.012525684,"teacher_disagreement_score":0.114648186,"about_ca_system_score_codex":0.0076126205,"about_ca_system_score_gemma":0.03575697,"threshold_uncertainty_score":0.6063248},"labels":[],"label_agreement":null},{"id":"W4321487680","doi":"10.1007/s40120-023-00449-w","title":"Pridopidine Does Not Significantly Prolong the QTc Interval at the Clinically Relevant Therapeutic Dose","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Teva Pharmaceutical Industries","keywords":"Medicine; QT interval; Neurology; Pharmacology; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.02787311845413496,"score_gpt":0.30724032847438015,"score_spread":0.27936721002024517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321487680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98576987,0.009708418,0.0012924763,0.00014121145,0.00013063163,0.00020362472,0.0006323762,0.00009395055,0.00202733],"genre_scores_gemma":[0.9963193,0.0012498716,0.000998725,0.00015826005,0.00008506558,0.00008423696,0.00048138632,0.000012746342,0.00061050686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996779,0.0001263781,0.000038209877,0.000060326784,0.000070457354,0.000026696041],"domain_scores_gemma":[0.99906486,0.00036248795,0.00026615948,0.00012262411,0.00006790915,0.00011594504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004698224,0.00023355747,0.0007706107,0.00011470805,0.000079532125,0.00028673213,0.00025282786,0.00038468337,0.0025924759],"category_scores_gemma":[0.0014450502,0.00015274431,0.00028358307,0.0001244536,0.00022830088,0.00021182233,0.000104034516,0.00075815327,0.0003231295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1424709,0.0022166534,0.008426236,0.0018139015,0.0010064986,0.0002774912,0.00020635911,0.0008306856,0.6951016,0.00025237983,0.0020777967,0.14531942],"study_design_scores_gemma":[0.050524365,0.31271854,0.20316868,0.00023661142,0.0016992625,0.0031948073,0.0001081409,0.0037519268,0.40218347,0.0002588148,0.02207436,0.00008093171],"about_ca_topic_score_codex":0.0002733107,"about_ca_topic_score_gemma":0.00064651563,"teacher_disagreement_score":0.0025924759,"about_ca_system_score_codex":0.00015210392,"about_ca_system_score_gemma":0.00025802018,"threshold_uncertainty_score":0.008672714},"labels":[],"label_agreement":null},{"id":"W4327682176","doi":"10.1007/s40120-023-00460-1","title":"Estimated Societal Value of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Eisai","keywords":"Medicine; Willingness to pay; CLARITY; Quality of life (healthcare); Disease; Caregiver burden; Quality-adjusted life year; Gerontology; Biomarker; Neurology; Psychiatry; Cost effectiveness; Dementia; Internal medicine","score_opus":0.06002915615347265,"score_gpt":0.356793999213452,"score_spread":0.29676484305997936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327682176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9072642,0.0027025742,0.06319054,0.00396216,0.0001063872,0.00034737168,0.0053557865,0.000106795844,0.016964154],"genre_scores_gemma":[0.9915746,0.0005830839,0.004677291,0.00018442691,0.000018744086,0.000178119,0.00096625334,0.000010944157,0.0018064121],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99906164,0.00060728536,0.000039294242,0.00010034519,0.00007750563,0.00011394851],"domain_scores_gemma":[0.99283457,0.0058816536,0.0005980459,0.000107881584,0.00035649835,0.00022135697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026814626,0.0008926538,0.0010445297,0.0011260026,0.0004128113,0.0018669991,0.001286627,0.0017551233,0.0039453525],"category_scores_gemma":[0.00967823,0.00054855505,0.0019202743,0.0012118113,0.00047164463,0.0010240942,0.0008504129,0.001564018,0.0003066907],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016300581,0.000044509114,0.0057061305,0.000045808523,0.00010793391,0.00010626177,0.000023404402,0.9888285,0.00007249423,0.0026258852,0.00032838076,0.0019477156],"study_design_scores_gemma":[0.00010214902,0.00014584693,0.002069615,0.000060545197,0.00014713597,0.0000797146,0.000053303604,0.9917162,0.00011051054,0.0046150843,0.0008797784,0.000020228295],"about_ca_topic_score_codex":0.028077632,"about_ca_topic_score_gemma":0.013790746,"teacher_disagreement_score":0.028077632,"about_ca_system_score_codex":0.0038283567,"about_ca_system_score_gemma":0.0025486895,"threshold_uncertainty_score":0.055828393},"labels":[],"label_agreement":null},{"id":"W4327811413","doi":"10.1007/s40120-023-00462-z","title":"Clinical and Scientific Challenges to Effectiveness Studies Under Coverage with Evidence Development in Alzheimer’s Disease","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Eisai","keywords":"Medicine; Medicaid; Food and drug administration; Disease; Health care; Drug development; Alzheimer's disease; Healthcare system; Neurology; Psychiatry; Drug; Pathology; Pharmacology; Political science","score_opus":0.6795240567739593,"score_gpt":0.5135187704976755,"score_spread":0.16600528627628386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327811413","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026416637,0.15176871,0.05618062,0.73200715,0.0032640581,0.0018819477,0.0011155527,0.00005570781,0.027309623],"genre_scores_gemma":[0.72287637,0.04602189,0.09233137,0.12021974,0.008940131,0.0077872355,0.00053112255,0.00011950321,0.001172642],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.2765796,0.6743755,0.02017708,0.005022865,0.021718154,0.0021267692],"domain_scores_gemma":[0.060372505,0.9005624,0.01728218,0.0074671125,0.013045175,0.0012706632],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6262071,0.0010710062,0.00433324,0.0052235737,0.002490419,0.012961964,0.004514314,0.008174677,0.0054306793],"category_scores_gemma":[0.8112916,0.0010555977,0.003044047,0.0073314384,0.019234315,0.013978012,0.008223344,0.009891543,0.0004349287],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023943288,0.000838341,0.028651446,0.01694237,0.0047697905,0.00045863757,0.0031951158,0.01573032,0.00018057939,0.5620909,0.037399244,0.327349],"study_design_scores_gemma":[0.0018883139,0.0013328565,0.018667907,0.029743295,0.0020564909,0.00043570777,0.003639999,0.017832903,0.0004896216,0.86644286,0.05726538,0.00020475466],"about_ca_topic_score_codex":0.006693948,"about_ca_topic_score_gemma":0.0054440238,"teacher_disagreement_score":0.3737929,"about_ca_system_score_codex":0.012470536,"about_ca_system_score_gemma":0.024707418,"threshold_uncertainty_score":0.46095324},"labels":[],"label_agreement":null},{"id":"W4360600322","doi":"10.1007/s40120-023-00466-9","title":"Design of a Non-Interventional Study to Assess Neurologists’ Perspectives and Pharmacological Treatment Decisions in Early Alzheimer's Disease","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; St. Michael's Hospital","funders":"Roche","keywords":"Neurology; Medicine; Disease; Alternative medicine; Intensive care medicine; Psychiatry; Pathology","score_opus":0.14083120854365191,"score_gpt":0.4333269126382176,"score_spread":0.2924957040945657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360600322","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521768,0.00010495021,0.0013650414,0.00030961167,0.00013531648,0.043764614,0.0005607036,0.000020324058,0.0015626862],"genre_scores_gemma":[0.7301665,0.00018083582,0.008560482,0.0014124514,0.00022428698,0.25568616,0.0008742723,0.0000095101805,0.0028855267],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.97999346,0.013728509,0.0013529886,0.0017048783,0.0016629082,0.0015573293],"domain_scores_gemma":[0.97310853,0.01585791,0.0053505935,0.0015592044,0.0019955882,0.0021282095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020183343,0.0015817569,0.0017511151,0.0015271897,0.0026822814,0.0020731704,0.0014546834,0.004217644,0.00796018],"category_scores_gemma":[0.027481979,0.001351348,0.0017626181,0.0010334605,0.0018679074,0.0023370697,0.0014402501,0.0027480794,0.0016936606],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20174895,0.4679638,0.27129653,0.0014087072,0.001363433,0.0009780171,0.0114006605,0.0030817818,0.0031058828,0.002542521,0.002556464,0.032553185],"study_design_scores_gemma":[0.09503479,0.6170596,0.25802743,0.00031778423,0.0006461972,0.0002802169,0.00797866,0.009005835,0.0014845895,0.0037696625,0.006206209,0.00018903406],"about_ca_topic_score_codex":0.0019058607,"about_ca_topic_score_gemma":0.0018836249,"teacher_disagreement_score":0.020183343,"about_ca_system_score_codex":0.0026299274,"about_ca_system_score_gemma":0.005835046,"threshold_uncertainty_score":0.10674095},"labels":[],"label_agreement":null},{"id":"W4362507008","doi":"10.1007/s40120-023-00473-w","title":"A Path to Improved Alzheimer’s Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer’s Disease from the CLARITY AD Trial","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Eisai","keywords":"Medicine; Dementia; Disease; Neurology; Alzheimer's disease; Cognitive decline; Quality of life (healthcare); Cognition; Internal medicine; Psychiatry","score_opus":0.06299750840487883,"score_gpt":0.37933115185925004,"score_spread":0.3163336434543712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362507008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9197896,0.010740474,0.035208505,0.0058611445,0.0005903265,0.002159719,0.014344283,0.00037764737,0.010928292],"genre_scores_gemma":[0.97918713,0.00097217254,0.010885173,0.0008170883,0.00009434781,0.001351234,0.0053590303,0.000030569143,0.0013032253],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99741346,0.0021911936,0.00006489716,0.00012611852,0.00007906933,0.000125326],"domain_scores_gemma":[0.9921232,0.006337071,0.0006083645,0.0002637499,0.00035861536,0.0003090467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008906184,0.0010664352,0.0023161045,0.0004796649,0.0002579415,0.0010729812,0.0016488974,0.0013464701,0.0043742303],"category_scores_gemma":[0.013831079,0.00048142733,0.0031402302,0.0005209913,0.00037057078,0.00056724215,0.0009028836,0.001577809,0.00031012966],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022525873,0.0012789572,0.014501424,0.0011379882,0.004385464,0.00024257883,0.00012202691,0.92079496,0.00033189956,0.0056430832,0.006168126,0.022867536],"study_design_scores_gemma":[0.024375284,0.0068396116,0.0056351963,0.0004405448,0.004406446,0.000106327694,0.000055423738,0.94480044,0.00034407392,0.008098023,0.004816696,0.000081982005],"about_ca_topic_score_codex":0.018452093,"about_ca_topic_score_gemma":0.012717888,"teacher_disagreement_score":0.018452093,"about_ca_system_score_codex":0.00193095,"about_ca_system_score_gemma":0.0024051366,"threshold_uncertainty_score":0.04710096},"labels":[],"label_agreement":null},{"id":"W4365811132","doi":"10.1007/s40120-023-00472-x","title":"Understanding Barriers Along the Patient Journey in Alzheimer’s Disease Using Social Media Data","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute on Aging; Eisai Incorporated; Eisai","keywords":"Social media; Medicine; Stakeholder; Disease; Anxiety; Health care; Family medicine; Psychiatry; Public relations; World Wide Web; Pathology; Political science","score_opus":0.5508424590705465,"score_gpt":0.4467249856737546,"score_spread":0.10411747339679189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365811132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856601,0.0011865031,0.002472786,0.0038787154,0.000029243001,0.00019414914,0.0044317422,0.000026390167,0.0021204227],"genre_scores_gemma":[0.98989385,0.0010891132,0.0055281385,0.00036403458,0.000047712983,0.00023588544,0.0025090415,0.000008905917,0.00032334833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970432,0.0013081003,0.0006021052,0.00035513067,0.00043669075,0.00025480348],"domain_scores_gemma":[0.96628475,0.02162201,0.008094861,0.00085091084,0.0022473144,0.000900061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004614018,0.00033965198,0.00033639578,0.0049765334,0.000935696,0.0030481683,0.00062991644,0.00078105705,0.0012011096],"category_scores_gemma":[0.03377038,0.00026906942,0.00045229707,0.004715927,0.00058480847,0.004759905,0.0022601073,0.00084578845,0.00026258559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016069945,0.00013184908,0.8919163,0.0015672877,0.00012278814,0.00086093246,0.037344187,0.0006506566,0.0007848054,0.0014859727,0.0029601373,0.06201437],"study_design_scores_gemma":[0.000021768328,0.00026149425,0.7872281,0.0022858365,0.00022576722,0.0015477191,0.15767081,0.0102704195,0.0015425168,0.007558614,0.031261604,0.00012529783],"about_ca_topic_score_codex":0.007632698,"about_ca_topic_score_gemma":0.017971577,"teacher_disagreement_score":0.007632698,"about_ca_system_score_codex":0.0010558179,"about_ca_system_score_gemma":0.0016269649,"threshold_uncertainty_score":0.024401486},"labels":[],"label_agreement":null},{"id":"W4376643230","doi":"10.1007/s40120-023-00492-7","title":"Predicting the Societal Value of Lecanemab in Early Alzheimer’s Disease in Japan: A Patient-Level Simulation","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Eisai Incorporated","keywords":"Medicine; Willingness to pay; Disease; Dementia; Quality of life (healthcare); Health care; Caregiver burden; Quality-adjusted life year; Gerontology; Neurology; Biomarker; CLARITY; Alzheimer's disease; Psychiatry; Internal medicine; Cost effectiveness; Nursing","score_opus":0.04653057928319896,"score_gpt":0.3357652207862911,"score_spread":0.28923464150309214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376643230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863412,0.00055210147,0.0083699655,0.0011203883,0.00003605173,0.00011577554,0.0010430914,0.000023636405,0.0023977368],"genre_scores_gemma":[0.996619,0.00019464655,0.0019973572,0.00012604319,0.000011860377,0.00009184681,0.00048474237,0.000005042155,0.0004693647],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988166,0.0007255614,0.000058072284,0.00015623528,0.00006509614,0.00017834734],"domain_scores_gemma":[0.9928288,0.0053925,0.0006670881,0.00014998,0.000469132,0.00049255986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003310147,0.0010543831,0.001414686,0.00079800305,0.00050886977,0.00149486,0.0011442819,0.0017469283,0.0026532388],"category_scores_gemma":[0.009287224,0.0005425029,0.0024150985,0.0008341085,0.00064792973,0.0008880194,0.0009701207,0.0014618133,0.00016592784],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075018016,0.00027710368,0.03350894,0.00008026436,0.00030011727,0.00033814347,0.000078904006,0.9586656,0.00020963594,0.0017487381,0.0006721228,0.0033701463],"study_design_scores_gemma":[0.0003212385,0.00035720124,0.005658685,0.000026566784,0.00024673494,0.0000864596,0.00008139707,0.9912928,0.00010939946,0.0014154548,0.00037776033,0.000026379605],"about_ca_topic_score_codex":0.045336593,"about_ca_topic_score_gemma":0.019759139,"teacher_disagreement_score":0.045336593,"about_ca_system_score_codex":0.0037670867,"about_ca_system_score_gemma":0.002797791,"threshold_uncertainty_score":0.09014541},"labels":[],"label_agreement":null},{"id":"W4378781211","doi":"10.1007/s40120-023-00498-1","title":"Estimating Transition Probabilities Across the Alzheimer’s Disease Continuum Using a Nationally Representative Real-World Database in the United States","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Eisai Incorporated; Eisai","keywords":"Neurology; Medicine; Disease; Alzheimer's disease; Database; Transition (genetics); Data science; Gerontology; Psychiatry; Computer science; Internal medicine; Chemistry","score_opus":0.0767510819299604,"score_gpt":0.40676956382653057,"score_spread":0.3300184818965702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378781211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97240317,0.00038389402,0.009955815,0.0004999605,0.000021835825,0.00017941535,0.01597579,0.00009631138,0.0004838222],"genre_scores_gemma":[0.97306395,0.00021188156,0.009183235,0.00019374581,0.00001746953,0.00030293953,0.016832039,0.000008158131,0.00018657175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99585694,0.0024333545,0.00038966618,0.0009631197,0.0001630546,0.00019392058],"domain_scores_gemma":[0.98023146,0.013161847,0.003619113,0.001685426,0.0008707414,0.0004313392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077872905,0.00036497173,0.0008916708,0.0014096355,0.00047137606,0.0012557984,0.0011757805,0.0010778732,0.0015307276],"category_scores_gemma":[0.02614747,0.0007025081,0.0016296997,0.0017022508,0.00033845566,0.0011817535,0.00096342945,0.0012520392,0.00032731207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004830205,0.00033354564,0.9443471,0.00011475018,0.0008821593,0.00015791519,0.00023754737,0.040328387,0.00008982021,0.0012887415,0.0025080878,0.009228971],"study_design_scores_gemma":[0.00029665336,0.00030108023,0.5183939,0.00020476071,0.00063106266,0.00046814108,0.0005909108,0.47165066,0.00023306828,0.0047001215,0.0024376977,0.000091886395],"about_ca_topic_score_codex":0.044647798,"about_ca_topic_score_gemma":0.029075421,"teacher_disagreement_score":0.044647798,"about_ca_system_score_codex":0.0013076775,"about_ca_system_score_gemma":0.0012245114,"threshold_uncertainty_score":0.08877587},"labels":[],"label_agreement":null},{"id":"W4378952249","doi":"10.1007/s40120-023-00504-6","title":"A Systematic Review of Clinical Practice Guidelines for Alzheimer’s Disease and Strategies for Future Advancements","year":2023,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Eisai","keywords":"Medicine; Dementia; Systematic review; Intensive care medicine; Disease; Biomarker; Rivastigmine; Clinical Practice; MEDLINE; Neurocognitive; Neurology; Memantine; Cognition; Pathology; Psychiatry; Donepezil; Physical therapy","score_opus":0.30575132696215385,"score_gpt":0.5798969847401684,"score_spread":0.27414565777801453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378952249","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003176945,0.9839035,0.001377002,0.008419833,0.0012227331,0.0019107948,0.0015597392,0.00006135913,0.0012273296],"genre_scores_gemma":[0.009068738,0.96494204,0.011941533,0.006172263,0.0005951738,0.0052089896,0.0016045513,0.000040448143,0.00042625974],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9196598,0.034188326,0.028786866,0.0043907533,0.011793903,0.001180434],"domain_scores_gemma":[0.82138467,0.10793766,0.031371925,0.0034322133,0.033873826,0.0019997275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06778406,0.0025865014,0.009556253,0.023903333,0.001819613,0.006652917,0.0056403195,0.0048530675,0.009309499],"category_scores_gemma":[0.2263021,0.0022103724,0.014500846,0.0172996,0.0020991126,0.0072059217,0.0042987,0.00450584,0.0015739361],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016212309,0.00002408302,0.00091488025,0.8419898,0.00497515,0.0001059478,0.00052589737,0.0003254167,0.000113189875,0.002343664,0.028027685,0.12049216],"study_design_scores_gemma":[0.00015146243,0.000046974863,0.00085266214,0.9474175,0.00909407,0.0000915005,0.0001813845,0.000118029595,0.000060904476,0.0014352775,0.040516336,0.000033881],"about_ca_topic_score_codex":0.021843519,"about_ca_topic_score_gemma":0.05602743,"teacher_disagreement_score":0.06778406,"about_ca_system_score_codex":0.014227179,"about_ca_system_score_gemma":0.063714325,"threshold_uncertainty_score":0.3584807},"labels":[],"label_agreement":null},{"id":"W4380576930","doi":"10.1007/s40120-023-00505-5","title":"Dietary Patterns and Their Associations with Symptom Levels Among People with Multiple Sclerosis: A Real-World Digital Study","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada","funders":"Innovationsfonden; Scleroseforeningen","keywords":"Multiple sclerosis; Neurology; Medicine; Gerontology; Psychiatry","score_opus":0.07206174104287816,"score_gpt":0.2949780695767183,"score_spread":0.22291632853384014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380576930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986986,0.0002613758,0.000064729604,0.000027878592,0.0000025462095,0.000010383052,0.0007520067,0.000001809772,0.00018075659],"genre_scores_gemma":[0.99922776,0.000117827636,0.00010073229,0.000014832685,0.0000043755654,0.000012223675,0.00042723148,0.0000010797808,0.00009399532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994511,0.00017811329,0.00008654609,0.00014824214,0.00007782796,0.000058261998],"domain_scores_gemma":[0.9987992,0.00017589217,0.00061329495,0.00014175745,0.00011785103,0.00015195251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006902905,0.00020379506,0.00041927744,0.00081665214,0.000463309,0.00093698513,0.00029874468,0.0005188736,0.001369542],"category_scores_gemma":[0.001718577,0.00029403114,0.00066112063,0.0018410691,0.00029857838,0.00067524315,0.0007273906,0.00043741197,0.00023999008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017040703,0.000036226982,0.99845994,0.000030038238,0.00013317046,0.000038134218,0.00017437809,0.000023362167,0.00010787927,0.00000793555,0.000035515826,0.0007830456],"study_design_scores_gemma":[0.000005227273,0.00008830864,0.9993492,0.000006485407,0.000039128423,0.000074447766,0.00024325126,0.000052733354,0.000015643318,0.000009822734,0.00011258561,0.0000031529855],"about_ca_topic_score_codex":0.0066139866,"about_ca_topic_score_gemma":0.00792135,"teacher_disagreement_score":0.0066139866,"about_ca_system_score_codex":0.00027437642,"about_ca_system_score_gemma":0.00021357289,"threshold_uncertainty_score":0.01315099},"labels":[],"label_agreement":null},{"id":"W4381308813","doi":"10.1007/s40120-023-00485-6","title":"Systematic Comparison of Muscle Ultrasound Thickness in Polyneuropathies and Other Neuromuscular Diseases","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Neurology; Neuromuscular disease; Ultrasound; Electromyography; Physical medicine and rehabilitation; Anatomy; Pathology; Radiology","score_opus":0.01864076105009953,"score_gpt":0.2789695339476709,"score_spread":0.26032877289757134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381308813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965661,0.0026062997,0.00022538418,0.000012089947,0.000010553611,0.000015999114,0.00035663985,0.000004371829,0.00020260207],"genre_scores_gemma":[0.9990784,0.00033146588,0.00014309768,0.000012308922,0.000009925401,0.00001668109,0.00034369985,0.0000018682066,0.00006263285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983726,0.0005603099,0.00027948292,0.00047665785,0.0002264198,0.00008467301],"domain_scores_gemma":[0.9956173,0.0011768135,0.002034786,0.0003639561,0.00058466074,0.00022251022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001974458,0.00028162217,0.0005357338,0.0013492928,0.0003102225,0.00037143164,0.00030330432,0.00031065135,0.0007234321],"category_scores_gemma":[0.0044782776,0.00021382578,0.00049777515,0.0012868373,0.00028318053,0.00024872523,0.00043596665,0.00017874363,0.00009945385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002312694,0.000007808513,0.99783283,0.000064580796,0.00023766728,0.000029558925,0.000033937762,0.000018338491,0.0002947255,0.0000053707886,0.000026293437,0.0012176516],"study_design_scores_gemma":[0.0000068827735,0.0001308429,0.9992518,0.00001742002,0.00012712173,0.00018499841,0.00003832691,0.000040956515,0.00009812485,0.0000072008643,0.00009475506,0.0000015557671],"about_ca_topic_score_codex":0.0018021351,"about_ca_topic_score_gemma":0.002829053,"teacher_disagreement_score":0.001974458,"about_ca_system_score_codex":0.00019304559,"about_ca_system_score_gemma":0.00029611122,"threshold_uncertainty_score":0.010442078},"labels":[],"label_agreement":null},{"id":"W4384663785","doi":"10.1007/s40120-023-00519-z","title":"What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Sanofi Genzyme; EMD Serono; Fondation Charcot; Teva Pharmaceutical Industries; Celgene; Merck KGaA; Sanofi; Biogen; Bristol-Myers Squibb","keywords":"Foundation (evidence); Medicine; Multiple sclerosis; Cognitive impairment; Neurology; Gerontology; Cognition; Neuroscience; Psychiatry; Psychology; Political science","score_opus":0.043031321534395504,"score_gpt":0.31949025083241683,"score_spread":0.27645892929802135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384663785","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008441719,0.008826473,0.00006466342,0.92994297,0.059326176,0.000018692886,0.00004898183,0.000009066398,0.0009188545],"genre_scores_gemma":[0.018812116,0.010372555,0.0002658011,0.8988323,0.06837015,0.00012450827,0.00008420378,0.00007466575,0.0030636485],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9760184,0.013124758,0.0019092086,0.0020266874,0.003952742,0.0029682117],"domain_scores_gemma":[0.9087455,0.059399206,0.0032534841,0.00085493096,0.01439822,0.013348612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03600504,0.0014862934,0.0019791743,0.0013471916,0.015845139,0.009489293,0.004572792,0.049763843,0.006430756],"category_scores_gemma":[0.08794679,0.0010601382,0.0030346757,0.0011704414,0.008450597,0.011180783,0.010276209,0.06172133,0.0014428034],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015523862,0.000041966003,0.00038284,0.0015036475,0.000049563616,0.0014483306,0.026944239,0.00007574996,0.0004216364,0.0040987376,0.9518317,0.013046324],"study_design_scores_gemma":[0.000060240698,0.00013467316,0.0010987327,0.0048445566,0.000061259125,0.00072558597,0.029131588,0.0000939764,0.00023968918,0.0023895986,0.96108264,0.00013737938],"about_ca_topic_score_codex":0.019624082,"about_ca_topic_score_gemma":0.026696507,"teacher_disagreement_score":0.049763843,"about_ca_system_score_codex":0.016273461,"about_ca_system_score_gemma":0.023481019,"threshold_uncertainty_score":0.19041508},"labels":[],"label_agreement":null},{"id":"W4386189439","doi":"10.1007/s40120-023-00533-1","title":"Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Lévis; Selkirk College","funders":"UCB Pharma; National Institutes of Health; Britannia Pharmaceuticals; H. Lundbeck A/S; Newcastle University; Eisai; University of Oxford; Wellcome Trust; Medical Research Council; International Parkinson and Movement Disorder Society; AbbVie; EVER Neuro Pharma; Ministero dell’Istruzione, dell’Università e della Ricerca; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Pfizer","keywords":"Medicine; Parkinson's disease; Open label; Neurology; Internal medicine; Pharmacology; Disease; Adverse effect; Psychiatry","score_opus":0.04677587415452242,"score_gpt":0.3153436746865626,"score_spread":0.2685678005320402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386189439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995061,0.0014319114,0.0003924489,0.00015595525,0.000049476403,0.0013387657,0.0008263868,0.000071358154,0.00067270803],"genre_scores_gemma":[0.99120235,0.0013374601,0.0012005008,0.0005726829,0.00015285655,0.0019545075,0.002208936,0.000035827,0.0013348104],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99930906,0.000252414,0.000046843004,0.00013768516,0.000114717615,0.00013930429],"domain_scores_gemma":[0.99862397,0.00018117901,0.00035960518,0.00012483215,0.00013660743,0.00057378056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023937433,0.0015822357,0.0029211864,0.000452376,0.0006492658,0.001279664,0.0010139723,0.0016485795,0.0032164934],"category_scores_gemma":[0.0011025318,0.00057096046,0.0019815248,0.0005184396,0.0011266362,0.0011296425,0.00033286028,0.0032689916,0.0008264627],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80325,0.0867934,0.004675123,0.00081511016,0.0015164425,0.0002952429,0.00037334822,0.0008383852,0.044482145,0.000077889585,0.001733432,0.05514945],"study_design_scores_gemma":[0.5466032,0.42765588,0.019818565,0.000040013834,0.00054182264,0.00026555476,0.00005998556,0.0006677647,0.0030956648,0.0001045686,0.0011085679,0.000038474915],"about_ca_topic_score_codex":0.0012897471,"about_ca_topic_score_gemma":0.0029444473,"teacher_disagreement_score":0.0032164934,"about_ca_system_score_codex":0.0009965095,"about_ca_system_score_gemma":0.0015558241,"threshold_uncertainty_score":0.0126594305},"labels":[],"label_agreement":null},{"id":"W4387002251","doi":"10.1007/s40120-023-00540-2","title":"Rule-Based Identification of Individuals with Mild Cognitive Impairment or Alzheimer’s Disease Using Clinical Notes from the United States Veterans Affairs Healthcare System","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Eisai Incorporated; National Institute on Aging; National Institutes of Health; Eisai","keywords":"Veterans Affairs; Diagnosis code; Medicine; Cognitive impairment; Disease; Gerontology; Cohort; Psychiatry; Internal medicine","score_opus":0.3720699163122119,"score_gpt":0.48910764434621246,"score_spread":0.11703772803400053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387002251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8301393,0.008513403,0.0348055,0.0024378782,0.00032747502,0.0051632086,0.10113541,0.0011714024,0.016306434],"genre_scores_gemma":[0.81558925,0.0028300695,0.0923993,0.0013366237,0.00018908334,0.0014038294,0.08498672,0.000085148306,0.0011800366],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99110717,0.0020533698,0.0031246135,0.0019024373,0.0014738657,0.0003385418],"domain_scores_gemma":[0.9660176,0.017856076,0.006788037,0.00242769,0.006105724,0.0008049428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007095854,0.0006759289,0.00089571334,0.010228587,0.0006779329,0.0029152662,0.0016226193,0.00077986345,0.0020289402],"category_scores_gemma":[0.051515605,0.00035677213,0.0011402457,0.0046806913,0.00031511558,0.0014520786,0.0022595818,0.00070153264,0.001118752],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000526664,0.00019939094,0.8715999,0.0019755666,0.00044104713,0.0013034096,0.0015159587,0.0021070037,0.0016819531,0.00084047375,0.016258242,0.10155049],"study_design_scores_gemma":[0.00034738405,0.00048083314,0.87532425,0.0059934147,0.0010257157,0.003218093,0.0061894124,0.041802112,0.0075795474,0.004767554,0.053022757,0.00024884872],"about_ca_topic_score_codex":0.03558029,"about_ca_topic_score_gemma":0.0554019,"teacher_disagreement_score":0.03558029,"about_ca_system_score_codex":0.0009923526,"about_ca_system_score_gemma":0.0042318385,"threshold_uncertainty_score":0.07074636},"labels":[],"label_agreement":null},{"id":"W4387478185","doi":"10.1007/s40120-023-00554-w","title":"Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study","year":2023,"lang":"en","type":"erratum","venue":"Neurology and Therapy","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Lévis; Selkirk College","funders":"","keywords":"Medicine; Open label; Parkinson's disease; Neurology; Physical medicine and rehabilitation; Internal medicine; Disease; Adverse effect; Psychiatry","score_opus":0.039757762395473364,"score_gpt":0.3080810154763792,"score_spread":0.2683232530809059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387478185","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046428785,0.0016089596,0.000982664,0.044754233,0.9471414,0.00007076057,0.0017880374,0.00088074506,0.002308992],"genre_scores_gemma":[0.032831956,0.01097186,0.011138397,0.16267517,0.60032946,0.00073074497,0.0041227723,0.0026079768,0.17459157],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948827,0.0008541891,0.001067993,0.0006098923,0.0021913399,0.00039395076],"domain_scores_gemma":[0.9645153,0.009622321,0.0030396567,0.0012636794,0.020284332,0.0012746112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004455273,0.0027119648,0.0026096075,0.0021108577,0.0017967672,0.0029395055,0.0037050308,0.007895099,0.03058192],"category_scores_gemma":[0.052630227,0.001053201,0.002235752,0.0015280036,0.0019015264,0.0015471383,0.001071375,0.0085423235,0.015767407],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013293969,0.000010333383,0.00007012167,0.0003708709,0.000029423876,0.0006535472,0.000028186185,0.000058643407,0.00014460029,0.00032146426,0.99263096,0.0055489168],"study_design_scores_gemma":[0.0005277815,0.00015717601,0.0022629688,0.001084471,0.00018470579,0.0030475236,0.000094746014,0.0009530512,0.00092949765,0.0013464424,0.9893155,0.00009619493],"about_ca_topic_score_codex":0.0149777485,"about_ca_topic_score_gemma":0.015601967,"teacher_disagreement_score":0.03058192,"about_ca_system_score_codex":0.0042851935,"about_ca_system_score_gemma":0.004544097,"threshold_uncertainty_score":0.10230672},"labels":[],"label_agreement":null},{"id":"W4387691701","doi":"10.1007/s40120-023-00548-8","title":"Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; Medical Research Council; National Institutes of Health; Motor Neurone Disease Association; Brain Research UK; National Institute on Aging; Barrow Neurological Foundation; Arizona Community Foundation","keywords":"C9orf72; Amyotrophic lateral sclerosis; Frontotemporal dementia; Medicine; Frontotemporal lobar degeneration; Neuroscience; Trinucleotide repeat expansion; Positron emission tomography; Disease; Bioinformatics; Dementia; Psychology; Genetics; Biology; Pathology; Gene; Allele","score_opus":0.07597706507016341,"score_gpt":0.3146109324541491,"score_spread":0.2386338673839857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387691701","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0239288,0.25861323,0.005016414,0.53238827,0.11317146,0.0017192856,0.0060933973,0.0008712732,0.05819788],"genre_scores_gemma":[0.17182283,0.26461703,0.020889286,0.26710254,0.09054024,0.00510123,0.03255271,0.00064928416,0.1467249],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99662566,0.00048599194,0.00014476855,0.00033678816,0.0011776034,0.0012291205],"domain_scores_gemma":[0.99177986,0.001629358,0.00029896502,0.00017423746,0.0028131418,0.0033043642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012057317,0.0023153496,0.00094303815,0.0020810736,0.0027773161,0.0046313726,0.0019460411,0.010360063,0.0123415105],"category_scores_gemma":[0.00800947,0.0006607213,0.0021533454,0.001220204,0.0012024095,0.0033191561,0.00792608,0.008876547,0.004685537],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052898773,0.000606948,0.0023534512,0.0012139231,0.00008988722,0.001555698,0.00055206555,0.00054346386,0.003229666,0.005239676,0.8374689,0.14661723],"study_design_scores_gemma":[0.00019433966,0.0006461822,0.011579441,0.001404278,0.0001516271,0.00036693603,0.0008165643,0.0005065364,0.001342748,0.0031164526,0.9797937,0.00008114256],"about_ca_topic_score_codex":0.015270432,"about_ca_topic_score_gemma":0.021477876,"teacher_disagreement_score":0.015270432,"about_ca_system_score_codex":0.0044227117,"about_ca_system_score_gemma":0.015512326,"threshold_uncertainty_score":0.06376594},"labels":[],"label_agreement":null},{"id":"W4389136728","doi":"10.1007/s40120-023-00566-6","title":"An Integrative Nomogram for Identifying Cognitive Impairment Using Seizure Type and Cerebral Small Vessel Disease Neuroimaging Markers in Patients with Late-Onset Epilepsy of Unknown Origin","year":2023,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroimaging; Epilepsy; Medicine; Neurology; Cognitive impairment; Neuroscience; Cognition; Disease; Nomogram; Pathology; Psychiatry; Internal medicine; Psychology","score_opus":0.03447406113874,"score_gpt":0.3342680577388482,"score_spread":0.2997939966001082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389136728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93460625,0.003209317,0.05238636,0.0010015363,0.00018652508,0.0003847425,0.0031024667,0.0006534811,0.004469378],"genre_scores_gemma":[0.9834046,0.00037841641,0.01429614,0.00005656584,0.00007662574,0.00015441627,0.0013467862,0.000029144992,0.0002572906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978908,0.0010286077,0.00019669063,0.00033087173,0.0003859943,0.00016712143],"domain_scores_gemma":[0.9899603,0.0048283353,0.0021337336,0.00066335814,0.0016910044,0.00072322396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008042966,0.0017351238,0.0014710146,0.00715892,0.0007601333,0.0020169541,0.0013291644,0.0009363327,0.0015787513],"category_scores_gemma":[0.0176679,0.00033963495,0.0020936052,0.0023798393,0.0006549862,0.0012610134,0.0015208458,0.0009337839,0.0005691655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005976611,0.000095450654,0.9565179,0.000096455675,0.0005435869,0.00019803787,0.00012507828,0.010186192,0.00035110017,0.0003789615,0.0017207757,0.029188778],"study_design_scores_gemma":[0.0001808029,0.0010613403,0.5735829,0.00030686718,0.0012769188,0.0021763223,0.0008408613,0.4100422,0.0011565302,0.0029640917,0.006222413,0.00018881095],"about_ca_topic_score_codex":0.0034104167,"about_ca_topic_score_gemma":0.0034263674,"teacher_disagreement_score":0.008042966,"about_ca_system_score_codex":0.0008440052,"about_ca_system_score_gemma":0.0013402158,"threshold_uncertainty_score":0.04253578},"labels":[],"label_agreement":null},{"id":"W4390663037","doi":"10.1007/s40120-023-00570-w","title":"The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy","year":2024,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"F. Hoffmann-La Roche; Bristol-Myers Squibb","keywords":"Myostatin; Duchenne muscular dystrophy; Medicine; Muscular dystrophy; Internal medicine; Clinical endpoint; Placebo; Endocrinology; Clinical trial; Skeletal muscle; Pathology","score_opus":0.026435878287992737,"score_gpt":0.326808358016509,"score_spread":0.3003724797285162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390663037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7084118,0.21228595,0.018457623,0.007879709,0.0016853829,0.002687146,0.004458358,0.0010485643,0.043085497],"genre_scores_gemma":[0.91003895,0.05475047,0.010555502,0.0043073427,0.00055167935,0.0008635739,0.004984678,0.00007691769,0.013870957],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996722,0.00010870104,0.000024366274,0.000052389332,0.000104290324,0.00003818496],"domain_scores_gemma":[0.9997384,0.00003859211,0.000047582056,0.000015686286,0.00006511391,0.00009468942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096004223,0.00046386642,0.00052387506,0.00048192227,0.00026943418,0.00068552856,0.00046407987,0.000822946,0.0026153119],"category_scores_gemma":[0.00051272195,0.00013478543,0.00057617965,0.0002770273,0.00042418836,0.0004065245,0.00028195878,0.0014407603,0.0011737405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009601996,0.004405203,0.0032058682,0.0025117807,0.0004088347,0.0012665647,0.00031681935,0.0015938999,0.30349308,0.0021709455,0.024785776,0.64623916],"study_design_scores_gemma":[0.026457366,0.12223553,0.034711655,0.0011959139,0.00083590625,0.011194383,0.0002597959,0.0045608412,0.2224071,0.0017795502,0.57422,0.00014197895],"about_ca_topic_score_codex":0.0007554963,"about_ca_topic_score_gemma":0.0024573023,"teacher_disagreement_score":0.0026153119,"about_ca_system_score_codex":0.0006080432,"about_ca_system_score_gemma":0.00063591445,"threshold_uncertainty_score":0.008749068},"labels":[],"label_agreement":null},{"id":"W4390743174","doi":"10.1007/s40120-023-00565-7","title":"Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives","year":2024,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Greenwich Biosciences; EMD Serono; Genentech; Horizon Therapeutics; Mylan; TG Therapeutics; Biogen; Celgene; Sanofi Genzyme; F. Hoffmann-La Roche; Alexion Pharmaceuticals; Jazz Pharmaceuticals; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; Sanofi; MedDay Pharmaceuticals; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Medicine; Multiple sclerosis; Neurology; Clinical trial; Immunosuppression; Disease; Interferon beta; Interferon beta-1a; Glatiramer acetate; Internal medicine; Oncology; Pediatrics; Immunology; Psychiatry","score_opus":0.09876984893684974,"score_gpt":0.32260762669681203,"score_spread":0.22383777775996228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390743174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009394288,0.9825916,0.00030655408,0.012507132,0.0015898569,0.0000060898674,0.00001903798,0.000010521905,0.0020296974],"genre_scores_gemma":[0.01322792,0.9599036,0.0007946207,0.015229578,0.009186542,0.000043583957,0.00007555825,0.000013632801,0.0015249015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927706,0.0002659498,0.00011762664,0.000104012455,0.00017711044,0.000058309375],"domain_scores_gemma":[0.99764615,0.0012540952,0.00031819986,0.00008810334,0.00041821276,0.0002751703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041243974,0.0005983565,0.00077110255,0.0006970263,0.0002965737,0.0015293441,0.0005913816,0.0015981969,0.0029867527],"category_scores_gemma":[0.0036676375,0.00015863834,0.00044531818,0.0008839993,0.001234565,0.0021478084,0.0006029874,0.0031016807,0.001365329],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081205915,0.00022247164,0.00074290746,0.0031855,0.00009103803,0.00029295712,0.00019412946,0.00021432014,0.0014742411,0.013186969,0.043448456,0.9361349],"study_design_scores_gemma":[0.00031431913,0.0015561016,0.0021490436,0.0048007956,0.0001901755,0.0014902938,0.00016664318,0.00020575745,0.00047263838,0.007558602,0.98106605,0.00002965034],"about_ca_topic_score_codex":0.00051370595,"about_ca_topic_score_gemma":0.0010296847,"teacher_disagreement_score":0.0041243974,"about_ca_system_score_codex":0.0009220123,"about_ca_system_score_gemma":0.0013454278,"threshold_uncertainty_score":0.0218122},"labels":[],"label_agreement":null},{"id":"W4391964471","doi":"10.1007/s40120-024-00579-9","title":"Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation","year":2024,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Merck KGaA","keywords":"Cognition; Multiple sclerosis; Medicine; Foundation (evidence); Neuropsychology; Quality of life (healthcare); Cognitive impairment; Gerontology; Activities of daily living; Independent living; Disease; Affect (linguistics); Psychology; Psychiatry; Nursing; Pathology","score_opus":0.07331094111534517,"score_gpt":0.35913218201356667,"score_spread":0.2858212408982215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391964471","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013408778,0.02432898,0.000080223464,0.8657904,0.1086995,0.000053963344,0.0001632389,0.00001055494,0.00073908106],"genre_scores_gemma":[0.0023888212,0.016364431,0.00029740547,0.8918125,0.086623654,0.00021861169,0.00011939288,0.00003732729,0.0021378964],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95638895,0.023945339,0.006309133,0.003327182,0.0077991243,0.0022303406],"domain_scores_gemma":[0.8129719,0.1325125,0.0065795756,0.0016806229,0.03800195,0.008253475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05399129,0.0023275276,0.0034712218,0.0038218813,0.00794281,0.0082270475,0.006488454,0.050195627,0.006866669],"category_scores_gemma":[0.14386909,0.0015873119,0.0055220695,0.00286559,0.0063434974,0.008996616,0.0049683163,0.046638306,0.0034053428],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014532598,0.000017290944,0.00010058904,0.0021544676,0.00006367528,0.00023222364,0.001344124,0.000037776583,0.00018393996,0.0014784469,0.9856469,0.008595223],"study_design_scores_gemma":[0.0001952212,0.00017302041,0.0008634149,0.015008481,0.00031680882,0.00043886062,0.0026518907,0.000096840595,0.00027151042,0.0029523552,0.97690386,0.00012774648],"about_ca_topic_score_codex":0.02601399,"about_ca_topic_score_gemma":0.031228617,"teacher_disagreement_score":0.05399129,"about_ca_system_score_codex":0.017239029,"about_ca_system_score_gemma":0.029428743,"threshold_uncertainty_score":0.28553665},"labels":[],"label_agreement":null},{"id":"W4392960370","doi":"10.1007/s40120-024-00596-8","title":"Publisher Correction: Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation","year":2024,"lang":"en","type":"erratum","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Foundation (evidence); Medicine; Cognitive impairment; Multiple sclerosis; Gerontology; Neurology; Cognition; Alternative medicine; Physical medicine and rehabilitation; Neuroscience; Psychology; Psychiatry; Pathology; Political science","score_opus":0.06265815489145371,"score_gpt":0.34320248225376687,"score_spread":0.28054432736231316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392960370","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002274737,0.0013446034,0.000065851396,0.23433813,0.7633006,0.00001842363,0.00023765232,0.00003317307,0.0006388269],"genre_scores_gemma":[0.0011038634,0.003648267,0.00043960716,0.5721987,0.40553123,0.00018932745,0.00020064041,0.00018192742,0.016506406],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9765771,0.0055079022,0.004765033,0.0022344072,0.009023659,0.00189193],"domain_scores_gemma":[0.8488863,0.07032795,0.0074296305,0.004985005,0.06195074,0.0064203357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027972078,0.0036540504,0.005529016,0.006327275,0.008781756,0.010515002,0.009361129,0.042138107,0.020998806],"category_scores_gemma":[0.18658778,0.0029962086,0.005045788,0.004527409,0.006769514,0.0048107775,0.004231907,0.05852724,0.015109467],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018134058,0.000002710074,0.00002386427,0.00011208531,0.000012768058,0.00006605703,0.000032852327,0.000009955597,0.000008743472,0.00025229683,0.99856704,0.00089354574],"study_design_scores_gemma":[0.00019527087,0.00003234387,0.000822754,0.0022258174,0.00019445857,0.00020591165,0.00028466203,0.00013128157,0.000110729015,0.0017477246,0.9939697,0.00007932396],"about_ca_topic_score_codex":0.090726875,"about_ca_topic_score_gemma":0.09818688,"teacher_disagreement_score":0.090726875,"about_ca_system_score_codex":0.015135966,"about_ca_system_score_gemma":0.02799377,"threshold_uncertainty_score":0.18039757},"labels":[],"label_agreement":null},{"id":"W4396922387","doi":"10.1007/s40120-024-00622-9","title":"Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder","year":2024,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Sleep and related disorders","field":"Psychology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal","funders":"Eisai Incorporated","keywords":"Insomnia; Medicine; Sleep onset; Alertness; Sleep disorder; Morning; Placebo; Sleep onset latency; Primary Insomnia; Epworth Sleepiness Scale; Excessive daytime sleepiness; Polysomnography; Physical therapy; Psychiatry; Internal medicine; Apnea","score_opus":0.006870321669033029,"score_gpt":0.25903289406426855,"score_spread":0.25216257239523554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396922387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99347115,0.004974744,0.00003214853,0.00014009744,0.00003443118,0.00008844081,0.00021319509,0.000015708429,0.0010300247],"genre_scores_gemma":[0.9960079,0.002207227,0.0001772784,0.000546208,0.00006622577,0.00009472772,0.0004155434,0.0000017966477,0.00048302315],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99984896,0.000047667625,0.00003051426,0.000022348951,0.000024507115,0.000025966214],"domain_scores_gemma":[0.99958545,0.00006485138,0.00016930138,0.000012725583,0.000041221767,0.00012639859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000637313,0.00032162416,0.0006388613,0.00028392993,0.0002629762,0.00025547197,0.0001564541,0.00034632112,0.0012862313],"category_scores_gemma":[0.0009523423,0.00016193134,0.0006862931,0.0002059318,0.000101957536,0.00024153567,0.00026644257,0.00042735087,0.00023765657],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29017442,0.012612433,0.38148376,0.0030124937,0.0029740115,0.00096866605,0.00090700283,0.000567377,0.032966778,0.00009950928,0.0037479112,0.27048564],"study_design_scores_gemma":[0.013454903,0.06702289,0.9140103,0.00027190664,0.0011167731,0.00031523273,0.00030508175,0.00035932576,0.00089063577,0.00004712195,0.0021804322,0.000025427078],"about_ca_topic_score_codex":0.0026044485,"about_ca_topic_score_gemma":0.009983668,"teacher_disagreement_score":0.0026044485,"about_ca_system_score_codex":0.00031290058,"about_ca_system_score_gemma":0.00030338124,"threshold_uncertainty_score":0.005178511},"labels":[],"label_agreement":null},{"id":"W4400950647","doi":"10.1007/s40120-024-00647-0","title":"Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri®) Dosing: NOVA Phase IIIb Extension Study (Part 2)","year":2024,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Natalizumab; Medicine; Dosing; Crossover study; Clinical endpoint; Randomized controlled trial; Anesthesia; Internal medicine; Placebo","score_opus":0.06544853152701602,"score_gpt":0.32205249108967166,"score_spread":0.25660395956265564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400950647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963689,0.00026858147,0.00028526047,0.00009842649,0.00004902683,0.0017887688,0.0004930014,0.000014288876,0.0006338024],"genre_scores_gemma":[0.9925345,0.0002653172,0.0014531045,0.00035989782,0.00009651999,0.00319644,0.0006388077,0.000008136285,0.0014472386],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9985531,0.0008703095,0.00010772083,0.0001529819,0.00019953989,0.000116373834],"domain_scores_gemma":[0.99800164,0.0005394664,0.00075293955,0.00014975405,0.000105514555,0.00045060454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035742093,0.00075742893,0.0010905769,0.00022024466,0.00033361476,0.0006350408,0.0005671984,0.00080384844,0.006860987],"category_scores_gemma":[0.002384946,0.00043127575,0.0013407156,0.00023193794,0.00062368484,0.00055074785,0.0003466767,0.0015318445,0.0009536707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88032037,0.059752222,0.010747205,0.00046933373,0.00070466025,0.00004291189,0.0002449341,0.0003263503,0.016988238,0.00012325637,0.0010471727,0.029233303],"study_design_scores_gemma":[0.2974506,0.65728915,0.037439667,0.000054616612,0.00047652266,0.0001554297,0.000076514625,0.0008508134,0.0042095673,0.00015544113,0.0017880348,0.00005357652],"about_ca_topic_score_codex":0.00043036873,"about_ca_topic_score_gemma":0.00069824466,"teacher_disagreement_score":0.006860987,"about_ca_system_score_codex":0.0005590575,"about_ca_system_score_gemma":0.0011509248,"threshold_uncertainty_score":0.022952318},"labels":[],"label_agreement":null},{"id":"W4402506270","doi":"10.1007/s40120-024-00656-z","title":"Advancements and Challenges in Exercise Training for Multiple Sclerosis: Comprehensive Review and Future Directions for Randomized Controlled Trials","year":2024,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Randomized controlled trial; Medicine; Neurology; Multiple sclerosis; Physical therapy; Physical medicine and rehabilitation; Alternative medicine; Internal medicine; Pathology; Psychiatry","score_opus":0.4063405494038279,"score_gpt":0.44346385427401935,"score_spread":0.03712330487019144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402506270","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037077032,0.9991535,0.00010006199,0.00042109838,0.00013672223,0.00006380673,0.000026848616,0.000005025517,0.000055793196],"genre_scores_gemma":[0.000925643,0.9971367,0.0006879444,0.00078154966,0.00016626275,0.00021305583,0.000044428212,0.000004054522,0.000040360173],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9822484,0.0076337936,0.006025527,0.0009588747,0.0027349372,0.00039844232],"domain_scores_gemma":[0.9146508,0.068301335,0.008889268,0.0013124769,0.006160368,0.0006857139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04325659,0.0020394565,0.015299679,0.0075640217,0.0008162915,0.0044799703,0.0031699017,0.0034799252,0.005897886],"category_scores_gemma":[0.07132805,0.0011007027,0.011984547,0.009267142,0.0014207616,0.00450694,0.0020604127,0.0035360493,0.00066308025],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058695296,0.000062590494,0.00028946283,0.7615706,0.0065740193,0.000071566734,0.00012424277,0.00019846803,0.00017843503,0.0013614587,0.005899849,0.22308233],"study_design_scores_gemma":[0.0006475432,0.00042103924,0.0015643302,0.859365,0.044619415,0.00020918294,0.0001903719,0.0002028304,0.00018086172,0.002819512,0.089719854,0.000060109698],"about_ca_topic_score_codex":0.004846072,"about_ca_topic_score_gemma":0.012819392,"teacher_disagreement_score":0.04325659,"about_ca_system_score_codex":0.0040300214,"about_ca_system_score_gemma":0.017140009,"threshold_uncertainty_score":0.22876549},"labels":[],"label_agreement":null},{"id":"W4402601342","doi":"10.1007/s40120-024-00661-2","title":"Development of a General Composite Scale (GENCOMS) for Progressive Neurodegenerative Diseases and Implications for the Assessment of Disease-Modifying Therapies","year":2024,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Neurology; Disease; Scale (ratio); Neuroscience; Internal medicine; Psychiatry; Biology","score_opus":0.05071219049739833,"score_gpt":0.38270741625987176,"score_spread":0.3319952257624734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402601342","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2674156,0.009936615,0.67183554,0.004243404,0.0013253229,0.0064400625,0.009263225,0.0017893618,0.027750785],"genre_scores_gemma":[0.48470193,0.0022942403,0.5014307,0.00074640475,0.00025215375,0.005279068,0.0033842921,0.00014775693,0.0017634701],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9900331,0.005638166,0.00075934123,0.0007459834,0.0026836484,0.00013967574],"domain_scores_gemma":[0.97688496,0.012008889,0.0037800586,0.0021337688,0.0045948676,0.0005973095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024057426,0.0011061376,0.0011134746,0.0028698237,0.00049284386,0.0015997216,0.0012147103,0.0009518847,0.0032427732],"category_scores_gemma":[0.04398685,0.00023967269,0.001920289,0.0021501745,0.0013945976,0.0012405508,0.0014432598,0.0018980652,0.00066036626],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001032864,0.00048164834,0.20248769,0.0028879426,0.001668936,0.00020418622,0.0022000438,0.015658943,0.00830601,0.037976034,0.02524284,0.7018528],"study_design_scores_gemma":[0.00041089504,0.005052103,0.7512287,0.0033001564,0.0010845674,0.0013750187,0.0017334571,0.06418555,0.007436163,0.0852512,0.07847771,0.00046446838],"about_ca_topic_score_codex":0.0017314397,"about_ca_topic_score_gemma":0.0031283114,"teacher_disagreement_score":0.024057426,"about_ca_system_score_codex":0.0012941775,"about_ca_system_score_gemma":0.003100634,"threshold_uncertainty_score":0.12722939},"labels":[],"label_agreement":null},{"id":"W4404012161","doi":"10.1007/s40120-024-00676-9","title":"Quality of Life in Mild Cognitive Impairment and Mild Dementia Associated with Alzheimer’s Disease: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; TransCanada (Canada)","funders":"Eisai Incorporated","keywords":"Dementia; Medicine; Neurology; Disease; Alzheimer's disease; Cognitive impairment; Quality of life (healthcare); Cognition; Psychiatry; Gerontology; Neuroscience; Psychology; Internal medicine","score_opus":0.08967961699036008,"score_gpt":0.4049455078359748,"score_spread":0.31526589084561474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404012161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008223927,0.99856144,0.00004830601,0.00010149365,0.00004674047,0.0000997714,0.00019072465,0.0000036902413,0.00012547922],"genre_scores_gemma":[0.01215023,0.98679984,0.00027242381,0.00026477326,0.000055398912,0.00023019237,0.00015545664,0.0000022318545,0.00006934598],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99736375,0.0009684334,0.00085957657,0.00021709575,0.00048386195,0.00010725128],"domain_scores_gemma":[0.9910608,0.0065043396,0.0016259439,0.00008289059,0.00060406275,0.000122053294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033263257,0.0012051194,0.0072786333,0.0059241066,0.0004312729,0.0017701574,0.001233819,0.001271209,0.0032704445],"category_scores_gemma":[0.016529797,0.0006545522,0.006721133,0.0060930643,0.00054360356,0.0013362799,0.0010934856,0.00096264353,0.0001772413],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018343085,0.000018212308,0.000929152,0.9418973,0.009124136,0.00006543273,0.00012528189,0.000098426455,0.00007846829,0.00015698232,0.0015368257,0.045786314],"study_design_scores_gemma":[0.00031322258,0.000294468,0.010353432,0.88087106,0.08731951,0.00049705885,0.0002603101,0.00014461354,0.00011274356,0.00034815934,0.01943424,0.00005123366],"about_ca_topic_score_codex":0.009879674,"about_ca_topic_score_gemma":0.028593905,"teacher_disagreement_score":0.009879674,"about_ca_system_score_codex":0.0025756706,"about_ca_system_score_gemma":0.006062376,"threshold_uncertainty_score":0.01964432},"labels":[],"label_agreement":null},{"id":"W4404439795","doi":"10.1007/s40120-024-00681-y","title":"Treatment Preferences of Physicians Treating Adult Patients with Attention-Deficit/Hyperactivity Disorder in the United States and Canada: A Discrete Choice Experiment","year":2024,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"Otsuka Pharmaceutical Development and Commercialization","keywords":"Attention deficit hyperactivity disorder; Neurology; Medicine; Psychiatry; Attention deficit; Attention deficit disorder","score_opus":0.015402258024053928,"score_gpt":0.27759532142542614,"score_spread":0.2621930634013722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404439795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967229,0.000049046677,0.00030688106,0.00024775928,0.000009641583,0.0005984912,0.00025096996,0.0000059056765,0.0018084628],"genre_scores_gemma":[0.9945682,0.00010164402,0.0020047124,0.0004037346,0.0000107520755,0.00081127574,0.0002827196,0.000002219032,0.001814734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976349,0.0012431552,0.00010580139,0.00020818842,0.00047477934,0.00033312387],"domain_scores_gemma":[0.9908398,0.005956427,0.0010049941,0.00035457604,0.000757528,0.0010868527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00468531,0.0004964723,0.00054382044,0.0002513303,0.0013369992,0.0010996091,0.0006119979,0.0009052882,0.0035944392],"category_scores_gemma":[0.010072774,0.0003092578,0.0005991029,0.0004129038,0.0012085392,0.00037320988,0.00037531246,0.0009779466,0.00022825366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16888824,0.117526226,0.4945143,0.0009981854,0.0017881804,0.00065594725,0.00961737,0.049996458,0.02027747,0.005913894,0.0103733195,0.11945041],"study_design_scores_gemma":[0.061349712,0.074774705,0.6324892,0.0003107122,0.0013877838,0.0002448414,0.0066080485,0.19306646,0.009936913,0.00447652,0.014722497,0.0006326245],"about_ca_topic_score_codex":0.55398273,"about_ca_topic_score_gemma":0.5828074,"teacher_disagreement_score":0.44601727,"about_ca_system_score_codex":0.009251661,"about_ca_system_score_gemma":0.014174318,"threshold_uncertainty_score":0.8972879},"labels":[],"label_agreement":null},{"id":"W4405390476","doi":"10.1007/s40120-024-00680-z","title":"Long-Term Safety and Effectiveness of Dimethyl Fumarate in Patients with Multiple Sclerosis Treated in Routine Medical Practice: Final Analysis of the ESTEEM Study","year":2024,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cambridge Memorial Hospital","funders":"Biogen","keywords":"Medicine; Discontinuation; Dimethyl fumarate; Adverse effect; Confidence interval; Internal medicine; Incidence (geometry); Multiple sclerosis; Rate ratio; Pediatrics; Surgery; Psychiatry","score_opus":0.033209622796934575,"score_gpt":0.3257044477275513,"score_spread":0.29249482493061674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405390476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949393,0.0021301452,0.00014134587,0.00012561303,0.000011278132,0.00020255531,0.0016982722,0.000009781712,0.0007417182],"genre_scores_gemma":[0.9960699,0.00050409447,0.00029935446,0.00014419714,0.00004755562,0.00016680155,0.002489678,0.00000394176,0.00027456478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971969,0.0015409839,0.000314091,0.00025591344,0.00056991,0.00012223644],"domain_scores_gemma":[0.990132,0.0026317963,0.0048831063,0.00052574166,0.0011091303,0.0007182238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0093293665,0.00042467687,0.0011591209,0.0006074023,0.00028278286,0.00081252767,0.00045381382,0.00058974925,0.0012198404],"category_scores_gemma":[0.009137256,0.00017555982,0.0024019685,0.00074285467,0.00031182164,0.0006534275,0.0006793212,0.0007049432,0.00023152013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09682812,0.0016890363,0.8507329,0.00096401887,0.008746296,0.00022610264,0.0004393269,0.0008012316,0.0012718923,0.00012498928,0.0014489384,0.03672704],"study_design_scores_gemma":[0.01091181,0.027900154,0.95292217,0.00017317718,0.0037050825,0.00036182345,0.0001867573,0.00094810984,0.0005206428,0.00011100168,0.0022146255,0.000044739627],"about_ca_topic_score_codex":0.0005250658,"about_ca_topic_score_gemma":0.0010341499,"teacher_disagreement_score":0.0093293665,"about_ca_system_score_codex":0.00043759338,"about_ca_system_score_gemma":0.00048668156,"threshold_uncertainty_score":0.049338996},"labels":[],"label_agreement":null},{"id":"W4405583612","doi":"10.1007/s40120-024-00689-4","title":"Infarct Growth in Patients with Emergent Large Vessel Occlusion Stroke Transferred for Endovascular Thrombectomy","year":2024,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Environmentally Friendly Materials and Occupational Health Research Institute, Anhui University of Science and Technology","keywords":"Medicine; Stroke (engine); Neurology; Cardiology; Internal medicine; Occlusion; Ischemic stroke; Ischemia","score_opus":0.007432533015911012,"score_gpt":0.23648056251260086,"score_spread":0.22904802949668984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405583612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994548,0.00007750058,0.000035305005,0.000032467044,0.0000030793324,0.000005338154,0.00016612183,0.0000018873156,0.00022335145],"genre_scores_gemma":[0.99940765,0.00007015553,0.000044111002,0.000014136838,0.000014030009,0.000006134848,0.00038880407,8.4313666e-7,0.00005404799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974436,0.00004670894,0.000044039887,0.000044162196,0.00006705874,0.00005361093],"domain_scores_gemma":[0.99809164,0.00031186687,0.0011772326,0.000059709695,0.000122000536,0.00023765887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047607685,0.00022078416,0.00029928147,0.00072054483,0.00031115854,0.00062314473,0.0002475853,0.00031112827,0.001241776],"category_scores_gemma":[0.0025937129,0.00013485292,0.00030056163,0.0009474241,0.00029401097,0.0005033267,0.00042905202,0.0006275187,0.00019302167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008545064,0.000014277512,0.9990557,0.0000043532245,0.000009734318,0.00011526166,0.000029325685,0.000033115233,0.000041185893,0.000008440886,0.00003899153,0.0005642543],"study_design_scores_gemma":[0.000006569527,0.00008968024,0.99879396,0.0000072715125,0.000011233944,0.00055684184,0.00014119329,0.00023678418,0.0000432341,0.000041848456,0.000068214526,0.000003111119],"about_ca_topic_score_codex":0.0020536673,"about_ca_topic_score_gemma":0.002544484,"teacher_disagreement_score":0.0020536673,"about_ca_system_score_codex":0.0003968076,"about_ca_system_score_gemma":0.00039046258,"threshold_uncertainty_score":0.0041541457},"labels":[],"label_agreement":null},{"id":"W4405590901","doi":"10.1007/s40120-024-00695-6","title":"Incidence and Prevalence of Alzheimer’s Disease in Medicare Beneficiaries","year":2024,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Eisai Incorporated","keywords":"Medicine; Incidence (geometry); Dementia; Epidemiology; Disease; Population; Medicare Part B; Neurology; Alzheimer's disease; Gerontology; Geriatrics; Population ageing; Diagnosis code; Demography; Pediatrics; Psychiatry; Internal medicine; Environmental health","score_opus":0.020603388954310808,"score_gpt":0.3271034797007168,"score_spread":0.306500090746406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405590901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844647,0.0012795154,0.00024019268,0.00024207516,0.000012457757,0.000026169482,0.012158991,0.000026504134,0.0015495063],"genre_scores_gemma":[0.99231815,0.0005160846,0.00033696476,0.00008025336,0.000028955092,0.000046188983,0.0064246273,0.0000025528532,0.0002463315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994073,0.000104244995,0.00012921022,0.00012053322,0.00017757327,0.00006111654],"domain_scores_gemma":[0.9973585,0.00026313853,0.0017519624,0.00008866265,0.00035594852,0.00018184503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008848429,0.00015739484,0.00018068579,0.0024941023,0.00024506063,0.0004614904,0.00033927738,0.000249451,0.0011460083],"category_scores_gemma":[0.0033987695,0.00014275327,0.00029760756,0.0017468253,0.00016036407,0.00045366568,0.00043513853,0.00023778532,0.00021151497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001311373,0.0000052730006,0.9985336,0.000015327296,0.000026324251,0.000011112616,0.00003357957,0.000030049565,0.000030011875,0.000015655467,0.0002862919,0.0009997836],"study_design_scores_gemma":[9.585245e-7,0.000008882526,0.9995171,0.000009497769,0.000007790286,0.00007646887,0.00004040247,0.00007336714,0.00002003408,0.000009751993,0.00023475358,9.8627e-7],"about_ca_topic_score_codex":0.018792646,"about_ca_topic_score_gemma":0.01359104,"teacher_disagreement_score":0.018792646,"about_ca_system_score_codex":0.00055817264,"about_ca_system_score_gemma":0.0004261912,"threshold_uncertainty_score":0.03736657},"labels":[],"label_agreement":null},{"id":"W4406311084","doi":"10.1007/s40120-024-00708-4","title":"Measurement Properties of the Friedreich Ataxia Rating Scale in Patients with Spinocerebellar Ataxia","year":2025,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Spinocerebellar ataxia; Ataxia; Rating scale; Cohort; Medicine; Activities of daily living; Physical therapy; Prom; Convergent validity; Physical medicine and rehabilitation; Psychometrics; Psychology; Internal consistency; Internal medicine; Clinical psychology; Psychiatry; Developmental psychology","score_opus":0.030983778484564895,"score_gpt":0.21973197139967385,"score_spread":0.18874819291510894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406311084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953557,0.0005621839,0.00095039554,0.00013949354,0.000034489687,0.00015567447,0.0008323739,0.000028349401,0.0019413389],"genre_scores_gemma":[0.9977361,0.00008402572,0.0009715498,0.000044493816,0.000013200084,0.00012795224,0.00087163365,0.0000040714935,0.00014683751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964483,0.0015240647,0.00052873563,0.00039947825,0.0009970312,0.00010240404],"domain_scores_gemma":[0.9895243,0.004743374,0.003389353,0.00056377565,0.001443082,0.00033613382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075136344,0.00037507567,0.0005997839,0.0008287055,0.000293972,0.0006153596,0.0004602026,0.00055726146,0.0009738601],"category_scores_gemma":[0.019942395,0.00016925333,0.0008333141,0.0006432701,0.0003176402,0.00059313636,0.00061209674,0.00069804676,0.00046576842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036969697,0.00010236501,0.98835576,0.000035390978,0.00022585246,0.000032823395,0.00015564579,0.00029104596,0.00031849512,0.000034204117,0.00031981213,0.009758948],"study_design_scores_gemma":[0.000043011358,0.00041697244,0.99796826,0.00001651536,0.000037592246,0.00017685484,0.000080833175,0.00079355156,0.00012110162,0.00005252892,0.00028509885,0.000007808583],"about_ca_topic_score_codex":0.0008644348,"about_ca_topic_score_gemma":0.0011395046,"teacher_disagreement_score":0.0075136344,"about_ca_system_score_codex":0.00031579708,"about_ca_system_score_gemma":0.00026837306,"threshold_uncertainty_score":0.03973633},"labels":[],"label_agreement":null},{"id":"W4407775486","doi":"10.1007/s40120-024-00697-4","title":"Effectiveness During 12-Month Adjunctive Brivaracetam Treatment in Patients with Focal-Onset Seizures in a Real-Life Setting: A Prospective, Observational Study in Europe","year":2025,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"UCB","keywords":"Observational study; Medicine; Neurology; Adjunctive treatment; Epilepsy; Pediatrics; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.025779321202230622,"score_gpt":0.31243263349886585,"score_spread":0.2866533122966352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407775486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984648,0.0010832351,0.00004008077,0.000022035796,0.0000037760044,0.000032020704,0.00020105204,0.0000013943944,0.000151461],"genre_scores_gemma":[0.9988953,0.00049384404,0.000089074754,0.00009121363,0.000015453856,0.000042922995,0.0003299897,0.0000014187699,0.000040685714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972319,0.0013251988,0.0004962056,0.0004634598,0.00031040443,0.00017285063],"domain_scores_gemma":[0.9947463,0.0010072127,0.0034254931,0.00021030538,0.0002692572,0.0003413678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002808419,0.0003690937,0.0010095378,0.00055942853,0.00033444498,0.00089408644,0.0003941572,0.00060682563,0.0012752941],"category_scores_gemma":[0.0055394867,0.00026288666,0.0012143372,0.0011625299,0.0004988508,0.0006869563,0.00047665968,0.0004651308,0.00020221755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006137904,0.0009024062,0.9836896,0.00035494624,0.0012292225,0.00019855234,0.00026803228,0.00007853156,0.0003366803,0.000027931494,0.00022167634,0.006554441],"study_design_scores_gemma":[0.0013344511,0.0044281776,0.99190277,0.00012448698,0.0005512244,0.0006138869,0.00031950345,0.00014970683,0.00011686332,0.000022217437,0.00041842103,0.000018220155],"about_ca_topic_score_codex":0.0016906793,"about_ca_topic_score_gemma":0.0017627146,"teacher_disagreement_score":0.002808419,"about_ca_system_score_codex":0.00057109544,"about_ca_system_score_gemma":0.0006401919,"threshold_uncertainty_score":0.014852524},"labels":[],"label_agreement":null},{"id":"W4409119298","doi":"10.1007/s40120-025-00724-y","title":"Are Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative Review","year":2025,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Brain and Cognition Discovery Foundation","funders":"","keywords":"Liraglutide; Exenatide; Medicine; Semaglutide; Neuroprotection; Glucagon-like peptide 1 receptor; Pharmacology; Internal medicine; Endocrinology; Diabetes mellitus; Receptor; Type 2 diabetes; Agonist","score_opus":0.02608192491742797,"score_gpt":0.30595950502951197,"score_spread":0.279877580112084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409119298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000133788,0.9989833,0.000031362328,0.00036682552,0.00012695711,0.000015511445,0.00006288334,0.000002584997,0.00027679623],"genre_scores_gemma":[0.0010157238,0.9981787,0.00008090244,0.00041320946,0.0001446817,0.000024315075,0.000059895137,0.0000013842075,0.000081290375],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99880505,0.00026587464,0.00045655653,0.00015993646,0.0002448168,0.000067809895],"domain_scores_gemma":[0.9926104,0.00515148,0.0013330212,0.000072771625,0.0006899937,0.00014241949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002161101,0.0010265401,0.0033586847,0.008380762,0.0004394532,0.0025179281,0.0015810723,0.0020419464,0.0055767037],"category_scores_gemma":[0.007848552,0.00049669476,0.002042751,0.009795807,0.00069699244,0.0034962841,0.001153815,0.0009935645,0.0008835049],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020209652,0.000027227145,0.00044792195,0.7564187,0.0008088372,0.00032091254,0.00032370415,0.00010841365,0.0004273107,0.0015639061,0.015628424,0.22372255],"study_design_scores_gemma":[0.00007982457,0.00018797518,0.0022515445,0.6622621,0.006080704,0.0020141078,0.0005823297,0.00007260994,0.00028656915,0.0012629539,0.32487488,0.00004441139],"about_ca_topic_score_codex":0.0019863483,"about_ca_topic_score_gemma":0.0038554403,"teacher_disagreement_score":0.008380762,"about_ca_system_score_codex":0.0012729858,"about_ca_system_score_gemma":0.0046015517,"threshold_uncertainty_score":0.018655896},"labels":[],"label_agreement":null},{"id":"W4410074912","doi":"10.1007/s40120-025-00756-4","title":"Characterizing the Journey of Early Alzheimer’s Disease in Patients Initiating Lecanemab Treatment in the United States: A Real-World Evidence Study","year":2025,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Biogen","keywords":"Medicine; Neurology; Disease; Alzheimer's disease; Neuroscience; Gerontology; Internal medicine; Psychiatry; Psychology","score_opus":0.07351256682237726,"score_gpt":0.38185914796161596,"score_spread":0.3083465811392387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410074912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8823056,0.10286357,0.000478081,0.0026504996,0.00008841046,0.0002499971,0.008395349,0.000009399354,0.002959021],"genre_scores_gemma":[0.9731223,0.021546792,0.0007483652,0.0006480929,0.00011643504,0.00015038127,0.003583539,0.000002828156,0.000081291655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937542,0.0028948602,0.0017097269,0.0006095795,0.00080786314,0.00022388932],"domain_scores_gemma":[0.9547917,0.016057063,0.024291048,0.0009213206,0.002916206,0.0010226683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008049787,0.0002748105,0.0007852393,0.002491252,0.00046150028,0.0019353227,0.000688157,0.0007039768,0.001810697],"category_scores_gemma":[0.026185675,0.00031283643,0.0016422708,0.0053682993,0.0005004866,0.0014371043,0.0008098925,0.00075783115,0.00016779524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089196046,0.00018025289,0.97720057,0.0023202533,0.0021189614,0.000070298694,0.00020085892,0.000116889336,0.000037545844,0.00014247812,0.0007236796,0.01599637],"study_design_scores_gemma":[0.0003425754,0.0009402689,0.9846556,0.004464695,0.003096111,0.00042137774,0.0013166618,0.0004011672,0.00007579987,0.0002509021,0.0040034796,0.00003141906],"about_ca_topic_score_codex":0.005399558,"about_ca_topic_score_gemma":0.01159022,"teacher_disagreement_score":0.008049787,"about_ca_system_score_codex":0.0011151269,"about_ca_system_score_gemma":0.0021041038,"threshold_uncertainty_score":0.042571843},"labels":[],"label_agreement":null},{"id":"W4410081720","doi":"10.1007/s40120-025-00746-6","title":"Feasibility of Identifying Acute Nontraumatic Intracerebral Hemorrhage Events Using Diagnostic Coding Among Veterans with Mild Cognitive Impairment or Alzheimer’s Dementia","year":2025,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Eisai Incorporated; National Institute on Aging; National Institutes of Health; Eisai; U.S. Department of Veterans Affairs","keywords":"Medicine; Neurology; Dementia; Intracerebral hemorrhage; Cognitive impairment; Coding (social sciences); Behavioral neurology; Neurochemistry; Cognition; Disease; Psychiatry; Internal medicine; Subarachnoid hemorrhage","score_opus":0.06858072446765487,"score_gpt":0.36053657987703325,"score_spread":0.2919558554093784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410081720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969048,0.0001844673,0.00114245,0.00015928486,0.000022046463,0.00017769898,0.0002784324,0.000014196375,0.0011166015],"genre_scores_gemma":[0.99804074,0.000056263005,0.0014613728,0.00003920209,0.000014602137,0.00005875134,0.00027972835,0.0000016429425,0.000047692174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916059,0.0047281897,0.0010478813,0.00066154567,0.0014960674,0.00046043593],"domain_scores_gemma":[0.9673505,0.016923463,0.009149897,0.0019731473,0.0039020504,0.0007009782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010870314,0.00030235792,0.00023738798,0.0016429566,0.00041097918,0.0010402001,0.00076083845,0.0004798636,0.00083610864],"category_scores_gemma":[0.055247027,0.00027143786,0.00039319927,0.000755307,0.000556412,0.0007246234,0.0010775719,0.00039196105,0.0002868448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011615804,0.000049931274,0.9911714,0.000029371171,0.000018899163,0.000038297476,0.00031026712,0.000089430076,0.00021874094,0.00003562283,0.00019433897,0.007727506],"study_design_scores_gemma":[0.000038950744,0.00040693884,0.990604,0.00014235218,0.00004564765,0.00065476133,0.0010733656,0.004969297,0.0011227961,0.00017673979,0.00074754626,0.000017797985],"about_ca_topic_score_codex":0.0039702216,"about_ca_topic_score_gemma":0.005215992,"teacher_disagreement_score":0.010870314,"about_ca_system_score_codex":0.0005255708,"about_ca_system_score_gemma":0.0011361175,"threshold_uncertainty_score":0.05748838},"labels":[],"label_agreement":null},{"id":"W4410279528","doi":"10.1007/s40120-025-00757-3","title":"The Modified Functional Status Questionnaire for Assessing Patients with Parkinson’s Disease Psychosis Treated with Pimavanserin: A Post Hoc Analysis","year":2025,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"ACADIA Pharmaceuticals","keywords":"Psychosis; Medicine; Parkinson's disease; Neurology; Disease; Post hoc; Post-hoc analysis; Psychiatry; Physical medicine and rehabilitation; Internal medicine","score_opus":0.010497228238013136,"score_gpt":0.2592852638900164,"score_spread":0.24878803565200325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410279528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605846,0.000101136764,0.00075608864,0.000048082973,0.000059302398,0.0004761988,0.001660379,0.000022358827,0.0008180637],"genre_scores_gemma":[0.9939214,0.00004739235,0.00091369404,0.000038155267,0.000049145216,0.0010592164,0.0031866077,0.000019919147,0.00076441944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977646,0.0008509344,0.00021695919,0.0003431911,0.00055122725,0.0002731676],"domain_scores_gemma":[0.99565166,0.0025151826,0.0006178501,0.00026763717,0.00066558656,0.00028199833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033197005,0.0007248448,0.0016425943,0.0012550977,0.00028019736,0.0006005782,0.0006662418,0.00038673254,0.0032292274],"category_scores_gemma":[0.005420708,0.00021584732,0.0021637452,0.0009971097,0.00035836763,0.00076714327,0.0006985355,0.0011467497,0.0004003261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04828809,0.0037792427,0.894636,0.00038778537,0.004375744,0.00059511396,0.0006859852,0.0021211742,0.0054357033,0.00022135988,0.0035333813,0.03594046],"study_design_scores_gemma":[0.0012079496,0.012255571,0.97846085,0.000015306678,0.00053399854,0.00016437187,0.00030790933,0.004893006,0.0009054846,0.00004966889,0.0011770902,0.000028735129],"about_ca_topic_score_codex":0.0018127692,"about_ca_topic_score_gemma":0.0020993783,"teacher_disagreement_score":0.0033197005,"about_ca_system_score_codex":0.0006424993,"about_ca_system_score_gemma":0.00087456894,"threshold_uncertainty_score":0.017556429},"labels":[],"label_agreement":null},{"id":"W4411321314","doi":"10.1007/s40120-025-00771-5","title":"Development and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson’s Disease","year":2025,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Broadcom (Canada)","funders":"Allergan","keywords":"Parkinson's disease; Medicine; Neurology; Disease; Neuroscience; Internal medicine; Psychology; Psychiatry","score_opus":0.018395808193910224,"score_gpt":0.3132663788559958,"score_spread":0.29487057066208555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411321314","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94821084,0.0026583604,0.027721172,0.0004292901,0.00020581091,0.0031029123,0.007189404,0.00033547843,0.0101467725],"genre_scores_gemma":[0.96242106,0.00048182806,0.02918039,0.0001121595,0.00006309724,0.0026238118,0.00424686,0.000038486203,0.0008323472],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99308395,0.0033058454,0.00079874374,0.0005325535,0.002117066,0.00016188296],"domain_scores_gemma":[0.9847327,0.005141953,0.0039808135,0.0010809572,0.0044573606,0.00060620037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013352516,0.0006670608,0.00062691374,0.001623504,0.00037623383,0.00083081657,0.00080528634,0.00045336786,0.0013503027],"category_scores_gemma":[0.02170686,0.0001981657,0.0013772767,0.0010015101,0.00036515584,0.0006831084,0.0011849774,0.001011367,0.00043452653],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002118569,0.0005925196,0.79293346,0.0004467617,0.00090301817,0.000064348074,0.0007350305,0.004682116,0.0019867697,0.0005972842,0.004354164,0.19058602],"study_design_scores_gemma":[0.0001746298,0.0016149392,0.9870877,0.00011673159,0.00013841005,0.00022423637,0.00016848059,0.0058195363,0.00074346486,0.00042123545,0.0034629256,0.00002768544],"about_ca_topic_score_codex":0.001939388,"about_ca_topic_score_gemma":0.0030527478,"teacher_disagreement_score":0.013352516,"about_ca_system_score_codex":0.00073296804,"about_ca_system_score_gemma":0.00109269,"threshold_uncertainty_score":0.07061571},"labels":[],"label_agreement":null},{"id":"W4411653218","doi":"10.1007/s40120-025-00758-2","title":"Correction: Are Glucagon-Like Peptide‑1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative Review","year":2025,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Brain and Cognition Discovery Foundation","funders":"","keywords":"Penetrant (biochemical); Central nervous system; Neuroscience; Glucagon-like peptide-1; Neurology; Medicine; Chemistry; Endocrinology; Biology; Diabetes mellitus","score_opus":0.020649379626404476,"score_gpt":0.2959119807250109,"score_spread":0.27526260109860645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411653218","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017407317,0.1574327,0.000609628,0.094947785,0.7413953,0.000058761154,0.0012656094,0.0001609671,0.0039552217],"genre_scores_gemma":[0.008829692,0.41832727,0.0024798661,0.16155882,0.35247093,0.00025773043,0.001895028,0.00043245693,0.05374829],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99709487,0.00076607586,0.00068109494,0.00029906494,0.0008879841,0.0002708906],"domain_scores_gemma":[0.9874643,0.0040263995,0.0017058889,0.00046708446,0.005650421,0.0006858325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00464552,0.001096424,0.0019480287,0.002529572,0.0008343764,0.0028796336,0.0019236414,0.003968951,0.040480394],"category_scores_gemma":[0.041198224,0.00044335728,0.0016039807,0.0019981642,0.0015518012,0.0030932103,0.002200447,0.0048531806,0.01639731],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008913968,0.0000050949934,0.00005540887,0.0058586397,0.000057599736,0.00026848682,0.000059292965,0.000034784676,0.000107454805,0.001127326,0.9542531,0.038083617],"study_design_scores_gemma":[0.000087004075,0.00002275085,0.00027217637,0.0064323344,0.00012878311,0.0009329601,0.000067076944,0.00002729524,0.00013269878,0.0008750372,0.9909985,0.000023396697],"about_ca_topic_score_codex":0.003696019,"about_ca_topic_score_gemma":0.0059998436,"teacher_disagreement_score":0.040480394,"about_ca_system_score_codex":0.0016232452,"about_ca_system_score_gemma":0.0056953477,"threshold_uncertainty_score":0.13542044},"labels":[],"label_agreement":null},{"id":"W4411991434","doi":"10.1007/s40120-025-00790-2","title":"Societal Costs and Efficiency of Subcutaneous versus Intravenous Lecanemab in Early Alzheimer’s Disease: A U.S. Cost Comparison Model","year":2025,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Eisai","keywords":"Medicine; Neurology; Disease; Alzheimer's disease; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.03553979778329394,"score_gpt":0.34027079465225585,"score_spread":0.3047309968689619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411991434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9168463,0.008369598,0.025151176,0.0037126674,0.00028585573,0.002319718,0.013844004,0.00016556654,0.02930518],"genre_scores_gemma":[0.9856662,0.001608093,0.0067818593,0.0004951844,0.000030431658,0.0009694925,0.0018719073,0.0000173579,0.0025593592],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99677557,0.0026012696,0.00009110491,0.00019171451,0.00013909406,0.00020115916],"domain_scores_gemma":[0.9904897,0.007958417,0.00057963957,0.00017312227,0.00057728007,0.00022178539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063546402,0.001918286,0.0016288892,0.0022375814,0.00050269475,0.002504603,0.0017236787,0.0018225627,0.0074929646],"category_scores_gemma":[0.013518705,0.0008975707,0.00393594,0.0023149247,0.0006629694,0.0016435878,0.0011286642,0.0018206916,0.0003661116],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036345606,0.0004647672,0.0053043924,0.00048472916,0.0010842279,0.00016942954,0.000050219776,0.96621877,0.00013131915,0.0065380833,0.0026536926,0.013265883],"study_design_scores_gemma":[0.0023458346,0.0023655053,0.006706673,0.0004943144,0.0021957569,0.00020532696,0.00027893853,0.972713,0.0002733864,0.008921068,0.0034059426,0.00009424179],"about_ca_topic_score_codex":0.036443893,"about_ca_topic_score_gemma":0.018996283,"teacher_disagreement_score":0.036443893,"about_ca_system_score_codex":0.00831874,"about_ca_system_score_gemma":0.0039089746,"threshold_uncertainty_score":0.07246351},"labels":[],"label_agreement":null},{"id":"W4412042106","doi":"10.1007/s40120-025-00782-2","title":"Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study","year":2025,"lang":"en","type":"editorial","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Merck","keywords":"Cladribine; Multiple sclerosis; Medicine; Neurology; Biomarker; Internal medicine; Oncology; Pharmacology; Immunology; Psychiatry","score_opus":0.04952971653575495,"score_gpt":0.3127057375482895,"score_spread":0.26317602101253457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412042106","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006066159,0.025223045,0.00023080052,0.038860776,0.93286735,0.000094839124,0.00038401352,0.0001431572,0.0015893427],"genre_scores_gemma":[0.002644605,0.017671375,0.00025467455,0.028983325,0.94432116,0.00011595457,0.00025398767,0.00005067009,0.005704157],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9970783,0.0009307294,0.00068781135,0.0004174461,0.0007538082,0.00013183201],"domain_scores_gemma":[0.9824706,0.010199895,0.00088667386,0.00034865167,0.004641145,0.0014531066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010299708,0.0030203864,0.0032723744,0.0021646607,0.0011155009,0.0048791785,0.002428063,0.008060924,0.0052152947],"category_scores_gemma":[0.021152552,0.00095436024,0.0019628578,0.0012370028,0.0009798935,0.0021756254,0.00064462185,0.0071106954,0.004256426],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007315976,0.00006626951,0.0004252427,0.0018830671,0.00019223252,0.0002105603,0.000044572193,0.00004248353,0.00019117563,0.00021620147,0.9727798,0.02321689],"study_design_scores_gemma":[0.002163952,0.000981414,0.008647276,0.004167236,0.001791636,0.0010608691,0.00028615544,0.0008794687,0.00087896053,0.0013385515,0.97770214,0.00010239468],"about_ca_topic_score_codex":0.001281463,"about_ca_topic_score_gemma":0.001859417,"teacher_disagreement_score":0.010299708,"about_ca_system_score_codex":0.0014756564,"about_ca_system_score_gemma":0.0016600381,"threshold_uncertainty_score":0.054470718},"labels":[],"label_agreement":null},{"id":"W4412370560","doi":"10.1007/s40120-025-00784-0","title":"Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis","year":2025,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"EMD Serono; Idorsia Pharmaceuticals; Schweizerische Multiple Sklerose Gesellschaft; Ministry of Health, Labour and Welfare; Fondazione Cariplo; Multiple Sclerosis Society; Shionogi; Argenx; Atara Biotherapeutics; Genentech; Amicus Therapeutics; Novartis; Celgene; Ministry of Education, Culture, Sports, Science and Technology; BioCryst; Sanofi; GW Pharmaceuticals; TG Therapeutics; Samsung; Bristol-Myers Squibb; CSL Behring; Pfizer; Biogen; F. Hoffmann-La Roche; Greenwich Biosciences; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Sanofi Genzyme; Patient-Centered Outcomes Research Institute","keywords":"Medicine; Ofatumumab; Multiple sclerosis; Neurology; Natalizumab; Internal medicine; Dermatology; Immunology; Psychiatry; Rituximab; Lymphoma","score_opus":0.022000231176926028,"score_gpt":0.2685536937391004,"score_spread":0.24655346256217434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412370560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960632,0.0017637606,0.00016442391,0.00012294693,0.000015941036,0.000053287447,0.0010809063,0.000008657705,0.0007268921],"genre_scores_gemma":[0.9979184,0.00027828495,0.000107732674,0.00004590198,0.000026832387,0.000045596265,0.0013170273,0.000001883103,0.00025828203],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9984151,0.0005577795,0.00021153221,0.00025465916,0.0003794816,0.00018155534],"domain_scores_gemma":[0.99399817,0.0010722562,0.0034797457,0.00028447885,0.0005976215,0.00056788226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049873525,0.00033619395,0.000708605,0.0007085098,0.00039447896,0.0007012953,0.0003396957,0.0005056209,0.0015760297],"category_scores_gemma":[0.0053066346,0.00013465439,0.0016332926,0.0007679818,0.00026773542,0.0007176292,0.00058258645,0.0007575225,0.0002854948],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031178562,0.00046232567,0.9312564,0.00041914708,0.0017538,0.00014219664,0.00033294846,0.00069419685,0.0006362965,0.000061790764,0.0006733066,0.03238898],"study_design_scores_gemma":[0.0006459994,0.0058562146,0.9908661,0.000068247246,0.00070178474,0.00021959454,0.000082727754,0.00031808412,0.0003175086,0.000109531364,0.00079330837,0.000020988808],"about_ca_topic_score_codex":0.0010876828,"about_ca_topic_score_gemma":0.0013931672,"teacher_disagreement_score":0.0049873525,"about_ca_system_score_codex":0.0005167267,"about_ca_system_score_gemma":0.00048620373,"threshold_uncertainty_score":0.026376009},"labels":[],"label_agreement":null},{"id":"W4413110291","doi":"10.1007/s40120-025-00810-1","title":"Advances in Ischemic Stroke Treatment: Current and Future Therapies","year":2025,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Journal of Administrative Sciences","funders":"","keywords":"Medicine; Neurorehabilitation; Stroke (engine); Neurology; Collateral circulation; Thrombolysis; Neuroplasticity; Blood pressure; Intensive care medicine; Cardiology; Cerebral blood flow; Internal medicine; Physical medicine and rehabilitation; Rehabilitation; Physical therapy; Myocardial infarction","score_opus":0.0190720796592383,"score_gpt":0.32794195928013925,"score_spread":0.30886987962090096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413110291","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005351791,0.9989372,0.000058798672,0.0003633215,0.00011917734,0.0000040647915,0.000014053702,0.000004458518,0.00044552458],"genre_scores_gemma":[0.00037440544,0.9989838,0.00014964161,0.00019635815,0.00013811344,0.000005602355,0.000017313803,0.000001012854,0.00013374176],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953985,0.00010862583,0.000101291545,0.000063524305,0.00014873852,0.000038033337],"domain_scores_gemma":[0.99912816,0.0005476,0.000101832105,0.000021072523,0.00016257679,0.000038779224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010505179,0.00088430586,0.0018158488,0.002258121,0.00032932626,0.0014692645,0.0007967352,0.001128539,0.006483857],"category_scores_gemma":[0.001747493,0.00027092514,0.00105926,0.0019278233,0.00047681644,0.0015979594,0.00080818334,0.0019364092,0.0017624988],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088575616,0.00007712179,0.00009398256,0.04712791,0.00015152177,0.00009106843,0.000075028256,0.00021851329,0.00047575365,0.003001402,0.020848617,0.9277504],"study_design_scores_gemma":[0.000043415734,0.00016717605,0.0009893586,0.04247901,0.0005868997,0.0007465685,0.00016234581,0.00014155394,0.00023958035,0.0050149425,0.9494,0.000029145165],"about_ca_topic_score_codex":0.0013429207,"about_ca_topic_score_gemma":0.002351448,"teacher_disagreement_score":0.006483857,"about_ca_system_score_codex":0.00069863437,"about_ca_system_score_gemma":0.0017884414,"threshold_uncertainty_score":0.021690667},"labels":[],"label_agreement":null},{"id":"W4413137480","doi":"10.1007/s40120-025-00802-1","title":"Profiles of Medicaid Beneficiaries with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray","year":2025,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Biotech","keywords":"Medicine; Medicaid; Depression (economics); Emergency department; Emergency medicine; Anxiety; Neurosurgery; Psychiatry; Health care","score_opus":0.020134218856363455,"score_gpt":0.2856034381202897,"score_spread":0.26546921926392625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413137480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968268,0.0002631104,0.000039319537,0.00019674755,0.000005329076,0.000018769515,0.0018368672,0.0000042151073,0.00080878014],"genre_scores_gemma":[0.9979962,0.00029058647,0.00008026507,0.00012902053,0.000013376757,0.00002248713,0.0012652843,0.0000016364643,0.00020115671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971026,0.0000380763,0.000050939572,0.00004693239,0.000092838614,0.000060960465],"domain_scores_gemma":[0.99873656,0.00011308092,0.0008439131,0.000022056933,0.00007639371,0.00020802554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034759624,0.00011202741,0.00020900046,0.0007704745,0.00040535966,0.00041009195,0.00019829591,0.00026103397,0.0025238178],"category_scores_gemma":[0.0012970275,0.00012734212,0.00036378752,0.0009055872,0.00014737624,0.00046145738,0.00039148887,0.00042005716,0.00020215566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003956681,0.00002858004,0.9982021,0.000008088176,0.000016676617,0.000045521236,0.00004003592,0.000020690906,0.000089760964,0.000014687827,0.00023884929,0.0012555436],"study_design_scores_gemma":[0.0000039460474,0.000034179408,0.9993344,0.000017251843,0.00000792939,0.0001711541,0.00014086608,0.00008395886,0.000022881522,0.000010278102,0.00017115197,0.0000019248218],"about_ca_topic_score_codex":0.008527886,"about_ca_topic_score_gemma":0.015839383,"teacher_disagreement_score":0.008527886,"about_ca_system_score_codex":0.00037305002,"about_ca_system_score_gemma":0.000441029,"threshold_uncertainty_score":0.016956449},"labels":[],"label_agreement":null},{"id":"W4413767126","doi":"10.1007/s40120-025-00815-w","title":"Global Societal Burden of Alzheimer’s Disease by Severity: a Targeted Literature Review","year":2025,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Neurology; Disease; Alzheimer's disease; Burden of disease; Intensive care medicine; Psychiatry; Internal medicine","score_opus":0.022737650105928126,"score_gpt":0.37075194544064594,"score_spread":0.34801429533471784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413767126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076772104,0.99807715,0.00007242139,0.00031730832,0.00007158912,0.000060987888,0.00030307152,0.0000043626815,0.00032523324],"genre_scores_gemma":[0.003784137,0.9955675,0.00018592285,0.00017821157,0.000045159308,0.00005630698,0.0001258527,0.0000018405459,0.000055107903],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968899,0.00084609573,0.0010899222,0.000286265,0.00072808884,0.00015978394],"domain_scores_gemma":[0.9920894,0.0051101753,0.0014758852,0.00008820929,0.0011228285,0.00011355478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036041236,0.0016013226,0.004430708,0.020357765,0.00049514783,0.0027412209,0.0010829174,0.0013840576,0.0041999356],"category_scores_gemma":[0.0121935345,0.0008383944,0.005680507,0.017870065,0.00047733716,0.002023159,0.0015487884,0.00081516284,0.00044256134],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014588828,0.000027816193,0.0016031627,0.82650995,0.00584982,0.00028708976,0.0004050543,0.000358913,0.000284227,0.0009790806,0.0066618603,0.15688722],"study_design_scores_gemma":[0.000074204465,0.00019167292,0.010657899,0.88174224,0.03303226,0.0014705628,0.00076361705,0.00019174257,0.0002035782,0.0010120813,0.070601285,0.00005885342],"about_ca_topic_score_codex":0.008052959,"about_ca_topic_score_gemma":0.017426008,"teacher_disagreement_score":0.020357765,"about_ca_system_score_codex":0.0036759444,"about_ca_system_score_gemma":0.007316899,"threshold_uncertainty_score":0.026670933},"labels":[],"label_agreement":null},{"id":"W4414031817","doi":"10.1007/s40120-025-00824-9","title":"Investigation of Sensory and Neuropsychological Parameters in Migraine Sufferers: A Cross-Sectional Study with Negative Findings","year":2025,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cross-sectional study; Neurology; Medicine; Neuropsychology; Migraine; Clinical psychology; Psychiatry; Audiology; Physical medicine and rehabilitation; Cognition; Pathology","score_opus":0.04890833893272112,"score_gpt":0.33165853693149305,"score_spread":0.28275019799877193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414031817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996061,0.000108015054,0.000041648236,0.000008103593,0.0000024757144,0.000009931515,0.000046754263,6.980024e-7,0.00017621466],"genre_scores_gemma":[0.9996939,0.000054888304,0.000054812976,0.00002226512,0.0000065516847,0.000012929122,0.00008939771,6.618892e-7,0.000064688655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994043,0.00020965806,0.000061025035,0.00013482894,0.00012042383,0.00006981544],"domain_scores_gemma":[0.9989813,0.00027414807,0.00032551357,0.00009399041,0.00014346378,0.00018158555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010449647,0.00028838695,0.00035849644,0.00063642225,0.0005443331,0.00043519394,0.00023725699,0.000515701,0.0015370738],"category_scores_gemma":[0.0017404924,0.00026087026,0.0002751112,0.0005057047,0.0003418377,0.0003790623,0.00037655875,0.00033084338,0.00029891246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057442783,0.00007765126,0.9985618,0.000009725277,0.000028760109,0.00014559612,0.00020180196,0.0000048751403,0.00034080722,0.000005621424,0.00002420948,0.0005418696],"study_design_scores_gemma":[0.0000051258285,0.00036018598,0.9985322,0.0000040765035,0.000020235919,0.0006577069,0.00027820608,0.000022093847,0.00003502607,0.0000073843466,0.00007613286,0.0000016732806],"about_ca_topic_score_codex":0.0013087335,"about_ca_topic_score_gemma":0.0012878353,"teacher_disagreement_score":0.0015370738,"about_ca_system_score_codex":0.0001213132,"about_ca_system_score_gemma":0.00018094544,"threshold_uncertainty_score":0.005526364},"labels":[],"label_agreement":null},{"id":"W4414371995","doi":"10.1007/s40120-025-00822-x","title":"Testing the Clinical Dementia Rating Sum of Boxes as an Outcome for Dementia with Lewy Bodies Clinical Trials","year":2025,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute on Aging","keywords":"Dementia with Lewy bodies; Clinical trial; Dementia; Outcome (game theory); Neurology; Clinical neurology; Clinical Dementia Rating; Drug trial","score_opus":0.264615632011641,"score_gpt":0.5241470820583223,"score_spread":0.25953145004668127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414371995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9062064,0.02067832,0.010789021,0.0020749946,0.0012186201,0.026750876,0.012842354,0.00033031264,0.019109022],"genre_scores_gemma":[0.95255953,0.001315906,0.008697474,0.0007972404,0.00040079583,0.029890174,0.005253681,0.000037723687,0.0010474372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9011537,0.07940903,0.009079156,0.0028629287,0.0064877453,0.001007334],"domain_scores_gemma":[0.85859305,0.08018761,0.03951227,0.0036999006,0.01344414,0.004562998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.094518915,0.0013115904,0.0027634664,0.0022967467,0.00085234974,0.0024537258,0.0018388674,0.0019913616,0.0035460687],"category_scores_gemma":[0.0919596,0.00034583118,0.0026633686,0.0023700024,0.0011460476,0.002637332,0.0015115221,0.0012322253,0.001092891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19560833,0.0039504245,0.6917229,0.0049056835,0.010610767,0.00023999401,0.00059380225,0.0036105018,0.0017087233,0.0015151115,0.008711684,0.07682204],"study_design_scores_gemma":[0.04249929,0.115499526,0.80900675,0.0012814022,0.0045510875,0.0006230345,0.00042995694,0.0094768405,0.0021578458,0.0022655595,0.012023303,0.00018544678],"about_ca_topic_score_codex":0.00050881546,"about_ca_topic_score_gemma":0.0007053844,"teacher_disagreement_score":0.094518915,"about_ca_system_score_codex":0.001087303,"about_ca_system_score_gemma":0.0019951398,"threshold_uncertainty_score":0.49986976},"labels":[],"label_agreement":null},{"id":"W4414760533","doi":"10.1007/s40120-025-00836-5","title":"Safety and Effectiveness of Direct Oral Anticoagulants in Combination with Antiseizure Medications: Protocol for a Systematic Review and Meta-analysis","year":2025,"lang":"en","type":"review","venue":"Neurology and Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Protocol (science); Neurology; MEDLINE; Stroke (engine); Dabigatran","score_opus":0.10959240661430604,"score_gpt":0.4410277105149581,"score_spread":0.33143530390065207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414760533","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007256208,0.005955375,0.002522647,0.0005306951,0.00048598705,0.9835512,0.0054565803,0.00016749141,0.0006043038],"genre_scores_gemma":[0.000729596,0.0014452925,0.0027586983,0.00021731241,0.000026844393,0.9940194,0.00055061554,0.000010033925,0.0002421573],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9795752,0.008609818,0.006158161,0.002132214,0.002471453,0.0010531404],"domain_scores_gemma":[0.9786607,0.008061847,0.0053256974,0.001989142,0.0051696463,0.00079297135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.044671185,0.006583298,0.023547383,0.008991129,0.0024811754,0.00672765,0.005308571,0.0060992907,0.05622989],"category_scores_gemma":[0.06604416,0.0042177523,0.03291561,0.0091947755,0.0029789433,0.005656686,0.0041449266,0.005611021,0.0051470846],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0101783965,0.0002471597,0.000860187,0.92498595,0.01966734,0.0004429219,0.00075772917,0.0018952163,0.0010346732,0.0038888075,0.017551405,0.018490108],"study_design_scores_gemma":[0.09330861,0.004128293,0.008751807,0.51455015,0.16107298,0.0007896444,0.0013046665,0.005386294,0.003220832,0.023553623,0.18302552,0.0009076296],"about_ca_topic_score_codex":0.006229517,"about_ca_topic_score_gemma":0.011062636,"teacher_disagreement_score":0.05622989,"about_ca_system_score_codex":0.011920103,"about_ca_system_score_gemma":0.02870319,"threshold_uncertainty_score":0.23624665},"labels":[],"label_agreement":null},{"id":"W4414896846","doi":"10.1007/s40120-025-00838-3","title":"The Use of Long-Acting Injectables for People with Schizophrenia: Consensus Panel Recommendations for Overcoming Barriers and Implementing Treatment","year":2025,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Allergan; HLS Therapeutics; Idorsia Pharmaceuticals; H. Lundbeck A/S; Mitsubishi Tanabe Pharma Corporation; Mylan; Astellas Pharma; Eisai; University of Oxford; National Health and Medical Research Council; University of Cambridge; Canadian Institutes of Health Research; Sunovion; Servier; Seqirus; Fondation Brain Canada; Bristol-Myers Squibb; Indivior; Teva Pharmaceutical Industries","keywords":"MEDLINE; Alternative medicine; Panel discussion; Expert opinion; Health professionals","score_opus":0.06910784830085255,"score_gpt":0.3360386661725365,"score_spread":0.266930817871684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414896846","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015209989,0.036788516,0.068539985,0.7511314,0.022388801,0.06335297,0.0034427033,0.0007455635,0.03840011],"genre_scores_gemma":[0.11824733,0.06774195,0.6008439,0.089780495,0.0043769884,0.09070949,0.0074676694,0.00035017225,0.020482004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.79259706,0.13674806,0.037566576,0.004885729,0.0213082,0.00689433],"domain_scores_gemma":[0.7071208,0.08636341,0.023057899,0.006525132,0.15498652,0.02194632],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.27109194,0.0024481239,0.0025860881,0.007150754,0.0050898194,0.00587142,0.009431797,0.0119625805,0.0069535775],"category_scores_gemma":[0.2252745,0.0024475849,0.008234419,0.004496922,0.003248536,0.008389366,0.010821353,0.012090232,0.0041717733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054455,0.0009219663,0.006950141,0.05045143,0.0007098874,0.0016102664,0.030986955,0.0023806116,0.0060746656,0.009338515,0.4332609,0.45677006],"study_design_scores_gemma":[0.00094982644,0.00090198265,0.015785022,0.14494503,0.0012164342,0.0009948083,0.03458085,0.0032706007,0.0026927497,0.03044711,0.76348156,0.0007340309],"about_ca_topic_score_codex":0.012887286,"about_ca_topic_score_gemma":0.015220086,"teacher_disagreement_score":0.27109194,"about_ca_system_score_codex":0.010909045,"about_ca_system_score_gemma":0.08834778,"threshold_uncertainty_score":0.8988734},"labels":[],"label_agreement":null}]}